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RECONSTITUTION AND MECHANISTIC STUDIES ON THE
STAPHYLOCOCCAL agr QUORUM SENSING CIRCUIT

Boyuan Wang, Ph.D.
The Rockefeller University 2016

Quorum sensing (QS) plays a central role in virulence induction in the commensal
pathogen, Staphylococcus aureus. This bacterium secretes an auto-inducer peptide (AIP),
a small, cyclic peptide containing a thiolactone linkage as an indicator of its population
density, and up-regulates virulence gene expression in response to high extracellular AIP
levels. We have investigated two key biochemical events in S. aureus QS and revealed
several underlying regulatory mechanisms. The first such event, formation of the highenergy thiolactone in AIP, is unusual in that it occurs directly through proteolysis of the
precursor peptide, AgrD, without free-energy input from ATP hydrolysis. We showed
that this proteolysis is, in line with the thermodynamic prediction, unfavorable and
strongly reversible in vitro. As a consequence, rapid degradation of the concomitantly
released C-terminal fragment of AgrD is required to power efficient AIP production in
vivo. This observation provides a novel connection between protein homeostasis and QS
in S. aureus. The second study focused on the AIP-sensing receptor histidine kinase
(HK), AgrC, whose auto-phosphorylation exhibits several remarkable properties in our
reconstitution system based on nanometer-scale lipid-bilayer discs (nanodiscs).
Activation of this receptor by its native activator, for instance, requires a membrane
environment enriched of anionic lipids mimicking the electrostatic property of the S.

	
  

	
  

aureus cell membrane. This strong dependence on lipid composition might explain why
homologous QS systems exist only in low-GC Gram-positive bacteria, or Firmicutes,
whose cell membranes are predominantly highly anionic. AgrC also binds to ATP at an
exceptionally weak affinity, likely due to its distinct adenine-binding pocket conserved
only in a small subfamily of HK receptors existing also exclusively in Firmicutes. The
low affinity to the nucleotide cofactor likely enables AgrC to sense the energy condition
of the bacterium and shut down the QS regardless of the population density when energy
starvation drives down the cellular ATP level. Even more intriguing is the plasticity of
AgrC auto-kinase activity when bound to different ligands. This behavior contrasts with
the generally accepted two-state model of HKs. To understand the plasticity of AgrC, we
systematically perturbed the conformation of the AgrC kinase domain using a fusion
protein strategy. We demonstrated that the conformational state of a helical linker
preceding the kinase domain exercises rheostat-like control over the kinase activity.
Using full-length AgrC embedded in nanodiscs, we showed that binding of activator and
inhibitor peptides results in twisting of the linker in different directions. These findings
provide the first view on molecular motions triggered by ligand binding on a membranebound receptor HK. The smooth input-response landscape of the AgrC kinase domain
also sheds new light on the mechanism of HK evolution through domain shuffling.
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Chapter One: Introduction
1.1 Quorum Sensing in Staphylococcus aureus
1.1.1 Introduction to Quorum Sensing
The concept of quorum sensing (QS) emerged out of the effort to understand the
observation that an individual Vibrio Fischeri cell, when present within a quorum of cells
from the same species, produces more light than in isolation (Figure 1.1a) (1). A series of
elegant genetic and biochemical studies led to the conclusion that this bacterium produces
a diffusive molecule, termed the autoinducer (AI), as an indicator of its local population
density (Figure 1.1a, small triangles) (2-4). Expression of light-production genes requires
high extracellular concentration of AI, and therefore occurs only within large populations
(Figure 1.1a, right panel) (5). This “autoinduction” behavior, along with the discovery of
similar regulatory principles in a spectrum of prokaryotic species, initiated a major
paradigm shift in microbiology (6, 7). With the ever-increasing evidence of intercellular
communication within and across species, prokayortes are no longer treated as the sum of
isolated, unicellular organism but instead a community with constant information
exchange (8). The signaling events that enable an individual bacterial cell to
communicate with its surrounding quorum via chemical messengers are therefore referred
to as QS. Importantly, autoinduction and QS are not used interchangeably in this
dissertation. While the outcome of QS in pure cultures is almost always autoinduction,
QS can have very a different impact on participant strains/species in mixed cultures or
natural habitats (vide infra).
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At high population densities, i.e., when a microorganism seizes dominance of a habitat, it
may undertake a variety of collective actions to bolster its population fitness. For
instance, some bacteria develop extracellular structures such as biofilms and/or capsules
for adhesion and protective purposes to increase their survival under stressed conditions,

Figure 1.1 Common features of bacterial quorum sensing
(a) Population-dependent collective behaviors exemplified by the light production in V.
fischeri. Diagram shows the situation at low or high cell densities. Cells and AI
molecules are depicted by ovals and small triangles, respectively. Light production
correlates to the AI level and occurs only at high population density. (b) Chemical
diversity of bacterial AIs. See text for details. Note that DPD cyclizes into S-2-methyl2,3,3,4-tetrahydroxytetrahydrofuran (S-THMF), which condenses with boric acid in
marine bacteria to yield the bicyclic S-THMF-borate. (c) QS in Vibrio harveyi integrates
signals from self, kin and distantly related species. See text for details. IM, inner
membrane; OM, outer membrane. (d) Autoinduction of S. aureus experiences an eclipse
phase in a murine infection model. An autoinduction-dependent luciferase reporter was
implemented in the bacteria. Panels show the intensity of bioluminescence at the
indicated time points in a pseudocolor scale. Note that the population size was roughly
constant between the 3.5-h and 72-h time points. The panel is adapted from citation (29).
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while others breakdown existing biofilm to let individual cells progress to the planktonic
stage of their life cycles (9). A spectrum of “common goods” are also under control by
autoinduction, including cytolytic toxins and hydrolases for further exploitation of
nutrients from the environment, secondary metabolites for defensive or metabolic
purposes, or factors that benefit the bacterium’s mutualistic host (10-12). Besides these
uniform behaviors, some bacteria also exhibit, at least partly in response to autoinduction,
stochastic decision making to increase the phenotypic diversity and hence the robustness
of the isogenic population. The most notable example exists in the community of Bacillus
subtilis, in which high-density-related phenotypes including competence, motility and
cannibalism are all controlled by stochasticity (13). Notably, however, for most collective
behaviors listed above, premature actions at insufficient population would be
energetically wasteful or counterproductive. As a result, the ability to sense the
population density and make timing decisions for collective behaviors confers substantial
evolutionary advantage to microorganisms, and is central to the phenotypic diversity of
the prokaryotic world. Furthermore, QS-related behavior is also considered the driving
force of speciation and the emergence of multicellularity (14-16).

Because of the enormous diversity of prokaryotes, it is essential for individual species to
distinguish AIs produced by its diverse neighbors and respond (or not respond) in such a
way that benefits its own fitness. To achieve this specificity, bacteria from different
taxonomic lineages have implemented AIs of an equivalent level of diversity, as well as
receptor proteins to sense them in a highly specific manner. Most AIs known to date fall
in one of a handful of categories, each featuring a characteristic “core” structure
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generated by a distinct set of biosynthetic genes. Best characterized AI categories include
linear, prenylated and (thio)lactone peptides in Firmicutes (17-20), acyl-homoserine
lactones (AHLs) , furanone derivatives and alkylquinolones in Proteobacteria (2, 21, 22),
and butyrolactones in Actinobacteria (Figure 1.1b) (23). While the core structure
provides rough distinction of AIs at the phylum level, a much greater source of diversity
is conferred by the starting-material variation in the biosynthesis. The structure of the
ribosomally-synthesized, post-translational modified AI peptides in Firmicutes is dictated
by their precursor sequence and the proteolytic processing sites, while that of AHLs
largely depends on the fatty-acyl group preference of their respective LuxI synthase.
Importantly, in both cases, the cognate receptors that sense these AIs are so specific that
minimal alteration of the AI structure at certain positions may alter its potency or efficacy
(24, 25). It is the strict specificity of the receptors that allows the bacteria to avoid the
interference of ever-existing environmental noises.

Despite the diversity of AI structures, inter-species crosstalk mediated by these chemical
messengers is prevalent. Vibrio harveyi, a free-living marine bacterium, produces three
distinct AIs and integrates their signals through a convergent phospho-relay signal
transduction system (Figure 1.1c) (26). Intriguingly, while the HSL-type HAI-I is highly
specific for detection by V. harveyi, the hydroxyketone signal CAI-I and the furanonetype AI-2 are also produced in the closely-related Vibrio kins and an even broader
spectrum of bacteria, respectively. Converging three signal-transduction systems
detecting these AIs onto a central regulator enables this bacterium to weigh differentially
the signals produced by self, kin and distantly related species for its decision-making
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process. By contrast to the cooperative crosstalk in the genus Vibrio, quorum quenching
(QQ), defined as the antagonism of QS by foreign chemicals, is also frequently described
as the means of interspecies competition (6, 27). The antagonizing reagent varies from
analogs of the native AI to biosynthetically/structurally unrelated compounds. Overall, it
is generally accepted that interspecies communication plays a central role in shaping the
ecological niche and the evolutionary trajectory of microbial organisms (28).

Finally, it is noteworthy that the outcome of QS-related signaling is not solely dependent
upon the population density or the extracellular AI concentration. Since QS induction
often leads to a profound change in gene-expression pattern and hence an often more
energetically expensive lifestyle, it is not surprising that checkpoints for cellular fitness
are implemented upstream to the QS-mediated gene-expression regulation. In line with
this notion, down-regulation of QS-induced behaviors after entrance of the stationary
phase has been observed in a few staphylococcal and streptococcal species when cultured
in liquid medium (29). In a murine Staphylococcus aureus infection model, activity of a
QS-regulated reporter gene experienced biphasic induction and was eclipsed between the
two induction phases due to the action of the host macrophages (Figure 1.1d) (30).
Possible mechanisms of such checkpoints have been proposed, however, no consensus
has been reached for any taxonomic phylum.

1.1.2 Discovery of the agr locus
Staphylococcus aureus is one of the low-GC gram-positive species in which
autoinduction behaviors were earliest described. This commensal pathogen has been
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known, since 1970s, to abruptly increase its extracellular protein secretion while decrease
its surface protein production in the late-exponential phase when cultured in liquid
medium (31). The chromosomal locus responsible for the global regulation of these
proteins was first identified in 1982 using a transposon-insertion strategy (See Figure 1.2)
(32). The mutant strain was found to possess an unaffected gene encoding alphacytotoxin but to be incapable of secreting this toxin. Further investigation of this mutant
revealed defect in up-regulation of a few other toxins and down-regulation of surface
protein-A, and the locus of transposon insertion was therefore named agr (for accessory
gene regulator) (33). The open reading frame (ORF) disrupted by the insertion encodes a
DNA-binding protein, AgrA, whose expression was once thought to be driven by a weak
promoter, P1, located immediately upstream to the ORF (Figure 1.2) (34). In 1988, this
ORF was also found in a larger, QS-inducible polycistronic mRNA, in which three
additional ORFs upstream to AgrA were identified to encode AgrB, AgrD and AgrC
proteins (Figure 1.2) (35). Meanwhile, the locus that encodes the delta-hemolysin (hld),
an agr-regulated effector toxin, was mapped in close proximity to agr, and surprisingly,
the mRNA transcript of the 26-amino acid (aa) toxin measures ~500-nucleotide (nt) in

Figure 1.2 The genetic arrangement of the S. aureus agr locus.
The DNA double strand of S. aureus chromosome is shown in two parallel lines, with the
location of promoters indicated with arrows. ORFs in RNAII and RNAIII are colored
boxes (not drawn to scale). Red bars on the DNA segment between P2 and P3 promoters
indicate the AgrA-binding DNA elements.
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length (Figure 1.2) (36). Intriguingly, the pleiotropic phenotype observed from the hld
transcript deletion was similar to that of agr deletion, suggesting that this RNA plays a
role in the global regulation of accessory-gene production (37). Following numerical
order, the QS-inducible promoters governing transcription of the polycistronic agr
operon and the hld transcript were named P2 and P3 and the their transcripts termed
RNAII and RNAIII, respectively. These two operons are transcribed in back-to-back
directions and promoter elements are located merely 41-nt apart from each other. Both
operons and the intergenic regulatory elements are collectively referred to as the agr
locus, due to their essentiality to the autoinduction behavior in S. aureus.

Given the functions of Agr proteins predicted by bioinformatic analysis and the
precedence of AIs in Gram-negative bacteria, the regulatory function of agr was expected
to occur through the production and sensing of a diffusive chemical messenger (38). In
1995, six years after characterization of the P2 operon, the first description of this AI was
achieved upon biochemical fractionation and HPLC-MS analysis (39). This, 8-aa small
peptide was named the AIP (autoinducer peptide). Edman analysis of this AIP revealed a
sequence embedded in the AgrD ORF, while MS of the native peptide as well as
treatment with iodoacetic acid and hydroxylamine suggested that the AIP contains a
thiolactone macrocycle formed by the condensation between the carboxyl group at the Cterminus and the thiol group on the side chain of a internal cysteine residue (see Figure
1.1b) (20). In 1998 the Muir Group unambiguously confirmed this distinctive cyclic
structure through chemical synthesis, thus completing the preliminary characterization of
all agr gene products (25).
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1.1.3 Basic architecture of the signaling circuit
It is particularly remarkable that the genetic interaction among the four Agr proteins and
the RNAIII had been correctly unraveled, through a combination of elegant genetic
experiments and bioinformatics analyses, even prior to the characterization of the AIP
(Figure 1.3) (38). In this early model, AgrB and AgrD produce or activate the production
of the AI, while the AI activates the two-component, phospho-relay signal transduction
system involving AgrC and AgrA. The active form of AgrA up-regulates the
transcription of both P2 and P3 operons, thus closing a positive feedback circuit (through
the activation of P2) and increasing the production of RNAIII. Function of AgrD and
AgrB were specified later on as the AIP precursor and the AgrD-processing peptidase,
respectively, however the basic architecture of the signaling circuit is retained.

Figure 1.3 Architecture of the agr autoinduction loop and effector regulation.
Left half: a diagram of the agr autoinduction loop. Colored arrows indicate enhancement
of activity or abundance through transcription, translation, enzymatic reactions and/or
biophysical interactions. Right half: regulation of agr effector protein production. See
text for details.

	
  

8	
  

For over a decade since its discovery, RNAIII had been considered as the only direct
effector of agr autoinduction. Ironically, its mechanism of action had been enigmatic for
an even longer period until Huntzinger et al. showed that it inhibits the translation of
surface protein A (Spa) through interacting with, and mediating the degradation of, the
spa mRNA (Figure 1.3) (40). Translation of several other agr-regulated proteins was
subsequently found activated or inhibited by RNAIII employing similar mechanisms (41,
42). Among them is the repressor of toxins (Rot), a transcription repressor targeting
genes of a series of secreted toxins and proteases (Figure 1.3) (43). Hence, there are at
least three known mechanisms by which RNAIII exercises control over agr effector
protein production: (i) acting as the coding mRNA (ii) blocking translation and/or
promoting degradation of the effector mRNA and (iii) indirectly influencing effector
transcription by down-regulation of rot.

Within the past decade, nucleic-acid array analysis extended our scope of agrautoinduction effectors beyond those under RNAIII regulation (44, 45). Employing a
DNA-array strategy, Shu et al. identified, in addition to P2 and P3, three operons
containing AgrA-binding elements in their promoter regions (Figure 1.3) (45). Two of
these three encode phenol-soluble modulins (PSMs) whose leukocidal activities are
essential for the bacterium’s immune evasion. In contrast to the DNA-array approach for
AgrA binding, hundreds of S. aureus genes were found influenced by agr autoinduction
in a comparative transcriptomic study (44). While this study provides no information on
the mechanism by which individual genes are affected, it assisted the identification of a
few genes carrying agr-related functions. As a notable example, PmtABCD, the only
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ABC transporter up-regulated upon induction of the agr system, was later shown to
involve the exportation of PSMs (46).

1.1.4 Interspecies variation of agr
One of the most intriguing features of the agr locus is its polymorphism within single
species. Within five years of the first agr locus being cloned, four allelic variants of this
locus were reported (20, 47). The variable region spans half the length of the P2 operon,
covering the main body of AgrB, the entire AgrD and the N-terminal half of AgrC ORFs.
This setting allows each agr variant to specifically produce, and mediate autoinduction in
response to, its own AIP (Figure 1.4a). In S. aureus strains carrying different agr
variants, the vast majority of conserved, structural genes (excluding mobile genetic
elements) are predominantly identical, suggesting that the variation occurs at a subspecies level. Strains harboring each agr allele are therefore classified as a pherotype or a
specificity subgroup.

While S. aureus from all four groups are capable of qualitatively similar autoinduction
when cultured alone, the effect of AIPs on the induction of a heterologous agr system is,
in most cases, strongly inhibitory (Figure 1.4a) (48). The only exception lies between the
two most closely related groups, I and IV—AIPs from these groups share 7 identical
residues out of 8 positions. Despite this level of similarity, AIP-I activates the induction
of group-IV strain three orders of magnitude less potently than AIP-IV. By contrast, the
thiolactone-forming cysteine is the only identical residue shared between AIP-I and AIPII. Clinical isolates of S. aureus from one infection site rarely exhibit variegation in the
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agr locus, primarily because an agr-heterologous cell population cannot achieve
cooperative autoinduction to support the fitness of all participant subgroups (49).

A long-standing puzzle of agr polymorphism concerns the evolutionary advantage
offered by individual agr alleles. Indeed, a correlation has been observed between agr
variants and infection types (49). For instance, group-III strains are overrepresented in
menstrual toxic shock syndromes, while the exfoliatin-producing strains causing scalded

Figure 1.4 Allelic variation of agr among four S. aureus subgroups
(a) Structure and efficacy of AIPs from all four subgroups. (b) Effect of agr variants on
the autoinduction timing when introduced to an isogenic, agr-null background. The
background strain carrying the indicated agr allele and a P3-driven β-lactamase reporter
was assayed for the β-lactamase activity in the medium supernatant at indicated time
points. Plot shows a time courses of the β-lactamase activity (closed symbols) and a
growth curve (open, gray symbols) for each agr allele tested. The figure was adapted
from citation (48).
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skin syndrome are predominantly group-IV. In a seminal study performed by Geisinger et
al., all four agr alleles were introduced, one at a time, into an agr-null background strain
through chromosomal insertion at an identical attachment site (50). Side-by-side
comparison of these alleles on an isogenic background revealed major differences in the
temporal control of autoinduction: induction was achieved earliest with group-I and
group-IV and latest with group-III alleles. This observation argues for a model in which
agr variants act as alarm clocks for the onset of autoinduction, and their correlation to
infection types originated from the infection site’s selection for the most favorable
induction timing. The mechanism underlying the differential autoinduction timing and
dynamics mediated by different agr variants, however, requires further investigation.

1.2 Biochemistry of the agr autoinduction
As was alluded to in section 1.1.3, central to agr autoinduction is a positive feedback
circuit consisting of two mutually enhancing pathways, namely the production and
sensing of AIP. AIP production begins from the translation of RNAII into four Agr
proteins. AgrD, the precursor of AIP, is first proteolytically processed by AgrB, a
membrane-integrated peptidase to generate a thiolactone intermediate. This intermediate
is then exported across the membrane and is subject to a second proteolysis step to
release the mature AIP pheromones into the extracellular space. This AIP-production
pathway enhances the sensing pathway by contributing the activation signal. AIP sensing
is achieved through its detection by the membrane-bound receptor histidine kinase
(RHK), AgrC. This interaction activates a phospho-relay cascade that leads to the
phosphorylation of the cognate response regulator (RR), AgrA. Upon phosphorylation,
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AgrA binds to the P2 promoter and up-regulates the transcription of RNAII, which
encodes all four Agr proteins. This enhances the synthesis of AgrB and AgrD proteins
and confers positive feedback to the AIP synthesis pathway.

This dissertation will primarily focus on the biochemical and biophysical characterization
of protein components involved in the above feedback loop. Thus, an in-depth, stepwise
review from biochemical perspectives will be provided in this section, covering works
published before and during my matriculation at the Rockefeller University, with the
exception of my own work, which will be presented in Chapters 2 through 5.

1.2.1 Translation of Agr proteins
Although the coding sequence of all four Agr proteins are co-transcribed in the
polycistronic RNAII, this transcript is exquisitely designed to finely coordinate their
translation. Discernible ribosomal binding sequences (RBS) are found immediately
upstream to each ORF (Figure 1.5a) (38). The RBS preceding the coding sequence of
AgrD and AgrA closely matches the consensus sequence, suggesting highly efficient
translation initiation (51). Furthermore, the AgrB and AgrD ORFs are concatenated in
such a way that the RBS of AgrD locates upstream to the AgrB stop codon. This design
harnesses the translation activity within the AgrB ORF to prevent secondary structure
formation that might otherwise occlude the translation initiation at the AgrD RBS, further
increasing the production efficiency of AgrD (52). By contrast, the ORFs of AgrB and
AgrC are expected to be less active due to (i) the less favorable RBS and (ii) the suboptimal initiating codons, i.e., UUG for AgrB and GUG for AgrC. These features are
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expected to result in the enzymatic substrates, AgrD and AgrA, being produced in excess
to their respective enzymes, AgrB and AgrC. Moreover, two out of four proteins encoded
by RNAII are integral membrane proteins. Since membrane insertion occurs cotranslationally, the polysome complex of RNAII, which also translates AgrD, must
localize in the proximity of the cell membrane (Figure 1.5b) (53). Because the 46-aa

Figure 1.5 Architecture of RNAII and the possible implication on the translation of
Agr proteins.
(a) The coding-strand DNA sequence of the polycistronic RNAII: four RBSs are
indicated with red boxes. ORFs are indicated with arrows following the color code in
Figure 1.2, accompanied with the translated sequence. Due to the space limit, only the
coding region of the first and last five amino acids is shown for each ORF. (b) Diagram
showing the putative membrane localization of the RNAII polysome as a consequence of
membrane-protein translocation.
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AgrD is highly hydrophobic and likely unstructured unless associated with the lipid
bilayer (vide infra, section 1.2.2), it might be an important protective measure to
synthesize AgrD in proximity to the cell membrane to prevent its aggregation or
degradation.

1.2.2 Formation of the AIP thiolactone
One of the most fascinating features of the agr system is the thiolactone structure of the
AIP. In reality, however, this thiolactone motif is generated by a single proteolysis
reaction involving AgrB and AgrD (54, 55). The substrate of this proteolysis, AgrD,
contains the mature AIP sequence sandwiched by an N-terminal leader peptide and a Cterminal recognition sequence (Figure 1.6a). The AgrB-catalyzed proteolysis clips off the
recognition sequence as a linear peptide and concomitantly installs the thiolactone to the
N-fragment, herein referred to as the thiolactone intermediate. The N-terminal 20
residues of the leader form an amphipathic helix and anchors AgrD to the cell membrane
putatively by lateral association (56). This positioning is required for AgrD processing, as
the substitution of its N-terminal region with an artificial amphipathic helical sequence,
but not a hydrophobic trans-membrane domain, is tolerated. In all staphylococcal AgrDs,
the amphipathic sequence is followed by an “IG” motif that might act as a helicity
breaker to facilitate the proteolytic release of mature AIP from the thiolactone
intermediate (57). The recognition sequence, on the other hand, is enriched in acidic
residues and highly conserved in staphylococcal AgrDs. The hydrophilicity of this region
has been thought to prevent full-length AgrD from premature exportation (Jeffery G.
Johnson, unpublished work). The significance of the sequence conservation is not yet
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fully understood despite some evidence showing a couple of positions are essential for
competent AIP production (Figure 1.6a) (55, 58).

Figure 1.6 Formation of the AIP thiolactone
(a and b) Sequence alignment of the four (a) AgrD and (b) AgrB variants from S. aureus:
acidic and basic residues are highlighted in red and blue, respectively. Residues playing
explicit roles in AgrD processing are highlighted with red boxes. In (a), the orange
cylinder and red stars indicate the amphipathic α-helical sequence and the positions on
which alanine mutagenesis abolishes AIP production. In (b), the topology of AgrB
predicted in silico by TMHMM 2.0 (TMHMM) or determined employing PhoA-fusion
(PhoA) or SCAM (SCAM) strategy is displayed above the alignment. I, O, H and R
denote an aligned position to reside intracellularly, extracellularly, within a TM helix or
within a re-entry loop, respectively. (c) The proposed mechanism of the thiolactone
formation exemplified by the cleavage of group-I AgrD.
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AgrB, the peptidase catalyzing the proteolysis of AgrD, is a multi-pass membrane
protein. The topology of AgrB has been experimentally determined twice, each time
yielding a model different from the computationally predicted one (Figure 1.6b) (58, 59).
Interestingly, while the experimental studies might be expected to be more credible, the
topology they determined does not conform to the generally accepted features of αhelical membrane proteins. The six-transmembrane (TM) model generated from a
phosphatase-fusion strategy, for instance, contained two 12-aa TM domains that are
obviously too short to span a typical bacterial cell membrane when adopting the α-helical
conformation (60). The substituted cysteine accessibility method (SCAM), on the other
hand, gave rise to a four-TM model in which most basic residues flanking the TM
domains localizes to the extracellular side. This configuration contradicts the “positiveinside” rule, which states that membrane-proximal basic residues prefer intracellular
localization due to the direction of the physiological electrochemical potential across the
cell membrane (61). Due to these controversies, cartoon presentation of AgrB in this
dissertation will avoid elaborating on its topology. Ultimately, this controversy may not
be addressed without a high-resolution structure of this protein.

The AgrB-catalyzed proteolysis of AgrD has been studied extensively employing both
genetic and biochemical approaches. Two residues invariable in all known AgrB
homologs, one cysteine and the other histidine, have been identified as the catalytic diad
(Figure 1.6b) (54). Interestingly, all three topology models agreed with each other
regarding to the intracellular localization of this catalytic diad, which ensures its
accessibility to the AgrD substrate. An elegant peptidyl-transfer mechanism has been
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proposed for this reaction (55), in which AgrB attacks the scissile bond by its active-site
cysteine to form an acyl-enzyme thioester intermediate with the concomintant release of
the linear AgrD C-fragment (Figure 1.6c). The intermediate is then resolved by
transferring the peptidyl group of the AgrD N-fragment to the side-chain thiol group of
its internal cysteine residue (C28). This releases the N-fragment as a thiolactone and
recycles the free enzyme. While this mechanism is attractive, direct characterization of
the thiolactone motif in the AgrD N-fragment has never been achieved. Despite this
ambiguity, two lines of evidence strongly support that AgrB is sufficient for the
production of the thiolactone intermediate (55). Firstly, co-expression of AgrB with the
AgrD C28A mutant, rather than the wild-type AgrD, resulted in the detection of the acylenzyme intermediate on non-reducing SDS-PAGE, suggesting that this cysteine is indeed
the acceptor of peptidyl transfer. Secondly, AIP-related activity was found in the growth
medium of Escherichia coli co-expressing AgrB and AgrD. This observation also argues
for the role of AgrB in the cyclization in that the thiolactone macrocycle is required for
the autoinduction activity of AIP, while an AgrD cyclase is not likely to exist in the
distantly related in E. coli.

Besides the catalytic diad, other regions and positions required for this activity have been
revealed in both AgrB and AgrD employing mutagenesis strategies (58). Important
findings include: (i) the cleavage site on AgrD is defined by residues on the -3, -1 and +2
positions, which are likely involved in enzyme-substrate recognition (Figure 1.6a); (ii)
truncating the leader peptide from the N-terminus or the recognition sequence from the
C-terminus impedes proteolysis and (iii) the conserved, soluble N-terminus of AgrB (aa

	
  

18	
  

1-42) is required for the proteolytic activity. With respect to group specificity,
heterologous AgrB-AgrD pairs involving AgrB-II or AgrD-II are inactive (62). This is
not surprising because at the -3 position relative to the cleavage site, AgrD-II has a serine
while the rest three have a phenylalanine. Determinants of group specificity in AgrB-II
have been determined through sequence shuffling (62). Collectively, these efforts shed
light on the AgrB-AgrD recognition despite the absence of a high-resolution structural
model.

1.2.3 Translocation and maturation of AIP
After being processed by AgrB, the thiolactone intermediate awaits another proteolysis
event to release the freely diffusive AIP pheromone from the membrane-anchoring Nterminal leader peptide. Moreover, an active or facilitated translocation event is also
required for the successful secretion of AIP due to its presumed lack of membrane
permeability. Intriguingly, the agr locus does not encode designated proteins to account
for these steps. While the AIP-sensing function of AgrC and AgrA could be confidently
predicted from sequence analysis, AgrB, a peptidase from a less studied protein family,
had been surmised to also export and/or cleave the thiolactone intermediate (59). While
the second cleavage activity turned out to be absent as was shown in biochemical studies
(54), the possibility of its involvement in AgrD translocation has not been formally ruled
out.

In principle, the translocation could occur either before or after the second proteolysis,
albeit the former scenario is favored by a few lines of evidence. In 2007, Kavanaugh and
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coworkers showed that the general signal peptidase, SpsB, cleaves a heptapeptide
mimicking the leader peptide-AIP junction of AgrD-I at the expected releasing site (57).
Because the catalytic domain of SpsB localizes in the extracelluar space, the authors
argued in favor of the translocation-first model. It should be noted that this study
provided no solid evidence on the cleavage of the native thiolactone intermediate by
SpsB, nor did it test the activity of SpsB on the releasing-site sequence from other S.
aureus subgroups. More recently, large quantities of the AgrD leader peptide have been
detected in the S. aureus extracellular matrix (63, 64). This result also corroborates the
translocation-first model, as the alternative, proteolysis-first model entails separate
translocation of both leader and AIP fragments, which would be substantially less
economical. The transporter responsible for AIP production, regardless of the substrate
being exported, is yet to be identified.

The second proteolysis of AgrD is fascinating in that it affords the tail-length variation
among AIPs. Because the C-terminal carboxylate of AIP participates the thiolactone
macrocycle, residues N-terminal to the conserved, thiolactone-forming cysteine are
collected referred to as the exocyclic tail. The tail length is 2 residues for AIP-III, 3 for
AIP-I and IV, and 4 for AIP-II (See Figure 1.4). The sequence contexts of the scissile
bonds are so diverged among groups-I, -II and –III that a single protease is not likely to
cleave all three with appropriate efficiency and specificity. In line with this notion, SpsB
failed to cleave group-II thiolactone intermediate under all conditions tested (Jeffery G.
Johnson, unpublished data).
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Although the exact identity of the transporter and AIP-releasing protease are unknown,
educated predictions can be made on the properties of these proteins. Due to the
autoinductory nature and the non-essential role of the agr system, they are expected to be
either housekeeping proteins (e.g., SpsB) highly efficient in their respective agr-related
function or agr-inducible proteins that carry out specific functions.

1.2.4 AIP-AgrC interaction
In S. aureus, AgrC is the only known receptor of the AIP. This 430-aa protein adopts the
modular architecture commonly seen for RHKs, consisting of an N-terminal, membraneintegrated sensor module that detects AIP and a C-terminal histidine kinase (HK) module
that carries out enzymatic functions (65). Topology analyses of the AgrC sensor module
have generated less controversy compared to that of AgrB (65-67). All experimental and
computational models agree on the intracellular localization of the HK domain as well as
the positioning of the last four TM domains between residue 78 and 204, while the major
debate lies on the number of TM domains within the N-terminal 77 residues. An earlier
phosphatase-fusion strategy and a set of topology-prediction programs argued for two
TM domains in this region (65), whereas a recent SCAM analysis and a different set of in
silico programs suggested three (66). It is worth mentioning that both experimental
studies were performed in E. coli, whose inner membrane may not support the exact fold
of AgrC in S. aureus due to the drastically different lipid composition (68). In this
dissertation, AgrC will be drawn following the former, 6-TM model that the Muir Lab
has accepted for a long period of time (Figure 1.7a). However, readers should bear in
mind that AgrC might adopt a 7-TM topology.
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The sensor domain is connected to the HK domain via a short interdomain linker. As in
most class-I RHKs, the AgrC HK domain contains two subdomains (Figure 1.7a) (69).
The subdomain proximal to the sensor is the dimerization and histidine phosphorylation
(DHp) subdomain, which folds into an α-helical hairpin and dimerizes through the

Figure 1.7 The AgrC-AIP interactions.
(a) Domain architecture of AgrC-I. The protein is shown as a homodimer with the
integral membrane sensor domain and cytoplasmic DHp and CA subdomains colored in
blue, brown and green, respectively. The interdomain linker and the DHp-CA linker
region are depicted as red and purple dashed lines. (b) The design of reporter-strain
assays: diagram shows the strategy to test the activating or inhibitory effect of a certain
compound. The reporter protein is a β-lactamase, and nitrocephin is a β-lactam that
displays a red color upon its hydrolysis. (c) A summary of the consensus conclusions
drawn from the SAR studies of S. aureus AIPs. (d) Diagram showing the two sets of
counteracting activities of a typical class-I RHK, with the kinase and phosphatase
activities shown in solid and dash arrows, respectively.
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formation of a four-helix bundle. Consequently, AgrC, as do most RHKs known to date,
forms obligatory dimers. The distal, C-terminal subdomain is the so called catalytic and
ATP-binding (CA) subdomain, which adopts the common fold of the GHKL (DNA
gyrase, Hsp90, histidine kinase and MutL) superfamily (70). The CA subdomain binds to
the triphosphate nucleotide and catalyzes the phosphorylation at a conserved histidine
residue on the DHp subdomain. Auto-phosphorylation of the AgrC homodimer occurs in
trans, i.e., the CA subdomain of one subunit catalyzes the phosphorylation of the DHp
subdomain of the other subunit (Figure 1.7a). This was concluded from the observation
that the agr- phenotype conferred by mutating the phospho-accepting histidine in agrC
could be complemented by another copy of agrC gene encoding a RHK deficient of
ATP-binding (71). The crystal structure of a nucleotide-free AgrC CA domain has been
available since 2014 (72).

The AIP binding site has been mapped using domain-swapping approaches. The variable
region of the P2 operon includes the coding sequence of the sensor but not HK domain.
Swapping the sensor and HK domains among subgroups demonstrated that the AgrC
sensor dictates the AIP-sensing specificity (73). Further swapping of the distal (Cterminal 4 TM domains) and the proximal (N-terminal 2 or 3 TM domains) sequences
leads to the conclusion that AIP binding, regardless of the efficacy, relies on the distal
part of the AgrC sensor (74). Taking advantage of the strong similarity between AgrC-I
and AgrC-IV, engineering also revealed that exchanging the second extracellular loop
(ECL2) completely switches their group specificity. Since AIP sequence of group-I and –
IV differs only at position 4, this residue likely interacts with the ECL2 on AgrC (75).
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To pinpoint the structural elements of AIPs required for AgrC binding and/or activation,
extensive structure-activity relationship (SAR) studies have been performed. Most of
these studies rely on agr reporter strains for readout. These agr-null strains harbor a
plasmid-born agr locus devoid of agrBD, with the P3 operon fused to a reporter gene, in
most cases the β-lactamase (blaZ) or green fluorescent protein (gfp) gene (Figure 1.7b)
(76, 77). Such designs render these strains deficient in AIP production but capable of
transducing extracellular AIP signals following the specificity dictated by the agrAC. The
activity of the reporter protein directly reflects the signaling outcome, i.e., the
transcription activity of P3. SAR studies on S. aureus AIPs published to date have
reached consensus on several important conclusions. First of all, the 5-aa, 16-membered
ring structure is of utmost importance for binding (Figure 1.7c) (25, 78). To date, no
linear peptide has ever shown any activity on a native AgrC. Alternating the ring size by
more than one atom has also never been tolerated, although recently the Muir Lab
showed that mutating the Asp5 in AIP-I to homo-β-Asp retains activation despite a loss
of potency (79). Notably, changing the thiolactone linkage to a lactam or oxolactone, a
modification that maintains the ring size, also abolishes the activation while retains the
cross-group inhibition activities (Figure 1.7c) (25, 78). Other modifications to the
macrocycle backbone, including methylation of amide bonds and substitution of single
residue with the corresponding peptoid mimic, showed heterogeneous effects depending
on the subject AIP and the modification site (80-82). Secondly, two positions at the Cterminal end of all known AIPs (not limited to S. aureus) are conserved for hydrophobic
amino acids (74). Their hydrophobicity is required for the tight binding to AgrC, as
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alanine mutation at either position abolishes both cognate-group activation and crossgroup inhibition (Figure 1.7c) (25, 78, 83). Last, but not least, the cognate-activation
activity of AIP is highly sensitive to structural modification. Modification of the
exocyclic tail or mutation of the second ring-participating residue has converted native
AIPs into cognate-group inhibitors (Figure 1.7c). Prominent examples include the
appendage of a tyrosine residue to the N-terminus of AIP-III, as well as the D5A
mutation in AIP-I and D4A in AIP-III (48, 78, 83). In all, these SAR studies provided
precious insights on the design principles of AIPs, which have guided the design of many
useful reagents including AIPs tagged with affinity epitopes or photocrosslinkers (Aishan
Zhao, unpublished work), as well as QS inhibitors of all S. aureus subgroups (48, 77).

By sequence homology, AgrC and AgrA forms a two-component signaling system
(TCS). Such systems exist in all three domains of life and are particularly prevalent in
bacteria (84). In a TCS, the RHK component usually processes two counteracting sets of
activities (Figure 1.7d): the auto- and trans-kinase activity that installs phosphorylation to
its cognate response regulator (RR); and the phosphatase activity that removes the
phosphorylation (69). In response to its cognate signal, RHK adjusts the balance between
its two sets of activities and thereby modulates the RR phosphorylation level. Signal
transduction employing TCSs is common among QS systems, however the effect of AI
binding on RHK’s kinase-phosphatase balance diverges (26). Importantly, using crude
membrane vesicles from E. coli over-expressing AgrC, Lina et al. have shown that the
presence of the cognate AIP activates the auto-kinase (65). Furthermore, Geisinger et al.
showed that the cognate AIP binding at one sensor domain within a dimer affords
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qualitatively similar activation to the phosphorylation of both subunits (71). Despite these
efforts, a detailed understanding of the biochemistry and the signaling mechanism of the
AgrC-AgrA TCS would entail high-resolution structural information as well as
quantitative biochemical/biophysical characterization.

1.2.5 AgrA phosphorylation and transcription activation
Acting as the phospho-receiver in the TCS as well as a transcription activator, AgrA
consists of two domains, each assuming one of its two functions. The N-terminal receiver
domain is shared across all RR proteins and dimerizes upon phosphorylation at its
conserved Asp residue (69). The C-terminal DNA binding domain belongs to the LytTR
protein family and binds to the consensus DNA elements located in the P2 and P3
promoter region (85). The crystal structure of the AgrA DNA binding domain in complex
with a cognate 16-nt DNA fragment has been solved (Figure 1.8a) (86). In stark contrast
to most known transcription factors that bind DNA using α–helices, AgrA LytTR domain
is enriched in β-strands and harnesses residues on its inter-strand loops for the interaction
with DNA. This unique binding pattern causes bending of the DNA double-helix by 38o
upon the interaction (Figure 1.8a). Amino acid residues required for the stability, DNAbinding and/or transcriptional activation have been identified employing structure-guided
or alanine-scan mutagenesis approaches (86, 87). Intriguingly, an AgrA mutant,
AgrAY229A, is deficient in activating transcription from the P3 promoter even through it
binds and bends the DNA element indistinguishably from the wild type. This finding
suggested that the surface patch surrounding Y229 might be specialized for transcription
regulation through an unknown mechanism.
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Figure 1.8 The crystal structure of AgrA and the regulatory elements of P2 and P3
transcription.
(a) Ribbon diagram of AgrA in complex with a 16-bp double-strand DNA containing its
cognate binding sequence. AgrA is shown in green, with the sulfur atoms in Cys199 and
Cys228 capable of disulfide formation under oxidative stress highlighted with yellow
spheres. A 38o arc next to the DNA strands illustrates the magnitude of DNA bending as
a consequence of AgrA binding. (b) Double-strand DNA sequence of the intergenic
region within the agr locus. The -10 and -35 elements with respect to the transcriptionstarting site (TSS) are marked with orange arrows and the AgrA-binding elements with
red arrows. Red boxes denote the binding elements for SarA.
Autoinduction of agr presupposes a different temporal pattern of P2 and P3 transcription.
Prior to autoinduction, a tight repression of the P3 operon is preferred to avoid
unnecessary RNAIII-mediated mRNA degradation, while a reasonable expression level
of P2 genes is required to set the stage of the autoinduction circuit. In agreement with this
idea, experiments have confirmed that the baseline transcription level of P2 is higher,
while its activation is less dramatic, compared to that of P3 (88). How could the same
pool of AgrA possibly exercise differential regulation over two operons? The answer lies
within their promoter sequences. Both P2 and P3 promoter regions contain, in the
orientation of transcription, two AgrA-binding elements followed by the -35 and -10
boxes required for RNA polymerase (RNAP) recognition (Figure 1.8b). In spite of the
similar architecture, AgrA-recognition sequences in P2 provide stronger affinity to AgrA
than that in P3 (89). Thus, the promoter occupancy of P2 would be higher than that of P3
given limited availability of phosphorylated AgrA. Moreover, the spacer between the -35
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and -10 boxes measures 18 nts in the P2 promoter and 20 nts in P3, both deviating from
the optimal, 17-nt length (Figure 1.8b) (88, 90). Strikingly, shortening the spacer of P3 to
the optimal length dramatically enhances the baseline transcription activity both in vitro
and in vivo (88, 91). In light of this observation, the DNA-bending effect of AgrA
binding as well as the dimerization induced by AgrA phosphorylation, has been surmised
to rearrange the -35 and -10 boxes back to the optimal conformation to facilitate the
binding of RNAP. Having been supported by in vitro transcription data, this theory
provides a solid explanation for the more substantial up-regulation of P3-gene production
during autoinduction.

The agr locus is a hot spot of signal integration due to its central role in direct regulation
of dozens of effector genes. AgrA, for instance, can be inactivated by oxidative stress
through the formation of a disulfide bond between two cysteine residues at positions 199
and 228 (Figure 1.8a) (92). Apart from AgrA, at least two transcription factors, SarA and
SarR, are known to bind directly within the intergenic sequence between P2 and P3
(Figure 1.8b) (93, 94). Production of both SarA and SarR is growth-phase dependent,
with their protein levels peaking during late-exponential and stationary phases,
respectively (95, 96). While SarA enhances AgrA-dependent P2 transcription, SarR
exhibits a repressive effect. Thus, their coordinated expression is thought to play a role in
the down-regulation of agr activity in the stationary phase. In contrast to these direct agrbinding factors, more factors/pathways are known to regulate agr effectors in an agrindependent manner. At least two TCSs, SaeSR and SrrAB, control the virulence gene
expression at the transcriptional level in response to stress conditions (97). Notably, a
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global metabolic regulator, CodY, has recently been found to influence agr gene
expression (98). The Bacillus homolog of this protein is known to respond to the
secondary messenger, guanosine tetraphosphate (ppGpp) (99). In S. aureus, however, the
codY deletion causes substantial over-expression of both P2 and P3 genes and hence a
premature-autoinduction phenotype (100). Unexpectedly, CodY has barely detectable
affinity to agr promoters, and the connection between CodY and agr gene products is
still unclear.

1.3 Reagent development for the manipulation of agr
S. aureus requires agr not for survival but virulence. Interfering with the autoinduction,
or QQ, should therefore be effective in combating the infection caused by this bacterium.
Meanwhile, the likelihood of resistance development against agr-targeting reagents is
expected to be lower since they impose milder selection pressure versus classic,
bactericidal or bacteristatic antibiotics (101). These potential properties qualify agrtargeting reagents as attractive candidates for the treatment of staphylococcal infection.
The cross-group inhibitory property of AIPs provides the first view of the effectiveness
of QQ (25). AIP inhibitors have been shown to attenuate the spread of S. aureus
infections in mice, phenocopying the use of agr-null S. aureus strains as infective agents
(25). Remarkably, administering the antagonistic AIP during the beginning 3 hours of
infection is sufficient for its attenuation effect despite the short lifetime of this peptide in
vivo (30).
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Although effective in containing new colonization by S. aureus, the effect of QQ reagents
on existing infections has not been reported. It is noteworthy that silencing of the agr
system is known to strengthen S. aureus biofilm and potentially benefits the maintenance
of chronic infection (102). Conversely, activation of the agr system might represent a
more attractive strategy in tackling S. aureus infection—not only does it disperse the
biofilm, the constant induction of the agr-regulated genes also takes tolls on the fitness of
the bacterium, rendering them more susceptible to classic antibiotics (103). Practical
application of this strategy would entail a global activator that simultaneously activates
the autoinduction of all four S. aureus subgroups. This reagent could potentially be a
cocktail of a series of “clean” activators that each activates one or more agr variants
without substantially affecting the rest. Unfortunately, the outcome of agr activators in
animal models has not been tested to date, nor has any clean agr activator ever been
developed. Because of the strong bias against agr activators in this field, the rest of this
section will be dedicated to the discovery of QQ reagents.

1.3.1 AIP scavenging in host defense
Even in the absence of exogenous drugs, the mammalian host is able to scavenge AIPs
and hence block autoinduction (Figure 1.9). Consequently, the lifetime of AIPs in vivo is
on the order of a couple of hours (104). There are two major mechanisms by which AIPs
are scavenged in the host serum. Firstly, AIP-I and AIP-IV contain, at their C-terminal
position, a methionine residue essential for their receptor binding. As a consequence,
oxidation of the thioether group on the methionine side chain by reactive oxygen species
(ROS) into a sulfoxide leads to complete inactivation of these two AIPs (Figure 1.9) (78).
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It was found thereafter that this oxidation also occurs in mice, and NADP oxidaseknockout animals are more susceptible to group-I S. aureus infection due to their
deficiency in ROS production induced by immune response (104). In addition to
oxidation, a more general neutralization strategy employing low-density and very-lowdensity lipoproteins (LDL and VLDL) is capable of removing AIPs free from oxidationsensitive residues (e.g., AIP-III) (105, 106). Upon sequestration into lipoprotein particles,
AIPs are then internalized by macrophages through receptor-mediated endocytosis and
subject to lysosomal degradation. Notably, pre-oxidation of LDL by the ROS generated
during the immune response significantly enhances its AIP-binding affinity, suggesting a

Figure 1.9 Mechanisms of AIP scavenging by mammalian hosts.
Diagram depicts two major mechanisms known to date, namely, lipoprotein sequestration
and direct oxidation, that allows mammalian hosts to inactivate S. aureus AIPs.
Inactivated AIPs upon oxidation are shown in gray, with X denoting the methionine
sulfoxide generated by oxidation.
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causal relationship between infection and the implication of AIP clearance machineries
(Figure 1.9) (106). While this arrangement has its physiological merit, the lack of
protection during the beginning few hours following invasion provides the pathogen
opportunities to expand and establish its colonization.

1.3.2 AgrC-targeting reagents
In principle, chemicals blocking any step within the autoinduction loop should effectively
accomplish quorum quenching. Unfortunately, out of five potential protein targets, i.e.,
AgrA, AgrB, AgrC, the AIP-releasing protease and the transporter, only the AgrA LytTR
domain and the AgrC CA subdomain have had their crystal structures solved, while the
last two proteins have not yet been unambiguously identified (72, 86). Consequently,
target-specific drug design is predominantly limited to chemical engineering based on the
AIP scaffold. Native AIPs provide a rich source of information for the design of QQ
reagents due to their cross-group inhibitory properties. As opposed to native AIPs,
however, QQ reagents are expected to inhibit the autoinduction of all four groups.
Guided by the structure-activity relationship of AIPs (vide supra, section 1.2.4), AIP-I, II and -III have all been successfully modified into global QQs of S. aureus (Figure
1.10a) (48, 77, 83). Despite this success, the AIP backbone is peptidic in nature and
hence suffers such drawbacks as high immunogenicity and lack of stability in vivo. In a
prominent attempt to address this problem, modification of single residues in AIP-III
through peptoid-mimic substitution or N-methylation has generated a few global QQs
(82). Full peptomer mimic possessing global QQ activities, however, has not yet been
identified.
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Aside from synthetic peptides derived from the native AIP scaffold, reported inhibitors of
S. aureus autoinduction are predominantly secondary metabolites from other microbes. It
should be pointed out that most these compounds have not been shown to directly interact
with AgrC, nor have their activities been tested against all four subgroups of S. aureus.
Nonetheless, some of these inhibitors share astonishing similarity to native AIP despite
their disparate origin. For instance, solonamides, a series of tetrapeptides produced by
marine bacteria from the genus Photobacterium, possess a 16-membered macrocycle
containing four one β-hydroxy-acid and four α-amino-acid building blocks (Figure
1.10b) (107). Thus, solonamides and a few other agr-repressing natural products

Figure 1.10 Synthetic molecules or natural products that targets agr.
(a) Global AgrC inhibitors derived from native AIPs. Groups that differ from the wildtype AIP are highlighted in red. (b) Putative AIP-mimic natural products. (c) The
Pseudomona autoinducer 3-oxo-C12-HSL and secondary metabolite HQNO. (d) The
AgrA-targeting lead compound, savarin.
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containing AIP-like macrocycles, including avellanin and cochinmicin (Figure 1.10b)
(108, 109), are believed to function through competitive inhibition of AgrC. Two other
natural products, 3-oxo-C12-HSL and 4-hydroxy-2-heptylquinoline N-oxide (HQNO)
originated from Pseudomonas aeruginosa, are capable of quenching S. aureus
autoinduction with a low-micromolar IC50 (Figure 1.10c) (110). Interestingly, both P.
aeruginosa and S. aureus are known to colonize the airways of cystic fibrosis patients,
and these two compounds might play a role in the inter-species competition (111). In
particular, the HSL compound has bactericidal activity at high-micromolar concentrations
and may act as an allosteric inhibitor of AgrC at lower concentrations as was inferred
from its interaction with AIPs in cell-based assays (112). Given the similar, amphiphilic
structure of these two compounds, it is tempting to surmise that they function through
interacting with the cell membrane.

1.3.3 AgrA-targeting reagents
In contrast to AgrC, which has four variants in S. aureus, targeting AgrA could be
simpler due to its uniform sequence in all four subgroups. On the other hand, because
AgrA localizes in the cytoplasm, membrane permeability would be required for effective
AgrA inhibition in living organisms. As opposed to the SAR-guided design of AIP
analogs into desired AgrC inhibitors, development of AgrA-targeting QQ reagents
predominantly relied on the library screening approach employing cell-based readouts.
AgrA was identified as the target in the validation process.
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According to the crystal structure of AgrA LytTR domain in the absence of bound DNA,
binding of a small organic compound to a hydrophobic cleft might disrupt the AgrADNA interaction (113). As a proof of principle, Leonard et al. screened over a 500member library and identified a few AgrA-targeting hits with low-milimolar affinity
(113). Screening of a much larger library led to the discovery of Staphylcoccus aureus
virulence inhibitor (savirin), which optimally blocks S. aureus autoinduction at 13.5µM
through the same mechanism (Figure 1.10d) (114). This drug robustly inhibits
autoinduction phenotypes of S. aureus and attenuates the lesion size in the classic murine
abscess model. Importantly, resistance did not emerge upon extensive passage of S.
aureus in the presence of savirin. Because of its optimal physicochemical properties and
biological activities, savirin is viewed as a promising lead compound awaiting further
SAR studies.

1.3.4 AIP-sequestration reagents
The last class of QQ reagent developed works through sequestration of AIPs from their
interaction with AgrC. Employing a stable, oxo-ester variant of AIP-IV as the antigen, a
set of AIP-IV specific, mouse monoclonal antibodies was developed (115). The
antibodies showed excellent QQ activity in vitro, and protected mice from the
development of skin-infection symptoms upon inoculation with a group-IV strain.
Nonetheless, the prohibitive cost of the development and production of antibody drugs
might present a formidable barrier for the application of QQ antibodies in practical antistaphylococci therapies.
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1.4 Summary: specific aims and significance
Elucidation of QS-dependent exo-protein regulation represents a major advance in the
understanding of S. aureus physiology and pathology. Key to this achievement is the
discovery and characterization of the agr locus, which can be divided into two phases
demarcated by the sequencing of agr allelic variants and the isolation of the AIP. Dr.
Richard P. Novick, a professor at New York University Medical Center and a close
collaborator of the Muir Group, has made leading contributions throughout the first
phase, primarily involving the isolation, cloning and sequencing of the agr locus.
Thereafter, the Muir Group joined the campaign since 1997 and the two groups
collectively initiated the second phase featuring the molecular and mechanistic
characterization of agr. In the following years up until the beginning of my dissertation,
the Novick-Muir collaboration has primarily focused on (i) the validation of the agr
autoinduction circuit as a potential drug target and (ii) the dissection of molecular
determinants in AIP and AgrC that define the affinity and signaling efficacy of their
interaction. Meanwhile, other research groups around the world have attempted to
understand the mechanisms of action for every single agr gene product, predominantly
employing cell-based genetic/biochemical approaches and qualitative detection methods.
Many fundamental biochemical questions, in particular with respect to integral
membrane proteins AgrB and AgrC, were therefore left open. During the same period of
time, geneticists have outlined the signaling network surrounding the autoinduction
circuit, but little effort has gone to identifying missing components of the autoinduction
circuit itself, namely the transporter and the AIP-releasing enzyme. In a quest to fill up
the knowledge gaps listed above, I decided to investigate individual biochemical events
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in the autoinduction circuit primarily through in vitro reconstitution using highly purified
synthetic or recombinant components. Importantly, this strategy conforms to the purechemistry spirit and chemical biology strength of the Muir Group.

The overall aim of this dissertation is to perform comprehensive biophysical, biochemical
and bioinformatic characterizations of AgrB and AgrC and thereby provide mechanistic
insights to the institution and regulation of their enzymatic activities. Specific aims are
addressed in each chapter. A comprehensive database search for homologs of AgrC
proteins is included in Chapter 2, accompanied by inferences from the perspective of
systematic evolution. To enable quantitative enzymology study on AgrC in various ligand
states, the receptor was reconstituted to the nanometer scale lipid-bilayer discs, or
nanodiscs, which contain a topologically open membrane. The reconstitution, the
recapitulation of ligand responses of AgrC, and the determination of parameters
describing its ligand binding and kinase activities are presented in Chapter 3. AgrC is
also unique for having a number of activity states depending on the ligands bound. In
Chapter 4, a conformation-activity landscape is charted and ligand-induced molecular
motions detected for AgrC to shed light on its signaling flexibility. Chapter 5 is dedicated
to the reconstitution of AgrB-catalyzed proteolysis of AgrD, focusing on identifying the
driving forces that power the formation of the high-energy AgrD thiolactone intermediate
without free-energy input from ATP.

QS-mediated behaviors are widely present in pathogenic bacteria. Gram-positive
pathogens including Listeria monocytogenes, Enterococcus faecalis and Clostridium
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perfringens all possess autoinduction systems sharing striking homology to the S. aureus
agr system in both protein sequences and regulatory architectures (116-119). This
dissertation establishes a solid body of knowledge concerning the biochemical principles
of the agr system, which may provide guidance for understanding of virulence-protein
regulation in many other clinically significant organisms. Moreover, the profound impact
of agr on protein production and energy expense can be harnessed to modulate the
microbe’s fitness under certain selective conditions. Although the effectiveness of agrtargeting reagents as the standalone drug is still under debate, they still hold considerable
potential as components of therapeutic cocktails against S. aureus infection. The in vitro
reconstitution system of AgrB and AgrC may enable target-specific library screening
employing the affinity-selection mass spectrometry (ASMS) strategy, which offers much
larger throughput compared to cell-based screening assays and should expand the chance
of discovering useful reagents in future anti-staphylococcal practices (120).
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Chapter Two: Bioinformatic Analysis of the S. aureus AgrC
To confer the enzymatic as well as the regulatory functions, most class-I RHKs share five
sequence motifs that enable them to bind the nucleotide/metal cofactor and, depending
upon the signaling state of the sensor domain(s), adopt the active or inactive
conformation through an appropriate DHp-CA interaction. In each motif, one or several
position(s) are highly conserved for certain amino acids. Therefore, these motifs are
named “homology boxes”, denoted by the amino acid on their respective most conserved
positions (69). The H-box, for instance, features the phospho-acceptor His residue, and is
involved in the kinase-competent DHp-CA interaction as well as the DHp-RR interaction
that supports the trans-kinase or phosphatase activity (Figure 2.1a) (121, 122). All other
four homology boxes reside in the CA subdomain. Among them, the F-box is unique for
its involvement in the kinase-inactive conformation: the conserved Phe associates to a
hydrophobic patch on the DHp subdomain and thus holds back the CA from approaching
the phospho-acceptor His (Figure 2.1b) (123). The remaining three motifs, namely the N, G1- and G2- boxes, interact with the divalent metal, the adenine base and the
triphosphate anion of the ATP-metal cofactor, respectively (Figure 2.1c-e) (124).
Because of their high levels of conservation, database search for RHK sequences depends
predominantly upon the detection of these homology boxes.

It has long been noticed that S. aureus AgrC protein possesses unusual sequence features
in several of its homology boxes. In a seminal study carried out by Grebe and Stock
(125), 384 RHK sequences known as of 1999 were classified into a series of subfamilies
based on sequence homology in their HK domains. Together with 14 close homologs all
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governing peptide-mediated intercellular communication, AgrC falls in the HPK10
subfamily, which was denoted to “show very distinct characteristics that clearly
distinguish them from other histidine kinases” (125). These characteristics include: (i) a
distinct H-box sequence pattern, F[RK]HDYxN; (ii) the absence of the first Asn residue
in the N-box motif, NxxxN; and (iii) the lack of any detectable G1-box motif, DxGxG.

Figure 2.1 Primary functions of HK homology boxes captured in crystal structures.
In all panels, the HK domain is shown in green ribbon diagram. Homology-box residues
participating interactions and adenosine nucleotide (if present) are highlighted with stick
model. Carbon atoms of the namesake residue and the adenosine nucleotide are colored
in magenta and cyan, respectively. Red dashes denotes important hydrogen/coordination
bonds. (a) The H-box of the E. coli stress sensor, CpxA docked to the surface of a CA
subdomain in an auto-kinase-competent conformation. PDBID: 4biv. (b) The F-box of
the Thermotoga maritima HK853 docked to a hydrophobic patch on the DHp subdomain
to enforce the inactive conformation. PDBID: 2c2a. (c) The N-box of the E. coli
chemoreceptor kinase, CheA in complex with ADPCP and Mn2+. The metal cation is
shown as a purple sphere. PDBID: 1i5a. (d) The G1-box of the M. maritima HK853 in
complex with ADP. Red spheres are the oxygen atoms of two water molecules. PDBID:
2c2a (e) The G2-box of the CheA kinase in complex with ADPCP and Mn2+. PDBID:
1i5a. In (d) and (e), structural elements sheltering the homolog boxes are removed for
clarity.
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Recently, computational analysis identified strong sequence co-variation between the Nand H-box motifs, suggesting that they likely interact at the DHp-CA interface required
for auto-phosphorylation (126). While a double-mutant cycle might account for the
deviation of AgrC N- and H-boxes from canonical sequences, the AgrC sequence at the
G1 region provides no hint on how this RHK harnesses ATP (or any triphosphate
nucleotide) for auto-phosphorylation. In this chapter, we first seek to identify, from the
genomic databases, more RHK sequences sharing the distinct features of the HPK10
subfamily. Sequence analysis was then performed, leading to a few hypotheses on the
biochemical properties of AgrC and the evolution trajectory of the agr system.

2.1 Identification of close AgrC homologs from genomic databases
Two rounds of database search were performed (Figure 2.2). In the first round, the
intracellular sequence of the group-I S. aureus AgrC (residues 205-430) was used as the

Figure 2.2 Flow chart of the database search for AgrC homologs. See text for details.
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query to search the reference-sequence protein database (Refseq_protein) with Pattern
Hit

Initiated

BLAST

(PHI-BLAST)

(127).

The

initial

pattern

was

[FILV][RK]H[DE][YF]. In order to preserve the initial pattern, no subsequent PSIBLAST was performed. Hits with E-values below 0.05 were pooled. To reduce the
redundancy of the hit pool, the CD-HIT program was used to cluster near-identical
sequences with an identity threshold of 80% (128). One representative sequence from
each cluster was included in the non-redundant sequence collection, which was aligned
using the COBALT program for the detection of the CA domain (129). False (non-RHK)
hits lacking a G2-box were removed manually. Out of 183 sequences obtained in the first
round, 12 most distantly related to AgrC-I were chosen as queries for a second round of
database search with similar strategies (see Appendix Table 1). Hit sequences obtained
from both rounds were pooled and, upon removal of redundant and false hits, returned
330 non-redundant RHK sequences (Appendix Table 1).

To understand the G1-box configuration in AgrC, we generated a sequence profile of the
330-sequence collection using HMMER (130), and aligned it to an RHK with a canonical
G1-box, the osmotic sensor EnvZ from E. coli. Strikingly, aligned to the first position of
the EnvZ G1 motif, “DxGxG”, is an Asn conserved in 326 out of 330 sequences, to
which we refer as the ‘G1-box Asn’ (Figure 2.3). Notably, the frequency of Asn at this
position is 9% in contrast to 85% for Asp in the GHKL super-family to which all CA
subdomains belong (70). In contrast, amino acids aligned to either EnvZ G1-box glycines
are not conserved among these 330 sequences. This result strongly suggests that AgrC,
one of the 326 possessing the G1-box Asn, employs this residue to interact with the
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nucleotide cofactor. Furthermore, since we did not assign any sequence pattern when
performing the PHI-BLAST, this unique G1-box feature must have co-evolved, directly
or indirectly, with the input H-box sequence pattern.

Further analysis revealed another common feature of these 326 sequences: although
covering 194 species from 22 taxonomic families, they all come from low-GC grampositive bacteria in line with 15 founding members of the HPK10 subfamily (Table 2.1).
Interestingly, the four sequence hits that did not conform to these two criteria contain
both a canonical G1-box and originate from Gram-negative bacteria or archaea. These
two features suggested that this 326-sequence collection represents a self-consistent
expansion of the original RHK10 subfamily. It is noteworthy that the lack of first Asn in
the NxxxN N-box motif [characteristic (ii)] no longer holds true within this expanded
RHK10 subfamily.

2.2 Sequence analysis of the HPK10 subfamily
Among the 326 sequences, 318 were predicted to span the membrane at least once and
286 to span five times or more, according to the TMHMM program (Figure 2.4a) (131).

Figure 2.3 Alignment of the E. coli EnvZ protein to HPK10 subfamily members at
the G1 box. The G1-box Asn and the conserved residues in canonical G1 boxes are
highlighted in orange and blue, respectively.
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Interestingly, with only one exception, none of these multi-span HPK10 sequences is
predicted to contain an extracellular sensor domain, suggesting that most HPK10

Table 2.1 Taxonomic coverage of the HPK10 subfamily
Phylum

Class
Negativicutes
Mollicutes
Erysipelotrichia

Clostridia

Order
Selenomonadales
Acholeplasmatales
Erysipelotrichales

Clostridiales

Thermoanaerobacterales
Firmicutes
Bacillales

Bacilli

Lactobacillales

Family
Veillonellaceae
Acholeplasmataceae
Erysipelotrichaceae
Lachnospiraceae
Peptostreptococcaceae
Eubacteriaceae
Clostridiaceae
Ruminococcaceae
Peptococcaceae
Thermoanaerobacteraceae
Listeriaceae
Sporolactobacillaceae
Paenibacillaceae
Bacillaceae
Staphylococcaceae
Planococcaceae
Aerococcaceae
Carnobacteriaceae
Enterococcaceae
Streptococcaceae
Lactobacillaceae
Leuconostocaceae

Figure 2.4 Statistics of the expanded HPK10 subfamily.
(a) Number of TM domains predicted for the 326-sequence collection by the software
package, TMHMM 2.0. (b) Predicted length of the interdomain linker (in residues) in the
multiple sequence alignment of the 285 sequences.
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subfamily members likely sense extracellular or intra-membrane signals with membraneembedded sensors (132). To better delineate the boundaries of the AgrC-I intracellular
modules, we generate a new hidden Markov model (HMM) using the alignment of these
286 multi-span sequences, and harnessed it to analyze a sub-alignment of 18 sequences,
each representing a taxonomic family (Figure 2.5a). These analyses revealed a less
conserved, short linker between the well-aligned last TMH and the DHp subdomain in all
sequences (Figures 2.4b and 2.5b). Specifically in AgrC-I, the conserved DHp subdomain
that aligns to the HMM with high confidence begins at residue 222 rather than at residue
200 immediately after the last TMH (Figure 2.5b). We therefore refer to AgrC-I1-200 as
the sensor domain and AgrC-I201-221 as the interdomain linker region.

Figure 2.5 Identification of a less conserved interdomain linker within AgrC
(a) Posterior probabilities of the 18-sequence sub-alignment according to the profile
HMM: positions in the HMM are displayed with numbering corresponding to residues in
AgrC-I; predicted domains of AgrC-I are shown above. (b) HPK10 subfamily alignment
from the last TMH to the first DHp helix: highly conserved residues and the phosphoacceptor histidine are highlighted in orange and blue, respectively.
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2.3 Summary and discussions
The taxonomic restriction of the HPK10 subfamily revealed in this chapter provides
intriguing insights on the evolution trajectory of the AgrCA TCS as well as the agr QS
circuit. First of all, that all subfamily members come from the phylum Firmicutes
strongly supports the theory that the ancestral HK domain carrying all HPK10-specific
features emerged after the branching of this phylum from the tree of life. A subphylumspecific emergence is also possible, as the distribution of HPK10 members across the
phylum is highly uneven, with more than 95% sequence found in orders Bacillales,
Lactobacillales and Clostridales.

Despite the rapid expansion of the sequence database, our knowledge on the function of
HPK10 subfamily members has not progressed as much. Founding members of the
subfamily were discovered about two decades ago for their involvement in the
autoinduction circuits encoded by homologs of the S. aureus agr locus and the
Streptococcus pneumoniae com locus—and this remains the only known function of this
RHK subfamily to date (125). In our database search, a number of HPK10 genes were
found without an agrB or a comAB homolog (see below) in their genomic context, and
their functions are so far intractable. The AI of the prototypical streptococcal com system
is a linear peptide named the CSP (for competence-stimulating peptide), which is sensed
by the ComDE TCS, a close homolog of AgrCA (Figure 2.6) (133). Notwithstanding the
homology of the AI-sensing module, the ComAB machinery that both processes and
secretes the CSP is completely unrelated to AgrB—rather it shares close homology with
the plasmid-borne E. coli hemolysin transporter, HlyBD (Figure 2.6) (134, 135).
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Interestingly, the AgrBD homologs were also found to exist in a broader spectrum of
Firmicutes than the intact agr system (136). These findings raised the possibility that
both systems emerged through the co-regulation of pre-existing AI production and
sensing genes, which were subsequently grouped into a single operon. Given the
prevalence of agr homologs in Bacillales and Clostridales and com homologs in
Lactobacillales, these two systems likely emerged independently and gained their
autoinductory function thereafter through convergent evolution. A comparative analysis
of the phylogeny of the HPK10 subfamily to that of AgrB and ComAB would test this
hypothesis more rigorously.

The bioinformatic analysis described in this chapter was directed to address two
questions, namely, what aspects of AgrC biochemical properties we should focus in the
subsequent in vitro reconstitution study and how to interpret the results from an
evolutionary perspective. While the classic theme of phospho-relay has been well

Figure 2.6 Comparison between the prototypic com and agr loci
Gene-products encoded by the (a) com and (b) agr loci are shown in arrows indicating
their direction of transcription. Coding region of the HPK10-subfamily RHK and the
LytTR-family RR are colored in green and blue, respectively.
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established for TCSs, the sequence peculiarity in the H- and G1-boxes of the HPK10
subfamily foreshadows some intriguing subfamily-specific behaviors related to these two
homology boxes. Specifically, the unique H-box sequence may enable a distinct
regulatory pattern of the AgrC auto-kinase, trans-kinase and phosphatase activities
following signal input. We will therefore investigate all three above activities of AgrC
under resting, activated or inhibited ligand states. Furthermore, as the only conserved
residue that putatively interacts with the nucleobase, the G1-box Asn must either harness
a different triphosphate nucleotide as the phosphoryl donor, or bind to the ATP adenine at
an altered affinity. Consequently, the nucleotide specificity and the affinity to the favorite
nucleotide will be another focus of our biochemical studies. Data that distinguish AgrC
from the majority of RHKs are expected, and will be interpreted within the boundary of
the HPK10 subfamily and the extracellular peptide sensing in Firmicutes.
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Chapter Three: Reconstitution of Biochemical Events Related to AgrC
Quantitative information on how AgrC works as a kinase and how its activity is regulated
by native AIP ligands is critical to the understanding of the regulatory architecture of S.
aureus autoinduction. Unfortunately, such information is in a short supply, however,
primarily due to the limitations of cell-based reporter assays. The complicated whole-cell
system occludes specific detection of individual proteins, while the reporter-protein
readout cannot faithfully reflect the rate of a single biochemical event involved in twocomponent signaling cascade. To circumvent these drawbacks and provide quantitative
insights into the activity and regulation of this pivotal receptor histidine kinase (RHK), an
in vitro reconstitution system involving highly purified components must be
implemented. In this chapter, we describe the reconstitution of AgrC homologs to an
artificial membrane system that restores their expected biochemical activity and ligand
response. During the course of our reconstitution attempts, a polyclonal, pan-specific
antibody for phosphohistidine (pHis) detection was developed in the Muir Lab, enabling
highly efficient, quantitative detection of AgrC phosphorylation (137). Taking advantage
of this new reagent as well as our reconstitution system, we determined physicochemical
parameters for the interaction between AgrC-I and native AIPs, as well as kinetic
parameters of the RHK’s auto-kinase and phospho-relay activities in the apo- and
activator-bound states.

3.1 Functional reconstitution of AgrC to nanodiscs
We elected to use nanometer-scale lipid-bilayer discs (nanodiscs) as the model membrane
for the incorporation of AgrC (Figure 3.1a) (138). Nanodiscs are a supramolecular mimic
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of high-density lipoproteins consisting of a discoidal lipid bilayer surrounded and
stabilized by two copies of a membrane scaffold protein (MSP). Importantly, the
topologically open nanodiscs, as opposed to membrane vesicles, enables AgrC, when
incorporated, to simultaneously access its AIP ligands and enzymatic substrates in the
bulk solution because both sets of reagents are membrane-impermeable.

Figure 3.1 Reconstitution of AgrC-I to nanodiscs composed of DMPC and DMPG
(a) Schematic showing the workflow used for reconstituting AgrC-I dimers into
nanodiscs. (b and c) Purification of (b) AgrC-I from E. coli membrane extract and (c)
AgrA from E. coli total soluble lysate as analyzed by SDS-PAGE with CBB-stain. Bands
corresponding to the target proteins are indicated. Asterisk indicates a 100-kDa protein
co-purified with AgrC-I. (d) Purification of reconstituted AgrC-I discs by Ni-NTA
affinity chromatography as analyzed by SDS-PAGE with Coomassie-brilliant blue (CBB)
staining; bands corresponding to AgrC-I and the scaffold protein (MSP) are indicated. (e)
AgrC-I discs analyzed by size exclusion chromatography (SEC). Fractions collected
between the dashed lines were further analyzed by SDS-PAGE with CBB staining
(bottom). (f) SEC-MALS analysis of empty and purified AgrC-I discs. Moverall
corresponds to the average molecular weight (MW) of the peak calculated from the UV,
light-scattering, and differential refractive-index readouts. Mprotein corresponds to the
measured MW of the proteins in each case; AgrC-I = 51 kDa, MSP = 29 kDa. (g)
Stoichiometry of AgrC-I discs as analyzed by SDS-PAGE: AgrC-I discs (left lane) and
an equimolar mixture of purified AgrC-I and MSP (right lane) were resolved and
visualized with CBB staining.
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Among four AgrC homologs in S. aureus, the group-I variant was the first to be
successfully over-expressed in E. coli and hence employed in nanodisc-reconstitution
trials. Both AgrC-I and AgrA were purified as His6-tagged recombinant proteins (Figure
3.1b and c). The detergent-solubilized AgrC-I did not have any auto-kinase activity
regardless of the presence of AIP (data not shown). We then set out to prepare
homogeneous nanodiscs containing one copy of the AgrC-I dimer per disc. To this end,
purified AgrC-I was added to mixed micelles containing excess MSP and lipids [1,2dimyristoyl-sn-3-glycero-phosphocholine (DMPC) and 1,2-dimyristoyl-sn-3-glycerophosphochglycerol (DMPG), molar ratio 1:3, see below], lowering the chance of
incorporating more than one copy of AgrC-I dimer in each nanodisc (Figure 3.1a) (139).
Detergent was then removed to drive self-assembly, and nanodiscs containing AgrC-I
(AgrC-I discs) were separated from empty discs using Ni-NTA affinity purification
(Figure 3.1a and d). Purified AgrC-I discs gave a single, symmetric peak on sizeexclusion chromatography (SEC) from which the peak fractions were pooled for further
studies (Figure 3.1e). The product has a narrow molecular weight distribution analyzed
by size-exclusion chromatography in tandem with multi-angle light scattering (SECMALS, Figure 3.1f) (140). The expected stoichiometry of one copy of AgrC-I dimer per
disc was also confirmed in the SEC-MALS experiment, as well as using SDS-PAGE
employing ratiometric standards (Figure 3.1g).

In preliminary trials of AgrC-I reconstitution, a series of phosphatidylcholines (PC) were
tested for their ability to mediate nanodisc assembly (139). DMPC was selected because
of the relative ease in obtaining a monodisperse population of AgrC-I discs (data not
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shown). Notwithstanding this favorable behavior, AgrC-I embedded in DMPC nanodiscs,
although possessing a basal level of auto-kinase activity, failed to activate upon binding
to AIP-I, its cognate activator peptide (Figure 3.2a, lanes 1 and 2). Because the major
phospholipid in S. aureus cell membrane is the anionic phosphatidylglycerol (PG), we
adjusted the nanodisc lipid to a mixture of DMPC and DMPG at a molar ratio of 1:3 and
successfully restored the AIP-I dependent auto-kinase activation of AgrC-I (Figure 3.2a,
lanes 3 and 4) (68). Surprisingly, co-migration assays showed that AgrC-I embedded in
nanodiscs with either lipid composition binds to the activator AIP with equal capacity,

Figure 3.2 Dependence of AgrC-I activation on lipid composition
(a) AgrC-I auto-kinase activation: AgrC-I discs reconstituted with different lipid mixtures
were phosphorylated with 1 mM ATP at 37 oC for 3 minutes. The cognate AIP-I was
included as indicated. pHis levels in AgrC-I were analyzed by anti-pHis western blotting
(upper). The blot was CBB stained thereafter as a loading control (lower). (b) Comigration assay of a fluorescein-labeled AIP-I, FAM-AIP-I (refer to Figure 3.7a) with
selected nanodisc samples: AgrC-I or empty discs assembled with DMPC only or a
DMPC-DMPG mixture were incubated with excess FAM-AIP-I and analyzed by SEC.
UV and fluorescence detection of the chromatograms are overlaid. (c) AgrC-I discs
reconstituted with DMPC and DMPG at a series of ratios were tested for auto-kinase
activation as in (a).
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suggesting that the zwitterionic DMPC membrane disrupts the translation of signal
binding into enzymatic response (Figure 3.2b). Lipid environments enriched for anionic
DMPS largely restored the responsiveness of the receptor to AIP (Figure 3.2a, lanes 5
and 6). To further dissect the role of zwitterionic and anionic lipids in AgrC-I activation,
we reconstituted the receptor into nanodiscs consisting of DMPC and/or DMPG at seven
different ratios. The magnitude of AIP-I-dependent activation increased gradually as the
DMPG content increased, reaching a maximal at a DMPG content of 75% (Figure 3.2c).
These data suggested that a reasonably high negative-charge density, rather than the
presence or absence of any specific lipid per se, is required for the full activation of the
AgrC-I auto-kinase. Thus, all AgrC-I discs in this dissertation, unless noted otherwise,
were assembled from this activation-optimal lipid mixture containing DMPC and DMPG
at a molar ratio of 1:3.

Subsequent success in the expression and purification of AgrC-II and AgrC-III allowed
us to reconstitute these two receptors for comparative studies versus AgrC-I (Figure
3.3a). Unexpectedly, neither AgrC-II nor AgrC-III was activated by the cognate AIP
when embedded in nanodiscs composed of the PG-rich, 1,2-dimyristoyl (DM)
phospholipid mixture (Figure 3.3b, lanes 7 and 8; 19 and 20). In search of a membrane
environment that bolsters their activation, we further varied the fatty-acyl groups of the
lipids participating the reconstitution. Gratifyingly, a mixture of 1-palmitoyl-2-oleyl-snglycero-phosphocholine (POPC) and 1-palmitoyl-2-oleyl-sn-glycero-phosphoglycerol
(POPG) at 1:3 molar ratio supports robust activation to both receptors (Figure 3.3b, lanes
11 and 12; 23 and 24). As a result, auto-kinase assays involving the comparison among
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three AgrC variants were performed on nanodiscs assembled with this lipid mixture. It is
noteworthy, however, that the AgrC nanodiscs prepared using 1-palmitoyl-2-oleyl (PO)
phospholipids did not exhibit solution behaviors as homogenous as those made of DM
phospholipids. The heterogeneity of the former was reflected by the SEC elution profile,
in which a shoulder eluted earlier than the major peak indicated the presence of
abnormally large particles (Figure 3.3c). As a result, only nanodiscs from the major-peak

Figure 3.3 Nanodisc reconstitution of AgrC-II and -III using POPC and POPG
(a) Purification of AgrC-II and AgrC-III from E. coli membrane extracts as analyzed by
SDS-PAGE with CBB-stain. The position of target-protein bands is indicated by “AgrC”.
Bands indicated by asterisks likely correspond the soluble HK domain generated from the
proteolysis of the full-length protein by host proteases. (b) Lipid-composition screen for
AgrC-II and AgrC-III activation: 3 µM AgrC dimer, 12 µM MSP and appropriate amount
of the indicated phospholipid stock were mixed and subject to detergent removal. The
post-assembly mixtures, without further purification, were treated with 20 µM [γ-32P]
ATP, 5 mM MgCl2 and the activator AIP (if indicated) at 37 oC for 40 minutes. pHis
levels were analyzed by autoradiography. (c) SEC traces of post-assembly mixtures
exemplified by AgrC-III discs. Fractions collected between the wider dashed lines were
further analyzed by SDS-PAGE with CBB staining (bottom). Shadow indicates the
segment of elution from which AgrC-III discs with expected sizes were pooled for further
use. (d) SEC-MALS analysis of empty and purified AgrC-III discs. As in Figure 3.1f,
Moverall and Mprotein of the peak were shown in each case; AgrC-III = 52 kDa, MSP = 29
kDa.
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fractions (Figure 3.3c, shadowed area) were collected for biochemical studies. The
expected, one-dimer-per-disc stoichiometry of this nanodisc sample was confirmed
employing SEC-MALS (Figure 3.3d).

3.2 Recapitulation of AIP-dependent regulation of AgrC kinase activity
Both AIP and AgrC from S. aureus subgroup-I have been extensively investigated for
their structure-activity relationships (48, 74, 75, 78). These studies provided access to
potent synthetic AIP agonists and antagonists of this system as well as a body of genetic
data on the cognate RHK, AgrC-I, including the availability of constitutive mutants of the
receptor. Next, we attempted to recapitulate major findings from these studies employing
our in vitro system. Auto-kinase assays revealed a baseline level of activity in AgrC-I
dimers embedded in nanodiscs composed of DMPC-DMPG mixture (Figure 3.4a, lane 5).
Native AIPs from all four S. aureus agr variants also behaved in line with what has been
observed previously in cell-based studies: AIP-I, the cognate AIP, strongly stimulated the
auto-kinase activity of AgrC-I; AIP-II suppressed AgrC-I activity below the basal level
and so acted as an inverse agonist, AIP-III behaved as a neutral antagonist and so did not
effect the basal activity, and AIP-IV was an agonistic ligand with similar efficacy to AIPI (Figure 3.4a, lanes 1-4 and Figure 3.4b) (48). Interestingly, a truncated AIP-I analog, trAIP-I, behaved as a partial agonist of AgrC-I when added at saturating concentrations
(Figure 3.4a, lane 6, Figure 3.4b and c) (48). Importantly, AgrC-I discs were pHis-free
prior to treatment with ATP, and the phosphorylation of AgrC-I survived treatment with a
few common buffer molecules at high concentrations, but was labile to hydroxylamine
treatment, a signature of pHis-containing proteins (Figure 3.4d and e) (141). The
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phosphorylation level also decreased upon incubation with ADP, which is indicative of
the reverse auto-kinase reaction seen in other systems (Figure 3.4d) (142). As expected,
auto-kinase activity was abolished when we reconstituted AgrC-I carrying inactivating

Figure 3.4 Auto-kinase activity and AIP-dependent regulation of AgrC-I
(a and b) Auto-kinase assays with AgrC-I variants or AIP analogs: 1.4 µM nanodiscs
containing AgrC-I wild-type (WT), constitutive mutant R238H (Con), DHp-inactive
mutant H239Q (His) or CA-inactive mutant G394A/G396A (Kin) were phosphorylated
with 20 µM [γ-32P] ATP at 37 oC for 40 minutes. WT-AgrC-I was treated with indicated
AIP peptides; truncated AIP-I is referred to as tr-I or tr-AIP-I. pHis levels were analyzed
by autoradiography in (a) or quantified using scintillation counting in (b). Bar-graph
shows CPM values normalized to the AIP-free reaction. Error bars = SD (n = 3). (c)
Saturation of tr-AIP-I binding to AgrC-I. 1.4µM AgrC-I discs were treated with tr-AIP-I
at indicated concentrations and then incubated with 20 µM [γ-32P] ATP at 37 oC for 40
minutes. Plot shows pHis levels normalized to the peptide-free reaction versus tr-AIP-I
concentration, fit to a saturation-binding model. Error bars = S.D. (n = 3). (d) Stability
test of phosphorylation on AgrC-I. Pre-phosphorylated AgrC-I discs (refer to Figure
3.10c) were treated with indicated reagent at 37 oC for 20 min in a buffer containing 50
mM Tris, pH = 8.0, 100 mM NaCl, 5 mM MgCl2. pHis levels of AgrC-I were analyzed
by anti-pHis immuno-blotting (upper). The blot was CBB-stained thereafter as a loading
control (lower). (e) Hydroxylamine (HA) treatment of phosphorylated AgrC-I. AgrC-I
discs were phosphorylated with ATP (lanes 1 and 2) as described in Figure 3A or mocktreated (lanes 3 and 4) and then incubated with either buffer (lanes 1 and 3) or 500 mM
HA (lanes 2 and 4) at 37oC for 5 min. pHis levels of AgrC-I were then analyzed by
western blotting.
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mutations in either the CA or DHp subdomains (Figure 3.4a, lanes 8 and 9) (71).
Conversely, incorporation of a constitutively active AgrC-I mutant into nanodiscs led to
significantly elevated levels of baseline activity (Figure 3.4a, lane 7) (143), providing
further evidence that this in vitro reconstitution system replicates the cellular behavior of
this RHK.

Quorum sensing is mutually inhibitory among S. aureus subgroups-I, -II and –III.
Because the effects of AIP-II and AIP-III on AgrC-I auto-kinase activity are qualitatively
different, it would be interesting to also distinguish inverse agonism versus neutral
antagonism on kinase activities conferred by other non-cognate AIP-AgrC pairs. To this
end, auto-kinase assays were performed on three AgrC homologs incorporated to POPCPOPG nanodiscs (Figure 3.5a and b). In this membrane environment, AgrC-I exhibited
similar responses to AIP-I and –II, although a slight but significant activation was
observed in the presence of AIP-III. The efficacy of non-cognate AIP binding is
reciprocal between every two groups: AIP-I confers weak activation to AgrC-III, while
all combinations involving AIP or AgrC from the more distantly related group-II causes
repression of the kinase activity. Intriguingly, with the presence of excess cognate AIPs,
AgrC-II and AgrC-III exhibited 70% and 40% the activity of their group-I homolog
(Figure 3.5a and b). The activity ranking of these AgrC homologs in their activated states
is consistent with the order of autoinduction timing of their respective subgroups: the
most active AgrC-I mediates the earliest induction in group-I cells, while group-III cells
harboring the least active AgrC-III induce at highest cell densities (50). Thus, the uneven
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kinase activity in AgrC homologs may act as the intrinsic timer for S. aureus
autoinduction.

3.3 The AgrC-I-AgrA phospho-relay and AgrA dephosphorylation
Phospho-relay from AgrC-I to AgrA was reconstituted by adding the purified full-length
RR to AgrC-I discs that had been pre-phosphorylated with [γ-32P]-ATP and then
exchanged into an ATP-free buffer. Time courses revealed efficient phosphoryl group
transfer between the RHK and RR, with a t1/2 of 66 seconds (Figure 3.6a, lanes 2-8 and
Figure 3.6b). The inclusion of AIP-1 in the mix had little effect on the rate of transfer

Figure 3.5 Comparison of the auto-kinase activity and regulation among S. aureus
subgroups-I, -II and -III
Auto-kinase assays of three AgrC homologs: 1.4 µM POPC-POPG nanodiscs containing
wild-type AgrC-I, AgrC-II or AgrC-III were pre-incubated with the indicated AIP peptide
or vehicle and then treated with 20 µM [γ-32P] ATP and 5 mM MgCl2 at 37 oC for 40
minutes. pHis levels were analyzed by autoradiography in (a) or quantified using
scintillation counting in (b). In (b), bar graph shows CPM values grouped according to
AgrC homologs, with bars colored for different ligand states. Error bar = S.D. (n = 3).
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Figure 3.6 Phospho-relay and phosphatase assays of AgrC-I and AgrA
(a) Phospho-relay from AgrC-I to AgrA: AgrA was incubated with AgrC-I discs labeled
with [γ-32P]-ATP and indicated AIPs. Aliquots removed at various time-points were
analyzed by SDS-PAGE followed by autoradiography. (b) Quantification of the
autoradiograms in panel (a) showing decay of pHis levels in AgrC-I (normalized to t = 0)
as a function of time. Error bars = range (n = 2). (c and d) Dephosphorylation of AgrA:
AgrA (2 µM) was phosphorylated by incubation with the constitutively active chimera
protein GC214 (0.1 µM dimer – see text for details) labeled with a [32P]-phosphoryl
group. This reaction was then supplemented with 2 µM AgrC-I discs and 10 µM AIP-I or
AIP-II as indicated. Progress of the reaction was (c) analyzed by autoradiography and (d)
plotted showing time courses of phosphorylation levels of GC214 (closed circles and
dashed lines) and AgrA (open squares and solid lines). In (d), time courses are colored
according to the presence of AgrC-I and/or indicated AIP. Error bars = S.D. (n = 2). (e)
Kinetics of AgrA chemical dephosphorylation: the AgrC-I-free reaction in (c) was
repeated and samples were withdrawn at more time points for analysis. Phosphorylation
levels of GC214 and AgrA-I were plotted as mean ± S.D. (n = 4). Data symbols and
connecting lines are same as in (d).
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(Figure 3.6a, lanes 10-16 and Figure 3.6b, t1/2 = 52 sec), indicating that the agonist AIP
acts solely at the level of AgrC phosphorylation. Surprisingly, we observed that the
presence of the inhibitor AIP-II slowed down the rate of transfer (Figure 3.6a, lanes 1824 and Figure 3.6b, t1/2 = 140 sec). Thus, this inverse-agonistic AIP can inhibit the TCS
both at the level of HK auto-phosphorylation and phospho-relay to the RR. Whether
similar inhibition of phospho-relay occurs in other inverse-agonistic AIP-AgrC
interactions is currently under investigation.

Next we asked if AgrC possesses any phosphatase activity against phosphorylated AgrA,
an activity common among RHKs (69). Since AgrA forms precipitate quickly following
acetyl-phosphate treatment (data not shown), we employed an enzymatic approach to
phosphorylate AgrA in situ using a soluble, highly active AgrC variant (GC214, see
Chapter 4) as the phospho-donor. We then monitored the decay of [32P]-phosphorylated
AgrA in the presence or absence of AgrC-I disks. Surprisingly, we found no acceleration
of AgrA dephosphorylation in the presence of AgrC-I disks at 20-fold excess to the
GC214 phospho-donor (Figure 3.6c, compare lanes 1-6 to 7-12, and Figure 3.6d).
Inclusion of either AIP-I or AIP-II along with AgrC-I discs also had no effect (Figure
3.6c, lanes 13-18, 19-24 and Figure 3.6d). Consequently, the decrease in AgrA
phosphorylation levels is due to the self-catalyzed dephosphorylation of the RR, with a
t1/2 of 3.9 minutes (Figures 3.6c and e). We therefore conclude that AIP signals do not
regulate agr signaling at the level of RR dephosphorylation.
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3.4 Physicochemical parameters of the AIP-I-AgrC-I interaction
All S. aureus AIPs feature a 5-residue macrocycle closed by a thiolactone bond formed
by condensation of the sulfhydryl group of a conserved cysteine and the peptide Cterminus (Figure 3.7a). It has been speculated that the intrinsic chemical reactivity of this
thiolactone could lead to a covalent interaction, either irreversible or transient, with AgrC

Figure 3.7 Ring-opening of the thiolactone is involved in AIP-AgrC interactions
(a) Schematic presentation of AIP-I and FAM-AIP-I. (b) Diagram showing the AgrCmediated ring-opening hypothesis (see text for details) and the rationale to capture the
covalent adduct employing iodoacetamide. (c) Stability test of AIPs in the presence of
AgrC-I discs: AIP-I or AIP-II (2 nmol) were incubated in the presence or absence of
AgrC-I discs (0.2 nmol) at 37oC. Percentage of intact AIP that remained after each
treatment was quantified using HPLC and plotted as mean ± SD (n = 3). (d) AgrC-I discs
were phosphorylated as described in Figure 3.2a with the indicated peptides (10 µM) for
3 minutes. The reactions were then analyzed by western blotting. (e) Attempt to capture
the putative covalent adduct between FAM-AIP-I and AgrC-I: AgrC-I discs (2 µM) were
incubated with vehicle (DMSO) or FAM-AIP-I (5 µM) at 37oC for 30min followed by
treatment with vehicle (buffer) or 50 mM iodoacetamide at 37oC for 30min. The reaction
mixture was analyzed by non-reducing SDS-PAGE and visualized by fluorescence (top
and middle panels). The gel was then stained with CBB for loading control (bottom
panel).
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(see Figure 3.7b) (25). This was readily tested using our in vitro system. The free levels
of intact AIP-I or AIP-II did not change after treatment with AgrC-I nanodiscs, indicating
that receptor engagement does not lead to an irreversible adduct or to release of
hydrolyzed peptide (Figure 3.7c). Conceivably, the covalent adduct could be transient
and chemically reversible. To explore this, we exploited a fluorescein-labeled AIP-I
analog (FAM-AIP-I) that has AgrC-I agonist activity indistinguishable from that of the
native AIP-I (Figure 3.7a and d) (48). Incubation of FAM-AIP-I and AgrC-I nanodiscs in
the presence of excess iodoacetamide, which would alkylate the newly generated cysteine
within the linearized AIP and hence trap the putative adduct, failed to produce any
fluorescently labeled AgrC-I as indicated by non-reducing SDS-PAGE (Figure 3.7b and
e). We therefore conclude that the AIP-AgrC complex does not rely on the chemical
reactivity of the thiolactone bond.

We next turned to the stoichiometry of the AIP-AgrC binding interaction. For this we
titrated AIP into AgrC-I nanodiscs fixed at a concentration of 1.25 µM, about two orders
of magnitude higher than the EC50 value for AIP-I (25, 48). Assuming that the EC50 value
is a reasonable estimate of the KD value (vide infra), the AIP-I added to the system should
bind to AgrC-I in a linear fashion until saturation of binding sites is achieved. The autokinase activity of AgrC-I was used as a measure of the level of AIP-I binding. As
predicted, the initial auto-kinase velocity of the system first increased linearly and then
reached a plateau after the AIP-I concentration reached ~2 equivalents with respect to
AgrC-I nanodiscs (Figure 3.8a). These observations strongly suggest that each AgrC-I
dimer possesses two binding sites for AIP-I, and more intriguingly, that AIP-I binding at
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one site causes the same level of auto-kinase activation regardless of the occupancy of the
other site – i.e., there is no evidence of cooperatives binding between the two subunits.

Figure 3.8 The stoichiometry and dissociation constants of the interaction between
AgrC-I and AIPs
(a) Stoichiometry of the AgrC-I/AIP-I interaction. AgrC-I discs were incubated with 20
µM [γ-32P]-ATP along with AIP-I at different concentrations and in each case the initial
auto-kinase velocity (vi) was determined by monitoring build-up of radio-labeled AgrC-I
over time using autoradiography. Plot shows vi (normalized to the AIP-free reaction)
versus [AIP-I]/[AgrC-I disc] ratio. Error bars = SD (n = 3). (b) Equilibrium binding of
FAM-AIP-I to AgrC-I discs. Corrected steady-state anisotropy change (ΔSSAc, see
Section 7.4.3) of FAM-AIP-I fluorescence was plotted as a function of added wild-type
(open circle and solid line) or mutant (S109VS116I, closed circles and dashed line)
AgrC-I discs and fit to a Hill equation. One representative titration of 4 is shown. Error
bars (technical) = SEM (n = 6). (c) Auto-kinase activation of AgrC-IS109VS116I dimers:
0.25 µM nanodiscs containing wild-type AgrC-I dimers (left four lanes) or AgrCIS109VS116I mutant dimers (right four lanes) were incubated with 1 mM ATP, 5 mM MgCl2
and AIP-I at indicated concentrations at 37oC for 3min. The reactions were then analyzed
by anti-pHis western-blotting (top) and Coomassie blue staining (bottom). (d)
Equilibrium binding of native AIPs to AgrC-I discs based on competitive displacement of
FAM-AIP-I from AgrC-I. ΔSSA of FAM-AIP-I is plotted as a function of added AIP-I
(open squares and the dashed curve) or AIP-II (closed triangles and the solid curve). The
data are fit to a competitive binding model (see Section 7.4.3). One representative
titration of 3 is shown. Error bars (technical) = SEM (n = 6).
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FAM-AIP-I also provided us with an opportunity to measure the equilibrium binding
affinity of the AIP-AgrC interaction using a fluorescence-based assay. The fluorescence
anisotropy of FAM-AIP-I was monitored as a function of added AgrC-I nanodiscs and
the data fit to a transformed Hill equation (Figure 3.8b). The binding isotherm yielded a
KD for FAM-AIP-I binding to AgrC-I of 122 ± 26 nM (n = 4), with a Hill coefficient of
0.97 ± 0.20. Importantly, we observed no change in anisotropy when AIP-I was titrated
with nanodiscs containing an AgrC-IS109VS116I mutant that is defective in AIP-I-dependent
activation (Figure 3.8b and c) (75). The lack of cooperation in the interaction between
AIP-I and AgrC-I correlates well with the independent, but additive, role of the two
binding sites in the auto-kinase activation of AgrC-I. The KD for native AIP-I and AIP-II
were 63 ± 13nM (n = 3) and 160 ± 20nM (n = 3), respectively, obtained from competitive
titrations of a pre-formed complex between FAM-AIP-I and AgrC-I (Figure 3.8d). The
KD for AIP-I was 2.2-fold greater than its EC50 (28nM) obtained from reporter-gene
assays, likely due to amplification effects in AgrC-mediated two-component signaling,
which have been seen in other types of signal transduction pathways (48).

3.5 Nucleotide specificity and kinetics of AgrC-I auto-phosphorylation
Atomic-resolution structures of CA subdomains in complex with adenosine nucleotides
reveal a role for the conserved ‘G1 box’ residues in nucleotide binding: the amine group
of the adenine ring hydrogen bonds to the Asp residue, while the negative charge on the
Asp is stabilized by interactions with the backbone amides of the two glycine residues
(Figure 3.9a) (123). Sequence analysis described in Chapter 2 suggested that AgrC-I
lacks these key residues and, therefore, the interaction between CA subdomain and ATP
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might be altered (Figure 3.9b). Notably, the Asn residue aligned to the position of the
conserved Asp is reminiscent of a GTP-dependent RHK, BA2291 from Bacillus
anthracis (144). This notwithstanding, AgrC-I apparently favors ATP over GTP, as no
substantial phosphorylation was observed upon incubation with the latter (Figure 3.9c).

To further investigate the influence of this non-canonical G1 motif on nucleotide binding,
we determined the apparent Km values for the cofactor in the presence or absence of AIPI using dot-blot-based kinetic assays (Figure 3.10a). The first-order kinetic constant (k1)
for AgrC-I auto-phosphorylation was determined at a series of ATP concentrations and fit

Figure 3-9 Nucleotide specificity of AgrC-I
(a) Diagram depicting the adenine binding by conserved G1-box residues in the crystal
structure of HK853 from Thermotoga maritime (PDB ID: 2c2a). The CA subdomain of
HK853 is shown as ribbon diagram in green, with ADP and the conserved Asp411,
Gly413 and Gly415 of HK853 highlighted by stick models. Two water molecules are
shown in red spheres, and hydrogen bonds in black dashed lines. An α-helix stacking
against the ADP nucleotide is omitted for clarity. (b) Sequence alignment showing the
G1 box in S. aureus AgrC and B. anthracis BA2291 versus three RHKs carrying
canonical G1-box sequences. Conserved Asp and Gly in canonical G1-boxes, Asn
residues aligned to the conserved Asp and a hydrophobic position well-aligned in all
sequences are highlighted in blue, green and red, respectively. (c) Nucleotide specificity
of AgrC-I: AgrC-I discs were incubated with 1 mM ATP or GTP, 5 mM MgCl2 and
excess AIP-I peptide at 37oC. Aliquots were removed from each reaction at indicated
time points, spotted in a row on the blotting membrane and analyzed for pHis levels
through immuno-blotting. (d) Comparison of the Km for ATP among RHKs. All shown
RHKs except AgrC possess canonical G1-box sequences.
	
  

65	
  

to the Michaelis-Menten kinetic model (Figure 3.10b). As expected, the presence of AIPI stimulated receptor auto-phosphorylation, reflected in an ~8-fold increase in the

Figure 3.10 Kinetics of the forward and reverse auto-kinase reactions in AgrC-I
(a and b) Kinetics of the auto-kinase reaction: AgrC-I discs were incubated at 37 oC with
ATP (at indicated concentration) and 5 mM MgCl2 in the presence or absence of 10 µM
AIP-I peptide. Aliquots were removed from each reaction at indicated time points and
spotted in a row on the blotting membrane. pHis levels of AgrC-I in each reaction were
(a) analyzed by anti-pHis immuno-blotting and (b) converted into first-order kinetic
constants and plotted as a function of ATP concentration for reactions in the presence
(open square, dashed curve) or absence (closed circles, solid curve) of 10 µM AIP-I.
Error bar = SD (n = 3). In (b), one representative membrane of three is shown. (c) Prephosphorylated AgrC-I discs analyzed by size-exclusion chromatography. Fractions
collected between the dashed lines were further analyzed by western blotting with antipHis antibody (inset). (d-f) Kinetics of the reverse reaction: pre-phosphorylated AgrC-I
discs were incubated at 37 oC with ADP (at indicated concentration) and 5 mM MgCl2 in
the presence or absence of 10 µM AIP-I peptide. Reactions were analyzed as in (a) and
Michaelis-Menten plotting was performed as in (b).
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Table 3.1 Kinetic parameters of AgrC-I forward and reverse auto-kinase activities
-1
KM (mM)
Reactions
AIP-I (µM)
k (min )a
max

Forward
10
Forward
0
Reverse
10
Reverse
0
a: kmax, the maximal first-order kinetic constant.

1.5 ± 0.5
2.8 ± 0.4
0.17 ± 0.06
0.26 ± 0.07

3.0 ± 0.5
0.33 ± 0.03
6.9 ± 0.6
7.2 ± 0.5

maximum first-order rate constant, kmax, compared to the apo receptor (Table 3.1). The
apparent Km for ATP was 2.8 mM for apo-AgrC-I and 1.5 mM for AIP-I-bound AgrC-I,
both at least an order of magnitude larger than a few well-characterized RHKs with
normal G1 boxes (Figure 3.9d) (142, 145, 146). Therefore, sequence variation in the G1box weakened the affinity between ATP and AgrC-I presumably due in part to the
substitution of a neutral Asn residue for a stronger hydrogen-bond acceptor, Asp.
Intriguingly, mutation of the G1-Asn back to Asp in AgrC-I abolished the auto-kinase
activity (data not shown), suggesting that the AgrC ATP-binding pocket has co-evolved
with this conserved Asn and is no longer able to adapt to its replacement by Asp.

A similar kinetic characterization was performed for the reverse auto-kinase reaction, in
which phosphorylated receptor transfers the phosphoryl group back to ADP. AgrC-I discs
were first phosphorylated in the absence of AIP and then separated from nucleotides
using size-exclusion chromatography (Figure 3.10c). Using this protocol, 52.5% of the
histidine sites were phosphorylated in the product. Kinetic constants for the reverse
reaction were determined at a series of ADP concentrations in the presence or absence of
AIP-I (Figures 3.10d and 3.10e). The reverse reaction was significantly more efficient:
the Km for ADP was lower while the kmax was higher than the forward reaction (Figure
3.10f and Table 3.1). This observation is consistent with the more favorable free energy
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of hydrolysis of phosphohistidine compared to ATP (-13 kcal/mol vs. -7.3 kcal/mol)
(141). More surprisingly, and in stark contrast to the forward reaction, the presence of
AIP-I had no significant effect on the efficiency of the reverse reaction. Thus, AIP-I
binding to AgrC-I shifts the equilibrium in the favor of the forward reaction.

3.6 Summary and discussions
In this Chapter, we have presented a comprehensive biochemical characterization of the
AgrCA TCS. We found that AgrC-I dimers reconstituted into lipid nanodiscs possess a
substantial level of basal activity. The cognate autoinducer non-cooperatively binds to
AgrC-I in a 2:2 stoichiometry with nanomolar affinity, with individual binding events
adding equally to stimulate the auto-kinase activity of the RHK. The pHis moiety on
auto-phosphorylated AgrC-I is stable under physiological conditions, but rapidly transfers
the phosphoryl group to AgrA. Remarkably, AgrC homologs from three S. aureus
subgroups exhibit uneven auto-kinase activities in the activator-bound state. Meanwhile,
AgrC lacks any detectable phosphatase activity, leaving self-catalyzed AgrA
dephosphorylation the only reaction that counteracts the phospho-relay cascade. These
biochemical properties are likely to play essential roles in controlling the onset of
virulence in S. aureus. At low cell density, for instance, the basal auto-kinase activity of
AgrC maintains a low level of phosphorylated AgrA that, due to its differential affinity to
the regulatory elements in the P2 and P3 promoter regions, enables baseline transcription
of the P2 operon rather than P3 (88). AIP, produced as a consequence, would accumulate
to levels that significantly activate the AgrCA TCS during log-phase bacterial growth.
The strong affinity of AIP for AgrC, the lack of phosphatase activity in AgrC, and the
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positive feedback of the autoinduction loop collectively leads to a burst of RNAIII
production and thereby an abrupt switch into a high-density, virulent mode of life. Since
AgrA, and hence the kinetics of AgrA chemical dephosphorylation is conserved, the
kinase activity conferred by the activated RHK is therefore most likely responsible for
the difference in autoinduction timing among S. aureus subgroups (50). Finally, the t1/2 of
phosphorylated AgrA is a mere 3.9 minutes at 37oC, shorter than most characterized
transcription-factor RRs including the E. coli osmolarity RR, OmpR (t1/2 ~ 70min), the E.
coli cation-homeostasis RR, PhoB (t1/2 ~ 15min) and the B. subtilis sporulation regulator
Spo0A (t1/2 ~ 7 min) (147). This enables agr-activated cells to rapidly turn off virulon
expression and revert to vegetative growth if separated from the quorum.

AgrC-I is also distinguished from most other characterized RHKs by its dramatically
lowered affinity for adenosine nucleotides, likely due to substitutions in the G1-box. We
reason that this atypically low affinity might allow AgrC to sense cellular ATP levels,
which vary significantly between optimal and stress conditions. Indeed, down regulation
of accessory gene expression in times of nutrient or oxygen deprivation had been
reported (29). Since the cellular ATP concentration data is not available for S. aureus, the
values for E. coli must be used as a reference (148). With abundant carbon source, E. coli
contains approximately 3.5 mM cellular ATP, which decreases to sub-milimolar levels at
stationary phase, or after switching to a weaker electron acceptor for respiration.
Assuming similar variations in S. aureus, a drastic decrease in the auto-kinase activity
would be expected for AgrC (apparent Km for AgrC-I ~2 mM) under nutrient-limiting or
anaerobic conditions. Thus, we propose that inactivation of the virulon under stress
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conditions is at least partly a consequence of the acute sensitivity of AgrC to falling ATP
levels, ultimately leading to a down-regulation of the agr response. This sensitivity may
extend to processes mediated by other receptors of the HPK10 subfamily given the
conserved nature of the altered G1-box.

During the course of our reconstitution studies, a remarkable dependence on anionic
bilayer environment was found for AgrC-I activation. The exact basis of this lipidsensitivity in AgrC-I activation remains unclear. We did, however, rule out the possibility
of global misfolding for AgrC-I embedded in 100% DMPC nanodiscs in that it forms
dimers that bind to a fluorescent AIP-I analog, albeit without any resulting auto-kinase
stimulation (Figure 3.2a and c). Given the highly basic amino acid sequence of the AgrCI sensor domain (theoretical pI = 9.3), we speculate that anionic lipids enable competent
conformational coupling between the AIP-binding site and AgrC-IHK by neutralizing
excessive positive charges in the sensor domain. Intriguingly, the strongly anionic cell
membrane found in S. aureus is shared among other species from the low-GC Grampositive phylum (Firmicutes), and distinguishes them from those representing major
Gram-negative phyla (149). In addition, our bioinformatic analysis revealed a striking
restriction of the HPK10 subfamily, to which AgrC belongs, to the phylum Firmicutes.
All characterized RHKs from this subfamily are receptors of peptidic pheromones, and,
perhaps not coincidentally, peptide-mediated QS is not known in any Gram negative
species. A plausible explanation for this taxonomic boundary is that HPK10 subfamily
receptors are all evolved in, and presumably well adapted to, the anionic lipid
environment. Such adaptation, if generally present, would create a considerable barrier to
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horizontal gene transfer of HPK10 homologs into Gram-negative species, which have
PE-rich inner membranes. Biochemical studies into additional HPK10 homologs, perhaps
using the nanodisc technology employed herein, might lend further support to the idea
that peptide-responsive RHKs are restricted to Gram-negative bacteria because of the
lipid composition of their membranes.
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Chapter Four: Mechanisms by which AgrC-I Responds to Signals
Quorum-sensing machineries in bacterial pathogens have been long regarded as potential
therapeutic targets and, consequently, previous drug-development campaigns provide a
broad spectrum of small-molecule ligands for several QS-mediating RHKs including
AgrC-I (27). Among all these RHKs, S. aureus AgrC-I stands out for its versatility in
ligand response (48). In line with the observations made from reporter strains, using the
in vitro reconstitution system described in Chapter 3, distinct levels of kinase activity
have been observed for AgrC-I in at least four ligand states (Figure 3.4a), contradicting
the common on/off switch view for RHKs (150). To understand this signaling flexibility
of AgrC, two pieces of information are needed, namely (i) the conformational change of
the AgrC-I HK domain induced by AIP binding and (ii) the response of the AgrC-I HK
activities to diverse conformational changes. Importantly, ligand-induced molecular
motions have never been detected for any membrane-bound RHKs prior to our study. In
this chapter, we first systematically perturb the conformation of the AgrC-I HK domain,
employing a protein-chimera strategy, in order to chart a conformation-activity landscape
of this module. The nanodisc reconstitution system was then harnessed for the detection
of molecular motions triggered by AIP binding.

Constitutive mutants of AgrC-I have been identified previously employing a libraryscreening approach (143). These mutants, although all capable of activating P3-driven
gene expression in reporter strains in the absence of AIP-I, vary dramatically with their
signaling behavior. Some mutants, for instance, do not respond to any AIP added, while
others are often revertible by AIP-II but not AIP-III. Interestingly, mutants in the first
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category all bear mutations in the HK domain, while those in the second may carry
mutations in either the sensor or the HK domain. In this chapter, we sought to understand
(i) how a constitutive mutation in the HK domain, R238H, alters the conformationactivity landscape and (ii) why AIP-II is able to revert constitutive activity of a subset of
mutants. Besides explaining some interesting in vivo phenotypes, the diverse in vitro
behaviors of these mutants revealed in this work expand our view on the evolvability of
the signal-response properties of AgrC-I.

4.1 Perturbing the conformation of the AgrC-I HK domain
Structural and functional studies on isolated HK domains have given rise to models of
receptor activation involving rotation of helices that comprise the DHp subdomain
(Figure 4.1a) (123, 150). These helical movements are thought to modify packing of the
DHp leading to a repositioning of the CA subdomain such that phosphorylation of the His
is, or is not, permitted on the basis of spatial proximity (123). This “helix-rotation” model
entails a relatively rigid linkage between the DHp subdomain and the preceding sensor or
transmission domains to enable effective propagation of conformational changes
generated by the sensor. Interestingly, in crystal structures obtained for dimeric RHKs,
the linkers between the DHp subdomain and the preceding module predominantly form a
pair of α-helices, extending the first α-helix of each DHp subdomain (DHp-α1) (123,
151-153). The possibility of the AgrC-I interdomain linker (residues 201-221) being
helical is particularly attractive because it would allow the formation of a contiguous
helix spanning the last TM domain, the linker and the DHp-α1, providing a ready conduit
for the conformational change in the sensor being transmitted to the HK domain (Figure
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4.1b). This idea is supported by or analysis of the amino-acid composition of the
interdomain linker sequence across the HPK10 subfamily (Figure 4.1c). Helical-breaking
residues, namely glycine and proline, are strongly underrepresented in this region
compared to their average frequency in proteins (154), suggesting a strong propensity of

Figure 4.1 An α-helical linker connecting the AgrC-I sensor and HK domains.
(a) Structural alignment of the DHp subdomain in the T. maritima RHK, HK853,
captured at the resting (green) and phosphatase-active (blue) states. Cβ atoms on residues
249 and 253 in the DHp-α1 are highlighted with spheres to help visualize the structural
rearrangement of the four-helix bundle. (b) Cartoon of full-length AgrC-I showing αhelical interdomain linkers (in red). Helical nucleation that would stabilize the linker
helix is highlighted with arrows. (c) Amino acid frequency in the interdomain linkers
within HPK10 sequences. Frequency of each amino acid is normalized to its overall
composition in proteins. Under-represented amino acids are indicated with arrows. (d)
Sequence of the wild-type linker peptide (upper) and the L205PM208P mutant peptide
(lower). Mutated residues are highlighted in red. (e) Helical content of linker peptides:
plot shows calculated helical content as a function of % TFE for the wild-type (black)
and L205P/M208P mutant (red) peptides. CD spectroscopy was performed at 20oC. The
15-µM peptide samples were prepared in buffers containing 10 mM phosphate, pH = 7.0
and 50 mM NaF and the indicated percentage of TFE (v/v). (f) Auto-kinase activation of
AgrC-IL205P/M208P mutant: nanodiscs containing wild-type (WT) or mutant AgrC-I dimers
were phosphorylated with [γ-32P]-ATP and analyzed by autoradiography. CBB indicates
the Coomassie-stained loading control.

	
  

74	
  

α-helix formation in this region (Figure 4.1c). Furthermore, we synthesized two peptides
corresponding to the AgrC-I linker, one with the wild-type sequence and the other with
two residues, Leu 205 and Met 208, mutated to Pro (Figure 4.1d). Analysis of these
peptides by circular dichroism (CD) spectroscopy revealed, in the presence of 20% (v/v)
2,2,2-trifluroethanol (TFE), high helical propensity in the wild-type peptide, which is
greatly attenuated in the case of the mutant (Figure 4.1e). No helicity was found in the
complete absence of TFE, suggesting that packing between two (or more) linkers is not
strong enough to stabilize the helical conformation as in classical coiled coil peptides.
Notably, this finding does not conflict with the linkers being helical in full-length AgrC-I
in which its helicity could be further promoted by the presence of flanking helical
elements through helical propagation (155). The L205P/M208P mutations that
diminished helicity of the linker peptide abolished the AIP-I-dependent kinase activation
in full-length AgrC-I, further underscoring the importance of the helical continuity in this
region (Figure 4.1f).

Given the dimeric configuration of the AgrC-I HK domain and the helical propensity of
the interdomain linker, we hypothesized that fusing the linker to a GCN4 peptide, which
adopts a dimeric, parallel coiled-coil conformation, would lend control to the rotational
conformation of the interdomain linker pair (Figure 4.2a). The GCN4 dimer is extremely
stable (KD = 0.28 nM) (156), which we expected to provide the rigid body needed to
impose twisting force on the appended linker region, presumably driving the
conformation away from the resting state. We prepared 15 chimera proteins, each
comprising an N-terminal GCN4 coiled-coil sequence and a C-terminal AgrC-I HK
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domain separated by an intervening interdomain linker segment of variable length. These
protein chimeras were termed GC205 to GC219 after GCN4-AgrC-I and the position of
the first AgrC-I residue fused to GCN4, to which we refer as the junction residue. Since
the C-terminal residue of the GCN4 portion registers at the ‘d’ position in the classic

Figure 4.2 Design principles of the GCN4-AgrC-I chimera series
(a) Cartoon of a GCN4-AgrC-I chimera with the interface between the GCN4 (in cyan)
and the interdomain linker (in red) indicated by a blue plane. The DHp and CA
subdomains are colored brown and green, respectively. Right panel, coiled-coil helical
wheel representation of the interface highlighting the register of the last residue of GCN4
(‘d’, in blue) and the junction residue (‘e’, in red). (b) Design of GCN4-AgrC-I chimera
proteins. The 25-aa GCN4 coiled-coil was sequentially fused to residues in the
interdomain linker. GCN4 residues registering at coiled-coil position ‘d’ are noted
underneath the sequence in blue. (c) Limited trypsinolysis of AgrC-I205-430 and three
chimera proteins: substrate proteins (4 mg/mL) were incubated with trypsin (60 µg/mL)
in ice for 20min. The reactions were stopped using protease inhibitors and resolved on
SDS-PAGE. Tryptic fragments either including the peptide bond next to Arg212 or
generated from the cleavage at this site are identified employing HPLC-MS (now shown).
Corresponding gel bands of these fragments are recognized based on their molecular
weight and abundance, and highlighted with cartoons and arrows.
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coiled-coil helical wheel, we inferred that the junction residue in each chimera should be
moved to the ‘e’ position (Figure 4-2b). Because the resting register of the linker residues
in full-length AgrC-I follows the α-helical periodicity, the magnitude that these chimeras
twist the linkers away from their resting conformation should exhibit the same periodicity
with respect to the linker length between the GCN4 coiled coil and the AgrC-I HK
domain.

Structural integrity of the interdomain-linker in these chimera proteins was preliminarily
investigated employing limited trypsinolysis. The peptide bond next to Arg212 in the
linker is highly susceptible to trypsin cleavage in an intracellular AgrC-I construct, AgrCI205-430 (Figure 4-2c). This result is reminiscent of the lack of helicity in the standalone
linker peptide, as was revealed in the CD-spectrometry experiment in the absence of
TFE. This peptide bond gains resistance against trypsin cleavage, however, in GC205,
GC206 and GC207 (Figure 4-2c), suggesting a more defined linker structure in these
chimera proteins. It is therefore highly probable that the interdomain linker adopts stable
helical conformations only when sandwiched by two other helical elements: this
requirement is fulfilled in both full-length AgrC and GCN4-AgrC-I chimeras, but not in
AgrC-I205-430.

4.2 Conformation-activity landscape of the AgrC-I HK domain and the molecular
motion induced in full-length AgrC-I by AIP-I or AIP-II binding
All 15 GCN4-AgrC-I chimeras were expressed in E. coli and purified for auto-kinase
assays. Strikingly, the phosphorylation levels of these GCN4-AgrC-I fusion proteins
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fluctuated periodically with the length of the linker (Figure 4.3a). The periodicity,
obtained from fitting the data to a sine wave function, was 3.6, constituting one turn of an
α-helix (Figure 4.3b). Because the magnitude of twisting applied to the linkers is also
expected to follow the same periodicity, this result directly correlates the auto-kinase

Figure 4.3 Twisting of the interdomain linkers exercises rheostat-like control over
the auto-kinase activity of the AgrC-I HK domain.
(a) Auto-kinase activities of GCN4-AgrC-I chimeras: dimeric chimeras and AgrC-I discs
(with or without added AIP as indicated) were treated with [γ-32P]-ATP and analyzed by
autoradiography as in Figure 4.1f. Linker length (in residues) is indicated underneath the
loading control. (b) Quantification of the data in panel (a). Plot shows normalized
phosphorylation levels of the chimeras (normalized to that of the apo-AgrC-I discs) as a
function of the linker length. Curve is a sinusoidal function fit to the data. Error bars =
SD (n = 3). (c) Classical helical wheel showing the angle (θ) by which each position on
the linker helix deviates from position 209. Since the linker conformation in GC209
resembles that of AgrC-I in the resting state (refer to Figure 4.4d and e), the putative
twisting angle imposed to the linker helices in each GCN4-AgrC-I chimera should be the
inverse number of θ for its junction residue position. (d) The conformation-activity
landscape of the AgrC-I HK domain: Plot shows activity of all 15 GCN4-AgrC-I
chimeras versus the putative twisting angle. Error bar = S.D. (n = 3).
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activity to the twisting movement of the linkers. Consequently, a conformation-activity
landscape is obtained from plotting the auto-kinase activity of each chimera with the
putative twisting angle of the linkers away from their resting conformation represented by
that in GC209 (Figure 4.3c and d, see below for the reason why GC209 is the reference).
This landscape is remarkably smooth, allowing the rheostat-like control of the kinase
activity by gradually twisting the linker helices. Chimeras with activity equivalent to that
of AgrC-I in all three ligand states were found (Figure 4.3a), suggesting that the liganddependent differential activities of the full-length receptor might also be achieved
through adjusting the linker conformation.

A Cys crosslinking strategy was used to study the conformational changes in the linker
region of full-length AgrC-I that accompany AIP binding. Based on the helical twisting
model that emerged from the GCN4 chimera data, we hypothesized that, depending on
the location of the Cys and the ligand state of the receptor, inter-subunit disulfide bonds
would be more or less likely to form under oxidizing conditions. The absence of native
Cys residues in the linker region facilitated this approach (Figure 4.1d). Five AgrC-I
mutants with Cys replacements at residues 205-209 were expressed, purified and
incorporated into nanodiscs. The mutants behaved similarly to wild-type AgrC-I in terms
of their auto-kinase response to agonist and antagonist AIPs (Figure 4.4a). Non-reducing
SDS-PAGE analysis of the mutants following oxidation with glutathione revealed a
marked difference in the amount of covalent dimer formed depending on the mutant and
the presence or absence of AIP (Figure 4.4b). The yield of covalent dimer from each
sample was normalized for loading, and grouped according to three activity states (apo,
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Figure 4.4. AIP binding induces rotational movement of the AgrC-I linker helices
(a) Auto-kinase activities of AgrC-I single-point Cys mutants. Nanodiscs containing
wild-type or Cys-mutant AgrC-I dimers were incubated with 20 µM [γ-32P]-ATP, 5 mM
MgCl2 and excess AIP peptide (as indicated) at 37oC for 40min. 32P-labeled AgrC-I in
each reaction was quantified through scintillation counting. Error bar = SD (n = 3). (b
and c) inter-subunit crosslinking of AgrC-I single-point Cys mutants: nanodiscs
incorporated with wild-type or mutant AgrC-I dimers were mock-treated or incubated
with 10 mM oxidized glutathione (GSSG) along with indicated AIPs. (b) Formation of
covalent dimers as analyzed by SDS-PAGE with Coomassie stain. MSP, membrane
scaffold protein. (c) Quantification of the crosslinking results. Plot shows levels of
disulfide-linked dimer formation normalized to loading, grouped according to the three
ligand states. Error bars = SD (n = 3). (d) Rotation of the interdomain linker helices in
AgrC-I induced by AIP binding. Top: Cartoons of AgrC-I dimer in the apo- (middle),
AIP-I-bound (left) and AIP-II-bound (right) states. Bottom: The corresponding
conformation of the linker helices is depicted with helical wheels showing the positions
205-209 according to the Cys crosslinking results. Ligand binding and the consequent
rotation of linker helices are highlighted between panels. (e) Auto-kinase activities of
chimera proteins in which interdomain linker conformation mimics that of AgrC-I in
three ligand states: plot shows normalized phosphorylation levels of GC205 through
GC212 as a function of junction residue positions (with AgrC-I numbering). Linkerconformation surrogate of each AgrC-I activity state is marked with an arrow.
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AIP-I-bound or AIP-II-bound) as in Figure 4.4c. This revealed a periodicity within each
state that, analogous to the GCN4 chimera data, could be interpreted by assigning
parallel, juxtaposed helical structure to the linkers (Figure 4.4d). When analyzed in this
way, the linker helices within the apo-AgrC-I dimer are oriented such that positions 205,
208 and 209 are juxtaposed and able to form crosslinks when Cys residues are placed at
these sites. Binding of the AIP-I activator leads to a ~80° counter-clockwise rotation of
the two linker helices in the dimer such that residues 206 and 209 are now in optimal
position to form crosslinks. Conversely, binding of the AIP-II inhibitor leads to a ~30°
clockwise rotation of the helices from the resting state resulting in residue 208 being
optimal for crosslinking.

This interpretation of the crosslinking data was used to further analyze the differential
activity associated with GCN4-chimeras. As noted above, the junction residue in each
chimera can be assigned to the ‘e’ position of the coiled-coil helical wheel. Based on this
logic, we predict that GC209, GC210 and GC205 should be conformational surrogates of
the apo-, AIP-I- and AIP-II-bound forms of AgrC-I, respectively (Figure 4.4d, refer to
Figure 4.3b for the register of position ‘e’). Remarkably, these chimeras accurately
phenocopy the three activity states of AgrC-I: compared to GC209, GC210 had much
higher auto-kinase activity while GC205 was not as active (Figure 4.4e). We therefore
conclude that ligand binding regulates the auto-kinase activity of AgrC-I by inducing
symmetric rotation in the helical TMH-DHp linker region.
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4.3 A constitutive mutation, R238H, modifies the conformation-activity landscape.
AgrC-IR238H is the most prominent and robust constitutive mutant among all such mutants
identified for AgrC-I. It conveys full activation to the P3-driven gene expression in the
absence of any ligand and, therefore, has been employed in a few studies as a surrogate of
wild-type AgrC-I in the AIP-I-bound state. The R238H mutation, however, occurs within
the DHp subdomain, suggesting a modulation of the input-response property of the HK
domain rather than the conformational states of the sensor. Perhaps as a consequence, the
activity of P3-driven reporter genes in S. aureus expressing this mutant is unaffected by
the presence of AIP-I or AIP-II. Being aware of the non-linearity of the reporter-gene
readout, we decided to further investigate the effect of both AIPs on the kinase activity of
nanodisc-embedded AgrC-IR238H.

AgrC-IR238H was expressed and purified from E. coli and reconstituted to nanodiscs in
which the lipid bilayer consists of POPC and POPG at a molar ratio of 1:3. Wild-type
AgrC-I discs of the same lipid composition were used for back-to-back comparison in the
auto-kinase assay. AgrC-IR238H had a strong baseline activity, which elevated only
moderately when the RHK binds to the activator AIP-I (Figures 4.5a and b). By contrast,
the wild-type RHK, although exhibiting a much lower baseline activity in the apo state,
was turned on by AIP-I-binding so potently that its activity surpassed that of the mutant
in the activated state (Figures 4.5a and b). This mutation also diminished the inhibitory
effect of AIP-II on the auto-kinase activity (Figures 4.5a and b). Consistent with the
unchanged sensor domain in this mutant, binding affinities of AIP peptides are largely
unaffected. The fluorophore-tagged AIP, for instance, binds to AgrC-IR238H discs with
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slightly stronger affinity than to the wild-type (51 vs 122 nM), as was determined in the
titration experiment employing a fluorescent-anisotropy readout (Figure 4.5c). The
presence of excess AIP-I or AIP-II effectively displaces FAM-AIP-I from its binding site
on the mutant (Figure 4.5d). We surmise, based on these observations, that this mutation
renders the AgrC-I HK domain less sensitive to the conformational input from the sensor
domains, rather than elevating its kinase activity at all conformational states.

Figure 4.5 Auto-kinase activity and ligand responses of AgrC-IR238H
(a and b) Auto-kinase assays comparing the R238H mutant to the wild type: the
nanodisc-incorporated receptors were pre-incubated with indicated AIP-peptides or the
vehicle (DMSO), and then phosphorylated with 20 µM [γ-32P] ATP at 37 oC for 40
minutes. pHis levels were analyzed by autoradiography in (a) or quantified using
scintillation counting in (b). In (b), the count per minute (CPM) values were normalized
to that of the wild-type AgrC-I in the absence of AIP. Error bars = S.D. (n = 3) (c)
Equilibrium binding of FAM-AIP-I to AgrC-IR238H discs. As in Figure 3.8b, corrected
steady-state anisotropy change (ΔSSAc, see Section 7.4.3) of FAM-AIP-I fluorescence
was plotted as a function of added AgrC-IR238H discs and fit to a Hill equation. One
representative titration of 3 is shown. Error bars (technical) = SEM (n = 6). (d)
Dissociation of FAM-AIP-I from AgrC-IR238H discs as a result of competition with native
AIPs: bar graph shows the ΔSSA of 20 nM FAM-AIP-I upon forming complex with 150
nM AgrC-IR238H discs alone (open bars) or in the presence of 10 µM indicated AIP
competitors (closed bars). Errors bars = S.D. (n = 3).
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To further substantiate this idea, we employed the chimera protein strategy introduced in
section 4.2 to chart the conformation-activity landscape for this mutant HK domain.
Eleven GCN4-AgrC-IR238H chimeras were prepared and their auto-kinase activities were
compared to the corresponding GCN4-AgrC-I constructs (Figure 4.6a-d). Remarkably,
activities of the mutant chimera series also changed periodically with the length of the
interdomain linker (Figure 4.6a and b). Fitting the activity-linker length relationship to a
sine wave function revealed that the fluctuation amplitude in the mutant chimera series is
less than 30% of that observed in the wild-type series (compare Figure 4.6b to d),
confirming the notion that the mutant HK domain is less responsive to conformational
perturbations. Other parameters of the two waves are strikingly similar: both followed the
α-helical “wavelength” of 3.6 residues, while no phase shift was observed between them.
The “baseline” of the two waves, defined as the mean of the maxima and minima of the
fluctuation, is also comparable between the two series. Previous experiments on the
GCN4-AgrC-I chimera series identified GC205, GC209 and GC210 as the
conformational surrogate of the AIP-II-bound, apo and AIP-I-bound AgrC-I and
phenocopy their activity levels (Figure 4.6e). These relationships hold true in the mutant
chimera series, as GC205R238H, GC209R238H and GC210R238H accurately recapitulated the
strong activity of AgrC-IR238H in the apo state and the weak effect that AIP-I and AIP-II
have on this system (Figure 4.6e). Plotting the auto-kinase activity of each GCN4-AgrCIR238H chimera as in Figure 4.3d revealed the conformation-activity landscape for the
mutant HK domain (Figure 4.6f). Notably, the activity minimum of this landscape is
much higher than that of the wild-type series, and this level of kinase activity probably
affords full activation of the P3 promoter in the reporter-strain settings.
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Figure 4.6 The R238H mutation renders the AgrC-I HK domain less responsive to
the twisting movement of linker helices.
(a and b) Auto-kinase assay of 11 GCN4-AgrC-I chimeras bearing the mutant AgrC-I
HK domain. An autoradiogram with the corresponding Coomassie-stained loading
control (a) and an activity-linker length plot (b) are shown. In (b), curve shows the
sinusoidal function fit to the data. (c and d) Auto-kinase assay data and the quantification
result for the chimera series carrying the wild-type AgrC-I HK domain. Note that the
panels in (a) and (c) were scanned from the same film (for autoradiograms) or stained in
the same gel (for loading controls). In (b) and (d), intensity of each band on the
autoradiogram was normalized to that of GC209. (e) Auto-kinase activity of the linkerconformation surrogates (refer to Figure 4.4 d and e) versus the full-length receptors. (f)
Comparison of the conformation-activity landscape between the wild-type and mutant
AgrC-I HK domains. Putative twisting angles are calculated according to Figures 4.4e.
Normalized auto-kinase activity of the chimera series bearing wild-type (gray bars) and
R238H mutant (black bars) HK domains are plotted. Fitting to a sinusoidal function
returns smoothened landscapes for the wild-type (dashed curve) and R238H (solid curve)
HK domain. For clarity, the wild-type data (gray bars) were shifted to the right by 10o
along the horizontal axis. In panels (a), (c) and (e), auto-phosphorylation was performed
employing [γ-32P] ATP and pHis levels analyzed by autoradiography.
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We next asked whether an intracellular construct, AgrC-I205-430 bearing the R238H
mutation would convey the high level of auto-kinase activity expected for the full-length
mutant. To our surprise, this construct gains very little activity upon the R238H mutation
(Figure 4.7a). Suspecting that the sensor domain might be necessary for the auto-kinase
activation by this mutation, we truncated AgrC-I to leave the C-terminal four, two or one
TM domain(s). All truncated AgrC-I mutants, after nanodisc reconstitution, exhibited
activities as strong as the full-length mutant (Figure 4.7a), suggesting the intact sensor
domains and the inter-subunit interaction mediated thereby are not required for the gain
of activity conferred by this mutation. Apart from bridging specific interactions, other
possible roles of TM domains in organizing the nanodisc-incorporated histidine kinase
include (i) anchoring the soluble portion of AgrC-I in proximity to the lipid bilayer and
(ii) propagating helicity to the interdomain linker to which it directly connects. The later
role is analogous to the GCN4-dependent stabilization of the linker helices in the chimera
proteins (see Figure 4.4e). To dissect between these two roles, we installed a pair of
phospholipid anchors to a dimeric AgrC-I soluble-domain (AgrC-I208-430) at the Nterminus of both subunits (Figure 4.7b and c). Reconstitution of this protein-lipid
conjugate to nanodiscs successfully attached the soluble AgrC-I construct to the lipid
bilayer (Figure 4.7d). Unexpectedly, this attachment via lipid moieties, as opposed to
TM-domain anchors, was detrimental to the auto-kinase activity of both the wild-type
and mutant AgrC-I208-430 (Figure 4.7e). On the other hand, kinase activation by the
R238H mutation is tolerant to the substitution of the TM sequence in the single-TM
AgrC-I construct with an unrelated TM domain from an E. coli protein (LepB) or the
insertion of a two-aa spacer to this LepB-AgrC-I chimera between the TM domain and
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Figure 4.7 Auto-kinase activation by the R238H mutation requires the attachment
of the AgrC-I construct to nanodiscs by a TM domain
(a) The effect of the R238H mutation on the auto-kinase activity of various truncated or
chimera AgrC-I constructs. All constructs except AgrC-I205-430 were first reconstituted to
nanodiscs prior to activity analysis. A domain diagram is displayed for each construct
next to the corresponding autoradiogram panel, with AgrC-I sensor domain shown in
blue, the E. coli LepB TM domain in ocher, the interdomain in red, the DHp subdomain
in salmon, and the CA subdomain in green. (b) The chemical structure and a cartoon
presentation of the phospholipid-maleimide derivative, 16:0 PE MCC. (c) Diagram
showing the putative configuration of the lipidated AgrC-I208-430 construct upon nanodisc
reconstitution. Intersection of the nanodisc membrane is shown in gray. (d) SEC analysis
of nanodiscs carrying the lipidated AgrC-I208-430. Fractions between the dotted lines were
analyzed by SDS-PAGE with Coomassie staining. MSP, membrane scaffold protein. (e)
Auto-kinase analysis of AgrC-I208-430 constructs with or without the R238H mutation.
Reaction contains the unmodified AgrC-I208-430 (condition 1), the unmodified AgrC-I208430
with empty nanodiscs added in trans (condition 2), or the nanodisc-reconstituted,
lipidated AgrC-I208-430 (condition 3). In panels (a) and (e), Auto-phosphorylation was
performed employing [γ-32P] ATP and pHis levels analyzed by autoradiography.
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the interdomain linker (Figure 4.7a). Therefore, the helicity, and perhaps the orientation
of the TM-domain anchors, rather than the HK domain’s proximity to the lipid bilayer,
plays a crucial role in supporting the strong kinase activity of the mutant HK domain.

4.4 Reconstitution of the AIP-II-revertible constitutive mutants
By contrast to what was observed for AgrC-IR238H, the activation of P3-driven gene
transcription caused by a subset of AgrC-I constitutive mutants is revertible by their
binding to AIP-II—the peptide was therefore identified as an inverse agonist of AgrC-I
(143). However, it is unclear how the baseline auto-kinase activity of AgrC-I and its
response to AIP binding change in these mutants. Constitutive point mutations causing
AIP-II revertible phenotypes were identified in all modules of AgrC-I. We picked four
representative mutants bearing mutation in the sensor (AgrC-IS183F), the interdomain
linker (AgrC-IL205R), the DHp subdomain (AgrC-IR238K) or the CA subdomain (AgrCIE306Q) for auto-kinase assays employing the nanodisc-reconstitution system.

The above four mutants were purified from recombinant expression in E. coli and
incorporated to nanodiscs (Figure 4.8a). The phospholipid stock used for nanodisc
assembly consisted of POPC and POPG at a molar ratio of 1:3. Auto-phosphorylation of
the wild-type and mutant AgrC-I discs with [γ-32P]-ATP and MgCl2 revealed mild
elevation of the baseline kinase activity in all four mutants (Figure 4.8b). In contrast to
the R238H mutant, however, AgrC-IR238K and AgrC-IE306Q carrying HK-domain
mutations maintained the sensitivity to AIP-I: their activities in the AIP-I-bound state
were indistinguishable from the wild type. AgrC-IS183F and AgrC-IL205R bearing
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mutations preceding the HK domain, on the other hand, were only moderately activated
by AIP-I. Surprisingly, all four mutants exhibited reduced sensitivity to the inverse
agonist, AIP-II. As a consequence, AgrC-IL205R and AgrC-IR238K exhibited, when bound
to AIP-II, substantially stronger auto-kinase activities compared to the baseline activity of

Figure 4.8 Ligand responses of the AIP-II-revertible constitutive mutants
(a) Affinity purification of AgrC-I mutants: fractions from the Ni-NTA purification of
indicated AgrC-I mutants were resolved on SDS-PAGE and proteins visualized by
Coomassie staining. The expected position for full-length AgrC-I is indicated next to the
gel. (c) Auto-kinase analysis of AIP-II-revertible AgrC-I mutants: wild-type or mutant
AgrC-I discs (0.7 µM) were incubated with 20 µM [γ-32P] ATP, 5 mM MgCl2 and 10 µM
AIP if indicated, and the pHis levels were analyzed with autoradiography.
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the wild type (Figure 4.8b, compare lanes 9 and 12 to lane 1). It is therefore unlikely that
AIP-II reverts the constitutive phenotype of these mutants solely by suppressing their
auto-kinase activities. We speculate that the newly discovered activity of AIP-II, i.e.,
retarding the AgrC-I-AgrA phospho-relay, might play the critical role in reverting the
constitutive phenotype of these mutants. This possibility will be investigated in the near
future.

4.5 Summary and discussions
4.5.1 Auto-kinase regulation of AgrC-I
In this chapter, we have combined the strength of the nanodisc-reconstitution system and
an artificial protein-chimera approach to investigate the signaling mechanism of AgrC-I.
Our studies indicate that the interdomain linker assumes a helical conformation whose
structural properties are intimately tied to the activity state of the receptor. Cys
crosslinking studies in the context of full-length AgrC-I revealed distinct crosslinking
patterns for the resting, activated and inhibited states, indicating a substantial
reorganization of the structure in the linker in response to binding of both activator and
inhibitor AIPs. Interestingly, the first of these patterns (resting state) is not a simple
weighted average of the latter two, which is inconsistent with a model wherein the
interdomain linkers are in equilibrium between ‘on’ and ‘off’ conformations with ligand
binding altering the equilibrium position of the system (Figure 4.9). Rather, this
crosslinking data is more consistent with discrete linker conformations for AgrC in all
three states.
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Figure 4.9 An alternative model of the linker conformation in three ligand states
In this model, the linkers are in an equilibrium between an ‘on’ state associated with high
auto-kinase activity and an ‘off’ state with low activity. Binding of activator or inhibitor
AIPs shifts the equilibrium position. See text for details.
Our analysis of a series of GCN4-AgrC-I chimeras provided further insight on the signalresponse behavior of AgrC-IHK. Assuming that the interdomain linker adopts a parallel
helical conformation, that the GCN4 coiled coil maintains itself as a rigid body in all
chimeras and that α-helicity continues at the GCN4-AgrC-I junction, then the activity of
AgrC-I HK domain is seen to change gradually as a function of the twisting angle away
from the resting state (Figure 4.3d). Intriguingly, the auto-kinase activity of full-length
AgrC-I in the activator-bound state is significant weaker than the maximum activity of
AgrC-I HK domain exhibited in chimeras GC207 and GC214 (Figure 4.4a), suggesting
that the “working range” of the native RHK might be tailored by natural selection to meet
the demand of optimal autoinduction timing.

Our chimera approach has some interesting parallels with the work of Moffat and
coworkers on FixL from Bradyrhizobium japonicum (157). Similar to AgrC, the linker
region in FixL connecting the sensor and HK domains is proposed to be helical.
Chimeras between the FixL HK domain and a LOV light sensor domain from a
heterologous protein (YtvA from B. subtilis) are active only when the FixL residue at the
junction occupies two periodically equivalent positions (‘i’ and ‘i + 4’) in each haptad
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repeat of the putative linker coiled-coil. Maintaining the appropriate periodicity of the
helical linker is therefore thought to be critical to the construction of functional RHKs via
shuffling between sensor and HK domains, including such events as they occur during
evolution (158). In stark contrast to the YtvA-FixL chimeras, our GCN4-AgrC-I
constructs exhibited many intermediate activities between the two extremes: the system is
remarkably plastic. Shuffling between the AgrC-IHK (or other HK domains with similar
behaviors) and heterologous sensory modules could therefore result in new RHKs
exhibiting variable degrees of basal kinase activity and possibly dynamic range,
depending on the fusion junction and the structural rearrangement of the sensor between
signaling states. Conceivably, such functional plasticity would be beneficial during RHK
evolution by increasing the chance of generating competent chimera receptors that could
serve as starting points for further selection for an optimal working range for the new
sensory function.

Following the publication of our work discussed above (159), three papers came out each
describing a crystal structure in which HK domain dimers were captured in the catalyticactive state (122, 153, 160). As opposed to the symmetric, inactive HKs (Figure 4.10a),
the active HK dimers are strikingly asymmetric: while one CA subdomain binds to the
phospho-acceptor His in a catalysis-competent conformation, the other still adopts the
inactive conformation as if in an inactive dimer (Figure 4.10b). Key to this asymmetry is
the extra bending of the DHp-α1 colored in yellow in Figures 4.10a and b (Figure 4.10a,
red arrow), which disrupts a hydrophobic patch that would otherwise sequester the
catalysis-competent CA subdomain (Figure 4.10a and b, compare the electrostatic surface
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in the dashed circle). In compliance with these structural evidences, helical “tilting” or
“scissoring” of the linkers preceding the DHp subdomains has been observed in a few
full-length RHKs as a consequence of signaling input (152, 161, 162). Rotational
movements, on the other hand, have been proposed in fewer models and mostly as a

Figure 4.10 New structural evidence on the molecular movement related to RHK
activation
(a and b) Comparison between crystal structures of two HK-domain dimers, one captured
in the inactive state (PDBID: 2c2a, panel a) and the other in the active state (PDBID: 4i5s,
panel b). In each dimer, one inactive CA subdomain is hidden for clarity. The remaining
CA subdomain is colored green, adopting the inactive conformation in (a) and the kinasecompetent conformation in (b). The DHp-α1 helix that experiences bending movement is
colored in yellow and the rest of the DHp four-helix bundle is shown in ocher. The
phospho-acceptor His that would react with the displayed CA is highlighted in magenta.
A transparent electrostatic surface is also displayed for the DHp subdomain. In (a), the Fbox Phe residue (black spheres) binds to a hydrophobic patch (dashed circle) in the DHp
four-helix bundle and holds the CA from approaching the phospho-acceptor His. A red
arrow indicates the bending motion of the yellow helical segment that would activate the
displayed CA subdomain. In (b), the dashed circle indicates the disruption of the
hydrophobic patch as a consequence of the bending motion, and the CA subdomain
relocated to bind the His in a catalysis-competent conformation. (c) The intracellular
domains of the E. coli stress sensor CpxA (PDBID: 4biv). The highly symmetric HAMP
domain is colored in blue, and the helical elements in the DHp subdomain are colored
sequentially in cyan, green and light green. Arrows highlight the differential helical
bending between the HAMP and DHp in two subunits that breaks the symmetry of the
dimer.
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component of the overall linker movement in conjunction with tilting or scissoring (152,
162). Notably, however, the local, symmetric helical rotation found in the AgrC-I
interdomain linkers in our study needs not contradict with the asymmetry in the HK
module necessary for kinase activation. This notion is supported by the perfect symmetry
of HAMP transmission modules in an overall asymmetric structure of the intracellular
portion of the E. coli stress sensor RHK, CpxA in its active conformation (Figure 4.10c)
(122). Specifically, the interdomain linkers connecting the HAMP and DHp modules are
bent at different magnitudes to adapt to the conformational mismatch between their
flanking modules (Figure 4.10c, black arrows). In our inter-subunit crosslinking analysis
of AgrC-I, the linker segment (residues 205-209) in which we performed Cys substitution
is very close to the sensor domain and perhaps upstream to the putative kink site.
Assuming this arrangement to be true, this segment of the linker pair may retain a twofold symmetry in full-length AgrC-I at different ligand states.

The success of the protein-chimera strategy also strictly relies on the capability of αhelices to bend and/or unwind in order to relieve conformational stress. According to the
designing principle, the junction residues would be rotated from its resting register by
about 180 degree in some chimeras. This movement, if faithfully propagated to the DHp
subdomain, would displace the hydrophobic residues out of the four-helix bundle core
and thereby dismantle the HK dimer. The interdomain linkers in these chimeras,
therefore, must modulate the severe rotational input into a combination of milder rotation
and tilting output discernible for the HK domain. Conceivably, this modulation is not
possible when the linker is too short and perhaps as a consequence, almost no

	
  

94	
  

intermediate level of auto-kinase activities was observed in chimeras with linker length
shorter than 7 residues (Figure 4.3a). It is currently unclear how this modulation enables
the continuous correlation between the rotational conformation input and the auto-kinase
activity. A multi-facet strategy involving high-resolution structural characterization and
single-molecule fluorescence measurement is proposed in section 6.1.3 to address this
fascinating puzzle.

4.5.2 Trans-kinase regulation of AgrC-I
Upon auto-phosphorylation, the RHK component relies on its trans-kinase activity to
relay the phosphoryl group to its cognate RR. Despite the essential role of this activity in
the TCS signaling, its regulation has been overlooked in most biochemical studies of
other TCS systems. Two reasons might account for the lack of quantitative kinetic studies
on phospho-relay reactions: (1) that these reactions are too fast to be accurately
quantified (t1/2 on the order of a few seconds, see Figure 3.6e); and (ii) that the
phosphatase activity of the RHK, which is also variable among signaling states, interferes
with the phospho-relay kinetics. In our in vitro reconstitution studies on the wild-type
AgrC-I, AIP-II was found to significantly inhibit the phospho-relay from the receptor to
its cognate RR, AgrA (Figure 3.6a and b). In fact, the cognate AIP-I slightly accelerates
this process (Figure 3.6a, compare lanes 11 and 12 to 3 and 4). Key to these findings is
the complete lack of phosphatase activity in AgrC-I (Figure 3.6c and d), a rare property
among RHKs that may facilitate further investigations into the conformation-activity
relationship of the AgrC-I HK domain with respect to the trans-kinase activity. To realize
quantitative measurement of the trans-kinase activity in the GCN4-AgrC-I chimera
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series, an assay based on a three-component phospho-equilibration system is designed in
section 6.1.2.

4.5.3 Mechanisms of constitutive activity
Novel TCSs emerge in two ways: lineage-specific expansion (LSE), in which the HK
domain of the ancestral RHK recombines with a new set of sensor domain(s) to carry out
a new sensory function in the same organism, or horizontal gene transfer (HGT), in
which the ancestral TCS is introduced to, and performs its original function in, a distantly
related organism (163). In both scenarios, however, successful establishment of a sensory
pathway entails adaptation of the nascent TCS to the signaling demand of the host
organism, which would depend primarily on natural selection on beneficial mutations that
occur randomly (158). Central to this adaptation is the adjustment of the threshold level
of the signal as well the sensitivity of the response to signals above the threshold. At the
molecular level, these properties of a TCS depend in part on the conformation-activity
landscape of the RHK component, which dictates its resting and activated kinase
activities. Therefore, how this landscape changes following point mutations would be
indicative to the evolutionary trajectory of RHKs. In this Chapter, we examined the
conformation-activity landscapes of an AgrC-I HK domain bearing a point mutation,
R238H. We found that the auto-kinase activity of this mutant is less sensitive to
rotational motions compared to the wild type: that it fluctuates so mildly around a
relatively high level, enables the corresponding full-length RHK, regardless of the ligand
state, to activate P3-driven reporter genes. This result exemplifies the profound impact
that a point mutation might have on the conformation-activity landscape of an HK
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domain, and should inspire a more comprehensive effort to understand the “evolvability”
of this landscape, perhaps employing a saturation mutagenesis approach (164).

In contrast to the HK-domain constitutive mutations (R238H, R238K and E306Q), those
occurring in or proximal to the sensor domain (S183F and L205R) apparently do not alter
the conformation-activity landscapes of the HK domain and, therefore, the mechanism of
action for these mutations is less tractable. In the previous report in which these mutants
were identified, the authors suggested that both mutants tend to shift the last TM domain
towards the cytoplasm and thereby mimic the activated conformation even in the absence
of AIP-I (143). Such “piston-like” movements have been ruled out for the mechanism of
type-I RHK activation (165, 166). Nonetheless, the multi-span sensor domain in AgrC-I
may allow this TM domain to, after the piston-like shift, rotate or tilt in order to optimize
its packing with the rest of the sensor domain and thereby confer auto-kinase activation.
This model needs to be tested experimentally in the future, primarily through assessing
the solvent accessibility of certain membrane-proximal residues and mapping the
mutation-induced conformational change of the interdomain linkers.
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Chapter Five: The Key Driving Forces That Power AIP Thiolactone Formation
As was described in section 1.2.3, the AIP contains a thiolactone ring formed by
condensation of the C-terminal carboxyl group and the sulfhydryl group of an internal
cysteine. This macrocyclic structure is absolutely necessary for binding of the peptide to
its receptor, AgrC. AIP biosynthesis is of particular interest to us because the high-energy
thiolactone linkage forms directly from the AgrB-catalyzed proteolysis of AgrD without
free-energy input from ATP hydrolysis (Figure 5.1a) (55). Notably, the reaction occurs at
the inner leaflet of the cytosolic membrane and the N-cleavage fragment, herein referred
to as AgrD(1-32)-thiolactone, is then translocated to the extracellular leaflet of the cell
membrane (Figure 5.1a) (56). It is unclear how the bacteria overcome the thermodynamic

Figure 5.1 The AIP biosynthesis pathway and the model for free-energy change
estimation for the thiolactone formation.
(a) The AIP production pathway in S. aureus cells as exemplified by processing of AgrDI. (b) A two-step model that recapitulates the thiolactone formation from a linear peptide.
Estimated values of free-energy change and/or equilibrium constant are shown for each
step. See text for details.
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challenge to maintain, on the cytoplasmic side of the cell membrane, an abundant pool of
the AgrD(1-32)-thiolactone to support its rapid translocation required for punctual agr
autoinduction. In this chapter, we both estimated the ∆G for the thiolactone-formation
reaction based on existing data and determined it experimentally. To account for the
discrepancy between the estimation and the experimental results, the stability of the
thiolactone macrocycle was also probed under various conditions employing a ringopening equilibrium approach. Our data show that efficient thiolactone production is
driven by two unanticipated features of the system; (i) membrane-association of the
thiolactone-containing intermediate which stabilizes the macrocycle and (ii) rapid
degradation of the C-terminal proteolysis fragment, AgrDC, which affects the reaction
equilibrium position.

5.1 Estimation of the free energy cost associated with thiolactone formation
To get a better picture for the thermodynamic challenge associated with conversion of
AgrD into a thiolactone, we first estimated the ∆G for the reaction based on existing data
on analogous model reactions. A two-step process would recapitulate such a reaction: the
scissile peptide bond first undergoes thiolysis with a coenzyme A mimic, Nacetylcysteamine (NAC), to give an N-terminal thioester fragment and an unmodified Cfragment (Figure 5.1b) and the N-terminal fragment subsequently cyclizes into a
thiolactone to release NAC (Figure 5.1b). In the following discussion, ∆Go’ is defined as
the free energy change of a chemical process at 37oC, 100kPa and pH = 7.0 with all
reactants involved present at standard activities.
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The first step can be accomplished through first the hydrolysis of the scissile peptide
bond and the subsequent thioesterification of the N-fragment by NAC. For the hydrolysis
process we referred to the hydrolysis of a Gly-Gly bond, ∆G0’ = 2.2kcal/mol (167). For
the thioesterification process, the ∆G0’ for the condensation between acetic acid and
coenzyme A (CoA), i.e., 7.5 kcal/mol (168), needs to be adjusted for the difference in
acidity between the C-terminal carboxylic group of a generic peptide (pKa = 3.3) and
acetic acid (pKa = 4.8) (169). pKa value of acids have been found to linearly correlate
with the pKeq (negative logarithm of the equilibrium constant) of the hydrolysis of their
methyl esters into their deprotonated anions and methanol (170). The slope is 1.02.
Assuming this linear relationship holds for thioesters, thioesterification of a C-terminal
carboxylate on a peptide should be 2.1 kcal/mol less favorable than that of acetate (169).
Therefore, the estimated overall ∆G10’ for the thiolysis of a generic peptide bond should
be:
∆G10’ = -2.2 + 7.5 + 2.1 = 7.4 kcal/mol

equation 5.1

With respect to the second, ring closure step, the ∆G0’ is strongly dependent on the ring
being formed. As a moderate estimation, we assume that the ring formed upon transthioesterification to be a typical large ring such that it is neither strongly stabilized, like a
five- or six-membered ring, nor destabilized like those in mid-sized rings. We also
assume that the trans-thioesterification is isoenthalpic, primarily because the pKa of the
thiol group in a cysteine side chain is close to that in NAC.

We calculate the ∆G20’ of the cyclization from an estimated equilibrium constant Keq,
which equals the apparent first-order kinetic constant of the forward reaction divided by
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the apparent second-order kinetic constant of the reverse (thiolysis) reaction. The
denominator should be equivalent to the secondary kinetic constant of a thiol-exchange
process involving a linear peptidyl-NAC thioester, in that the rotational movements
around the bonds adjacent to the thioester motif are not restrained in the large ring. The
equilibrium constant therefore equals to the ratio between the first-order kinetic constant
of the intramolecular (cyclization) reaction and the second kinetic constant of an
analogous intermolecular (thiol-exchange) reaction between a thioester and a thiol group.
This ratio, by definition, represents the effective molarity (EM) of the cyclization.
Empirically, the EM of large, unstrained ring formation from bifunctional chain
molecules falls predominantly within the range 0.01M - 0.05M independent of the
functional groups involved, as was summarized by Illuminati and Mandonlini (171). This
range corresponds to a ∆G20’ value ranging from 1.8 to 2.8 kcal/mol. We hence used
∆G20’ = 2.3 kcal/mol to calculate the ∆G0’overall and the Keq, overall for the strain-free
thiolactone formation from a generic peptide (equations 5.2 and 5.3).
∆G0’overall = ∆G10’ + ∆G20’ = 9.7 kcal/mol

equation 5.2;

Keq, overall = exp (-∆G0’overall / RT) = 1.4 × 10-7

equation 5.3.

The estimated Keq, overall, if applied to the AgrD(1-32)-thiolactone formation from AgrD,
would restrict the intracellular abundance of the former to a level incompatible with the
AIP production rate required for agr autoinduction (see Discussion). Therefore, assuming
the thiolactone intermediate to be the direct product of AgrB-mediated proteolysis in
vivo, some mechanism must exist to render the reaction more permissible.
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5.2 Expression and purification of recombinant AgrB and AgrD constructs
We elected to study AgrB and AgrD from S. aureus group-I and -II for our reconstitution
studies. The current model of AIP biosynthesis has been developed primarily using
group-I Agr proteins, which are significantly diverged from their group-II counterparts:
AgrB-II and AgrD-II share 61% and 48% sequence identity with AgrB-I and AgrD-I,
respectively. Importantly, genetic studies show that heterologous processing of AgrD is
forbidden between these two groups (62).

Wild-type AgrD-I and AgrD-II, as well as N-terminally FlagHis6-tagged versions thereof,
were generated using a recombinant fusion protein strategy (Figures 5.2a and 7.1,
Appendix Figure 1 and Appendix Table 2). AgrB-I and AgrB-II were over-expressed in
E. coli as His6-tagged recombinant proteins and purified (Figure 5.2b). Surprisingly,
AgrB-I showed multiple bands when analyzed by SDS-PAGE, while AgrB-II migrated
primarily as a single species of the expected molecular weight with a small amount of an
apparent dimer. Western blot analysis revealed the presence of the His6-tag in all of these
high molecular weight species, indicating that they relate to AgrB-I and AgrB-II (Figure
5.2b). That these high molecular weight species might result from covalent oligomers,
was ruled out by matrix-assisted laser desorption ionization mass spectrometry (MALDIMS) (Figure 5.2c).

The unusual electrophoretic behavior of AgrB-I, and to a lesser extent AgrB-II, could be
a consequence of heterologous oligomerization induced by SDS micelles. However,
native inter-subunit interactions within membrane protein complexes are often resistant to
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SDS (172), leading us to wonder whether AgrB might oligomerize under more native
conditions. This idea was supported by a crosslinking experiment on AgrB-II solubilized
with a zwitterionic detergent, fos-choline-12, in which specific dimer formation was
observed upon short glutaraldehyde treatment (Figure 5.3a). Since detergent-solubilized
AgrB-II is not active (data not shown), we asked whether the dimerization persists upon
incorporation to nanometer-scale lipid bilayer discs, or nanodiscs (see chapter 3) (138).
Boldog and coworkers have employed a clever nanodisc based strategy to show that the
bacterial chemoreceptor, Tar, forms stable dimers (173). We adapted this strategy to

Figure 5.2 Preparation of recombinant AgrB and AgrD
(a and b) SDS-PAGE analysis of all four AgrD constructs prepared herein (panel a) and
samples from the affinity purification of AgrB proteins (panel b). L: bacterial membrane
extract; FT: flow through; E: elution. An anti-His6 western blot of purified AgrB proteins
is shown to the right. (c) MALDI mass spectrum of AgrB-I (calculated molecular weight
= 22.7 kDa) showing the absence of covalent dimer. Bovine cytochrome C (molecular
weight = 12,384 Da, showed up at m/z = 12,407 Da) was used as an internal standard for
m/z calibration. The monovalent and divalent ions of the AgrB-I peak at m/z = 23006 Da
and 11513 Da, respectively.
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study the oligomerization behavior of AgrB in a bilayer (Figure 5.3b). Accordingly,
nanodiscs were assembled in the presence of different amounts AgrB-II, such that the
amount of the protein varied from being sub-stoichiometric relative to the number of
discs to being in large excess. AgrB-II-incorporated nanodiscs from each assembly were
isolated through Ni-NTA purification followed by size-exclusion chromatography (SEC),
and the averaged protein molecular weight in each particle was analyzed using SEC in
tandem with a multi-angle light scattering detector (SEC-MALS, Figure 5.3c). The
average AgrB-II (22 kDa) copy number per nanodisc was calculated by factoring in two

Figure 5.3. Dimerization of AgrB under native conditions.
(a) SDS-PAGE analysis of detergent-solubilized AgrB-II before or after glutaraldehyde
treatment. (b) Theoretical distribution of AgrB structural units in nanodiscs: diagram
showing the scenarios of reconstituting AgrB into excess nanodiscs assuming AgrB
preferably forms monomers or dimers. (c and d) Protein content per disc (c) and AgrB
copy number per disc (d) of affinity-purified AgrB-II nanodiscs as a function of preassembly AgrB-to-nanodisc ratio. (e) Proteolysis of FlagHis6-AgrD-II after treatment
with AgrB-II nanodiscs: reactions were analyzed by SDS-PAGE. Average AgrB-II copy
number per disc is indicated. The products, AgrD-II-(1-32) fragments (linear and/or
thiolactone) are collectively indicated as AgrD-IIN. MSP, membrane scaffold protein.
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copies of MSP (30 kDa each) per particle, a known feature of this system (Figures 5.3c
and d) (173). In line with our finding using detergent-solubilized protein, AgrB-II was
incorporated as dimers when deposited at a monomer-to-disc ratio of 0.5:1 or 1:1. It is
noteworthy that the monomer-to-disc ratio of the purified AgrB-II discs levels out at 4,
suggesting that the 12.8 nm-diameter nanodisc is capable of accommodating two AgrB-II
dimers. The proteolytic activity of these nanodiscs was tested using the FlagHis6-tagged
AgrD-II substrate (Figure 5.3e). Interestingly, nanodiscs containing a single copy of the
AgrB-II dimer were more active than those containing two copies of the dimer (Figure
5.3e, compare lanes 2 and 3 to lanes 6 and 7). This is possibly due to the better
availability of membrane surface necessary for substrate docking in nanodiscs containing
single copy of AgrB-II dimer (56). The key result, however, is that AgrB appears to form
stable dimers in a biologically active state.

5.3 AgrD(1-32)-thiolactone is the major product of the AgrB-catalyzed proteolysis of
AgrD
We next set out to characterize the products of AgrB-mediated proteolysis of AgrD. To
this end, AgrB and AgrD (from agr-I or -II) were co-reconstituted into liposomes
composed of POPC and POPG at a ratio of 3:1. This lipid composition was selected
based on preliminary proteolysis assays employing AgrB embedded in liposomes
comprising POPC-POPG mixtures at different ratios (Figures 5.4a and b). Tris-Tricine
SDS-PAGE revealed efficient proteolysis occurring between cognate AgrB-AgrD pairs
but not heterologous ones (Figure 5.4c). Further characterization of the proteolysis
products of non-tagged AgrD-I and AgrD-II was achieved using reverse-phase (RP)
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HPLC and mass-spectrometry (MS) (Figure 5.5a). For each reaction, RP-HPLC/MS
identified three products in additional to the starting material, namely; AgrDC, AgrD(132)-thiolactone and linear-AgrD(1-32) (Figures 5.5b-d and Appendix Figure 2).
Importantly, consistent with the AIP biosynthesis model depicted in Figure 5.1a, the
thiolactone is the major AgrD(1-32) fragment in both reactions (Figures 5.5.b and d,
green arrows). We therefore refer to the AgrB-catalyzed processing of AgrD as the
‘proteolytic cyclization’.

Figure 5.4 Lipid-composition dependence and subgroup specificity of the AgrBcatalyzed proteolysis of AgrD.
(a and b) Lipid-composition dependence of AgrB-I activity. FlagHis6-AgrD-I was treated
with AgrB-I proteoliposomes consisting of phospholipids at indicated compositions.
Samples were withdrawn at indicated time points for SDS-PAGE analysis. (a) SDSPAGE analysis of one representative time course and (b) kinetic plot of AgrD-I
consumption from densitometric quantification of the gel are shown. Error bars = range
(n = 2). (c) Proteolysis specificity between AgrB-AgrD pairs from agr-I and agr-II
alleles. FlagHis6-tagged AgrDs were treated with indicated liposomal reagents at 37oC for
6hrs. The reactions were resolved on Tris-Tricine SDS-PAGE and proteins visualized
with SYPRO-Ruby staining (Invitrogen). In panels (a) and (c), the AgrD(1-32) fragments
(linear and/or thiolactone) are collectively indicated as AgrD-IN or AgrD-IIN.
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5.4 AgrD processing by AgrB is a reversible process
In our initial reconstitution trials, complete consumption of AgrD was never observed,
despite significant production of AgrD(1-32)-thiolactone. To account for this, we
speculated that the proteolytic cyclization might have reached a balanced equilibrium
under our reaction conditions. To test this idea, we treated AgrD-I (the FlagHis6-tagged
version, 20 µM) with proteoliposomes containing 1 µM AgrB-I and analyzed the reaction

Figure 5.5 AgrD(1-32)-thiolactone is the major product of the AgrB-catalyzed
proteolysis of AgrD.
(a) Schematic representation of the proteolysis reaction. (b and c) C4 RP-HPLC
chromatograms of the proteolysis reactions of (b) AgrD-I and (c) AgrD-II. Product peaks
are indicated with arrows. (d and e) Deconvoluted MS highlighting the isotopic profile of
the AgrD(1-32)-thiolactone species (green arrows) generated from (d) AgrD-I and (e)
AgrD-II.
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mixture by RP-HPLC at a series of time points (Figure 5.6a). We observed timedependent consumption of the starting material, as well as the production of three new
species identified by MS as the AgrDC cleavage fragment, and the thiolactone- and linear
AgrD(1-32) fragment. The amount of starting material and products were quantified
based on integration of the RP-HPLC traces and the molarity of each species was
normalized to the starting molarity of AgrD (Figure 5.6b). During the initial stage of the
reaction (t < 10 minutes), the full-length precursor AgrD was efficiently cyclized to
AgrD(1-32)-thiolactone (with the concomitant release of the AgrDC fragment), while
only small amounts of linear AgrD(1-32) were generated. The cyclization then gradually
slowed down, reaching a maximum by about 30 minutes, which is likely due to the
dynamic equilibrium being reached (vide infra). In contrast to this equilibration behavior,
the linear AgrD(1-32) was produced irreversibly at a slow but constant rate throughout
the time course (Figure 5.6b). Intriguingly, its production after t = 30 minutes was
coupled to a concerted decrease in the molar fraction of AgrD and AgrD(1-32)thiolactone (Figure 5.6b). This kinetic observation can be understood in terms of a preequilibrium model, in which the proteolytic cyclization is a reversible process occurring
much faster than the irreversible production of linear AgrD(1-32). In this model, the fast
reaction reaches a quasi-equilibrium state that approximates the real thermodynamic
equilibrium.

To further explore the apparent reversibility of the proteolytic cyclization, we synthesized
an AgrD-IC peptide with a C-terminal carboxyamide (AgrD-IC-NH2) and attempted to
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Figure 5.6 AgrD processing by AgrB is a reversible process.
(a and b) Time course of the proteolytic cyclization: a representative set of RP-HPLC
curves (a) and a kinetic plot of indicated species generated from integrated peak areas
thereof (b) are shown. In (b), all molarity was normalized to the amount of full-length
AgrD at t = 0. Error bars = SD (n = 3). (c and d) Time course of the ligation reaction:
samples were resolved on RP-HPLC and amount of full-length AgrD and both AgrD(132) fragments was quantified using MS employing standards. A representative set of
deconvoluted MS spectra (c) and a kinetic plot of indicated species (d) are shown. Error
bars = SD (n = 3). (e) Scheme showing the mechanism of AgrB-catalyzed proteolysis of
AgrD. (f) Ligation reactions starting at a series of AgrDC concentrations: reactions were
analyzed at t = 120 min and deconvoluted mass spectra are shown as in panel (c). (g) Plot
showing the equilibrium molar ratio between AgrD and AgrD(1-32)-thiolactone as a
function of the molarity of AgrDC in the ligation (black circles) and proteolysis (red
circles) systems. Error bars = SD (n = 3).
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ligate it to a recombinantly prepared, FlagHis6-tagged AgrD-I(1-32)-thiolactone (Figure
7.1 and Appendix Figure 1) in the presence of AgrB-I proteoliposomes, thereby
generating the corresponding full-length AgrD-I construct (Appendix Figure 2). Since
this ligation product co-eluted with the AgrD(1-32)-thiolactone starting material on RPHPLC, quantification of these two species relied on MS analysis employing ratiometric
standards (Figures 5.6c and d). The ligation reaction occurred rapidly and a quasiequilibrium state was achieved within 40 minutes. Importantly, the post-equilibration
behavior of the ligation system (after t = 40 minutes) showed a marked similarity to that
observed with the proteolysis reaction (compare Figures 5.6d to b): the molar fraction of
both AgrD and AgrD(1-32)-thiolactone dropped in a concerted fashion, while the ratio
between them stayed roughly constant. This result unambiguously demonstrated a
balanced, dynamic equilibrium of AgrD proteolysis under our reaction conditions.

It has been proposed that the active-site cysteine within AgrB (Cys84) attacks the scissile
peptide bond in AgrD to form an acyl-enzyme intermediate that subsequently undergoes
an intramolecular trans-thioesterification to give the AgrD(1-32)-thiolactone (Figure
5.6e) (55). Hydrolytic resolution of this acyl-enzyme intermediate could potentially yield
the linear AgrD(1-32) peptide. In accordance with this model, the inactive AgrBC84A
mutant is unable to ligate the AgrDC peptide to AgrD(1-32)-thiolactone or to hydrolyze
the thiolactone (Figure 5.6c, top spectrum and Figures 5.7a and b). Therefore, we
conclude that the catalytic activity of AgrB supports the proteolysis/ligation equilibrium
and the irreversible production of AgrD(1-32) (Figure 5.6e).
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We next set out to determine the equilibrium constant of the proteolytic cyclization
reaction. To this end, the pre-equilibrium positions in the presence of different
concentrations of AgrDC were monitored and plotted (Figures 5.6f and g, black data
points). As expected, the pre-equilibrium position shifted towards the formation of fulllength AgrD at higher AgrDC concentrations. Linear regression of the plot in Figure 5.6g
returned an equilibrium constant for the proteolytic cyclization, Keq = 1.0x10-5, or if one
treats AgrDC as a reversible ligand for the thiolactone, a dissociation constant (KD) of 10
µM. This corresponds to a ∆G0’ of 7.1 kcal/mol, which is 2.6 kcal/mol more favorable
than expected based on our initial estimate from model reactions. Gratifyingly, the preequilibrium state obtained using AgrD as the starting material (Figure 5.6b) conformed
well to this equilibrium constant derived form the linear regression (Figure 5.6g, the red
data point).

Figure 5.7. Generation of AgrD(1-32) is dependent upon AgrB catalysis.
The AgrD(1-32)-thiolactone was treated with indicated liposomal reagent at 37 oC for 1hr
and then Sep-Pak processed and resolved on RP-HPLC. A representative set of
chromatograms (a) and a bar graph showing the percentage of hydrolysis (corrected for
SPE recovery) (b) are shown. Error bars = range (n = 2).
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5.5 AgrD(1-32)-thiolactone is stabilized by phospholipids
Our experimentally measured equilibrium constant for proteolytic cyclization indicates
the reaction is about 70-fold more favorable than might be expected based on model
reactions (Keq = 1.0 x 10-5 vs. 1.4 x 10-7). In an effort to gain some insight into this
discrepancy, we asked whether the macrocycle within the AgrD(1-32)-thiolactone was
somehow stabilized under the reaction conditions. With this in mind, we compared the
susceptibility of AIP-I and FlagHis6-AgrD-I(1-32)-thiolactone to ring-opening thiolysis
by NAC to give the respective linear thioesters (Figure 5.8a). Equilibration between
thiolactone and linear thioester species was monitored at a series of NAC concentrations
by RP-HPLC/MS. Treating NAC as a ligand that reversibly binds to the thiolactones, its
dissociation constant, KD, NAC, was calculated from the equilibrium positions. Importantly
for the following discussion, we observed essentially unbiased partitioning of NAC
between aqueous and 1-octanol phases at pH = 7.5 (logP = -0.03, Figure 5.8b). Thus, the
effective concentration of NAC should stay constant across the bulk solution and the
membrane environment.

To begin, we treated AIP-I with NAC ranging from 1.0 to 100 mM in aqueous solution
buffered at pH 7.0 (Figure 5.8c, circles, dotted line and Table 5.1). The KD, NAC for AIP-I
is 5.8 mM. Ring closure of AIP-I from its linear thioester is therefore less favorable than
we estimated for the formation of an unstrained thiolactone, for which the equilibrium
constant would be 24 mM (see Figure 5.1b). Since AgrD-I(1-32)-thiolactone is insoluble
in the buffer system used to establish the thiolysis equilibrium for AIP-I, we dispersed
this molecule in a suspension of lipid vesicles in the presence of different NAC
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concentrations. With a calculated KD, NAC of 95 mM, this thiolactone appears to be much
more stable than AIP-I (Figure 5.8c, squares, solid line and Table 5.1). The less favorable

Figure 5.8 Ring-opening equilibrium of AIP-I and FlagHis6-AgrD-I(1-32)thiolactones.
(a) Schematic representation of the ring-opening equilibrium. (b) The octanol-water
partitioning equilibrium of NAC: 100 µL NAC was added to 2 mL aqueous PBS buffer
(pH = 7.5) and 2 mL 1-octanol and the system was allowed to equilibrate at RT. The
panel shows GC-MS chromatograms of equivolume samples from the aqueous and 1octanol phases. (c) Double-log plot showing equilibrium positions as a function of NAC
concentration for AIP-I (circles) or AgrD-I(1-32)-thiolactone (squares) with the absence
(dotted line) or presence (solid lines) of phospholipids. Error bars = SD (n = 4). TE,
thioester; TL, thiolactone. (d) Time course of FlagHis6-AgrD-I(1-32)-NAC ring closure
in HBS buffer, pH = 7.0 containing 1.5 mM POPC and 0.5 mM POPG in the presence of
indicated level of NAC. Plot shows the molar fraction of the thioester (TE) as a function
of time (dashed lines). The ring-opening time courses (solid lines) under each NAC
concentration are overlaid. (e) As in (c), equilibrium positions were plotted for the AIP-I
(closed circles, solid line) and FlagHis6-AgrD-I(1-32)-thiolactone (open squares, dashed
line) in 6M GuHCl buffered at pH = 7.0. For (c) and (e), Error bars = range (n = 2) and
are not visible due to the size of data symbols for most data points.
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ring opening is not an effect of hysteresis, as reactions starting from the purified AgrDI(1-32)-NAC thioester reached roughly the same equilibrium positions (Figure 5.8d).
Intriguingly, the stability of AIP-I towards ring opening was only slightly enhanced (1fold) in the presence of lipid vesicles (Figure 5.8c, circles, solid line and Table 5.1),
despite the fact that it shares the identical macrocycle with AgrD-I(1-32)-thiolactone. It
should also be noted that both thiolactones were equally susceptible to ring opening
thiolysis in aqueous buffers containing chaotropic agents (Figure 5.8e and Table 5.1).
Thus, the remarkable disparity in stability must originate from differential lipid-bilayer
association of the macrocycle moiety. AgrD is thought to be targeted to the lipid bilayer
by its N-terminal, amphipathic leader peptide (56). We confirmed this targeting effect
using a co-migration assay on SEC, in which all AgrD constructs containing the Nterminal leader peptide, showed strong interaction to bilayer nanodiscs (Figures 5.9a-c).
By contrast, AIP-I does not co-migrate with nanodiscs (Figures 5.9d and e). Based on
this, we speculate that the membrane targeting property of the leader peptide places the
macrocycle into proximity with the lipid bilayer and hence induces its membrane
partitioning and thereby stabilizes it against ring opening thiolysis.

Table 5.1. Ring-closure equilibrium constants of thiolactones
Thiolactone
AIP-I

AgrD-I(1-32)
AIP-I tri-Ala**

Condition*
HBS
HBS, 2 mM POPC-POPG
6M GuHCl
HBS, 2 mM POPC-POPG
HBS, 2 mM DGDG
6M GuHCl

KD, NAC (mM)
5.8 ± 0.2
11.4 ± 1.1
21.9 ± 1.4
95 ± 31
56 ± 7
15.6 ± 2.2

HBS

8.0 ± 0.4

AgrD-I(1-32) tri-Ala**
HBS, 2 mM POPC-POPG
11.0 ± 0.4
* HBS, HEPES-buffer saline pH = 7.0; the POPC-POPG molar ratio is 3:1;
** Constructs bearing mutations F30A/I31A/M32A (in AgrD-I numbering).
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To explore the molecular determinants of this putative partitioning interaction, we
examined atomic-resolution structures available for S. aureus AIPs. We noticed that in a

Figure 5.9. Nanodisc co-migration assays for AIP-I and AgrD-I constructs.
(a) SEC chromatograms: SEC sample (250 µL) contained 12 µM appropriate AgrD
peptide and/or equimolar bilayer nanodiscs as indicated. The bilayer discs consisted of
POPC-POPG in a molar ratio of 3:1. Shadow indicates the position at which nanodiscs
(unbound or bound to AgrD) are eluted. FlagHis6-AgrD(1-32)-Cys is a linear peptide
prepared from treating the FlagHis6-AgrD(1-32)-thiolactone with cysteine (see section
7.3.3), and was used as the surrogate of FlagHis6-AgrD(1-32) in this experiment. (b)
Recovery of AgrD peptides within eluate containing nanodiscs: for each sample
containing AgrD peptide, the pre-SEC sample (denoted as S) and the combined fractions
from the shadowed segment in (a) (denoted as F) were analyzed by SDS-PAGE. (c)
Quantification of the gel in (b). Bar graph depicts the recovery of indicated AgrD peptide
from the shadowed segment of elution after resolved on SEC alone (close bars) or in the
presence of bilayer nanodiscs (open bars). (d) SEC chromatograms of the co-migration
assay of indicated AIP-I peptide. Positions where nanodiscs and AIP-I were eluted are
indicated by asterisk and shadow, respectively. (e) RP-HPLC traces showing the recovery
of either AIP-I peptide from the shadowed segment of elution in (d) to be unaffected by
the presence of nanodiscs in the SEC samples.
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crystal structure determined for a monoclonal antibody in complex to AIP-IV (174), three
endocyclic AIP amides donate hydrogen bonds to a glutamate residue of the antibody,
while side chains of residues Phe6, Ile7 and Met8 (all shared between AIP-IV and AIP-I)
are buried in a large, contiguous hydrophobic cleft on the antibody surface (Figures 5.10a

Figure 5.10 Hydrophobic side chains on the ring-forming residues are required for
the liposome-dependent stabilization of the thiolactone.
(a and b) AIP-IV-antibody interface in a crystal structure (PDBID: 3QG6): An overview
(panel a) and a zoom-in view at the interface (red rectangle in a, panel b) are shown.
AIP-IV is presented as a stick model with the backbone carbons in cyan and side-chain
carbons of Phe6, Ile7 and Met8 in gray. Side chains of Tyr1, Ser2, Thr3 and Asp4 are not
shown for clarity. The ribbon diagram and electrostatic surface of the antibody are
displayed. In (b), Hydrogen bonds between a glutamate residue in the antibody
(highlighted in green) and the AIP backbone are highlighted by black dashes. (c)
Arbitrarily positioned stick models of AIP-I and POPC depicting the proposed
interactions by which lipid vesicles stabilize the macrocycle: carbon atoms in POPC, are
shown in green, and hydrogen bonds are highlighted by black dashes. Note that all
displayed side chains in the AIP-I model are identical in AIP-IV. (d) As in Figure 5.8c,
equilibrium positions were plotted for the mutant (open symbols) or wild type (closed
symbols) AIP-I (circles) or AgrD-I(1-32)-thiolactone (squares) in aqueous buffer alone
(dotted lines) or that containing phospholipids (solid lines) or glycolipids (dashed lines).
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and b). Based on this crystal structure, we envisioned that the putative partitioning of the
macrocycle in the membrane might be driven by analogous interactions, specifically: the
anionic phosphodiester motif in lipid head groups might form hydrogen bonds to the AIP
endocyclic amide groups and hydrophobic side chains could be embedded in the greasy
interior of the bilayer (Figure 5.10c). In line with this model, mutating all three
endocyclic hydrophobic residues to Ala in AgrD-I(1-32)-thiolactone abolished
stabilization of the macrocycle in the presence of liposomes (Figure 5.10d and Table 5.1),
even though this mutant still associated with membranes, presumably through its leader
sequence that remains intact (Figures 5.9a-c). Indeed, this mutant exhibited thiolysis
equilibrium positions similar to that of AIP-I, either the wild type peptide or that bearing
the triple-Ala mutant macrocycle (Figure 5.10d and Table 5.1). In addition, liposomes
primarily composed of a non-charged glycolipid, digalactosidyldiacylglycerol (DGDG)
conferred slightly weaker stabilization to wild-type AgrD-I(1-32)-thiolactone than did
POPC-POPG liposomes (Figure 5.10d and Table 5.1). Collectively, these observations
are consistent with a role for both hydrophobic and polar interactions in the stabilization
of the thiolactone macrocycle as a consequence of membrane targeting.

5.6 AgrD processing by AgrB is a reversible process in vivo
Finally, we asked whether the reversibility of proteolytic cyclization observed in our in
vitro reconstituted system had relevance to AIP production in S. aureus cells. To this end,
we constructed S. aureus plasmids for production of two AgrD-IC peptides, one with
wild-type sequence and the other a scrambled sequence. These AgrD-IC peptides were
fused to a Flag-tagged ubiquitin (Ub-Flag2) for detection purposes (Figure 5.11a). Both
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plasmids were introduced to a S. aureus strain carrying an agr-I locus, resulting in two
transformants with similar growth rates (Figure 5.11b). Immuno-blotting revealed the
presence of AgrD-I-Ub-Flag2, the expected ligation product between the AgrD-IC

Figure 5.11. Reversibility of the proteolytic cyclization in vivo.
(a) Schematic showing the experimental design: production in S. aureus of wild-type
AgrD-IC peptide (purple), but not the scrambled control (teal), is expected to give rise to
AgrD-I-Ub-Flag2 (red) through the reverse activity of AgrB-I. (b) Growth curves of agr-I
cells producing indicated AgrD-IC peptides at 30oC. Error bar = range (n = 2). (c)
Western-blot analysis of cells producing AgrD-IC peptides: cells with indicated
genotypes were grown at 30 oC to indicated optical density (OD600) prior to lysis. A highmolecular-weight slice of the gel was Coomassie-stained as a loading-control. (d) Bar
graph showing AIP-I activity in the medium isolated from agr-I cells producing indicated
AgrD-IC peptides determined by an agr-I-specific reporter gene assay. Error bar = SD (n
= 6).
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construct and endogenous AgrD-I(1-32)-thiolactone, in cells expressing the wild-type
construct (Figure 5.11c, lanes 4-7, red arrowhead) but, importantly, not the scrambled
construct (Figure 5.11c, lanes 8-11). As expected, this ligation product was not present in
transformed agr-knockout cells expressing the wild type AgrD-IC construct (Figure
5.11c, lanes 13-15). Remarkably, AIP-I secretion was significantly lower in agr-I cells
expressing the wild type AgrD-IC construct as compared to those expressing the
scrambled construct, as determined using an agr-I-specific reporter gene assay (Fig. 5C).
We interpret this as resulting from sequestration of AgrD-I(1-32)-thiolactone as a
consequence of AgrB-I-mediated ligation with wild-type AgrD-IC-Ub-Flag2, but not the
scrambled control.

5.7 Summary and Discussion
5.7.1 Factors that facilitate AgrD proteolytic cyclization
When a polypeptide undergoes proteolysis, the peptidyl fragment N-terminal to the
scissile bond is transferred to an acceptor nucleophile. While water is by far the most
frequent acceptor, nature also efficiently harnesses a spectrum of N- or O-nucleophiles,
leading to the formation of various branched, cyclic or C-terminally modified peptides or
proteins (175). To the best of our knowledge, the first step in AIP biosynthesis is the only
known proteolytic event where an S-nucleophile serves as the final acceptor of the
peptidyl group – this definition excludes the transient, thioester-linked acyl-enzyme
intermediates associated with the activity of cysteine proteases. It is noteworthy that
nature typically couples ATP hydrolysis to the conversion of a carboxyl group (via an
adenylation step) into a thioester, e.g. the activity of the ubiquitin activating enzyme, E1
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(176). In this study, we broke down the thiolactone-forming proteolysis reaction into the
following half-reactions; (1) thiolysis of AgrD at the scissile peptide bond, and (2) ring
closure from the resulted linear thioester (Fig. 1B). Employing chemical equilibrium
approaches, we experimentally determined the ∆G0’ for the overall proteolytic
cyclization reaction (7.1 kcal/mol) and the ring closure from the linear AgrD(1-32)-NAC
thioester (1.4 kcal/mol, calculated from KD, NAC = 95 mM). The former reaction is 2.6
kcal/mol more favorable than our estimation based on model reactions, whereas the latter
is more favorable by 0.9 kcal/mol. This comparison indicates that the initial thiolysis step
is also more facile (by 1.7 kcal/mol) than might be expected. To account for this, we
propose that the scissile bond in AgrD is more sensitive to proteolysis than a generic
peptide bond. Indeed, it has been shown that the free energy of hydrolysis for an
individual peptide bond may vary by a few kcal/mol as a function of sequence context in
folded proteins (177). Conceivably, targeting of AgrD to the lipid bilayer by the Nterminal leader peptide could also help sensitize the scissile amide to proteolysis due to
changes in the local chemical environment around this bond (e.g. changes in the
dielectric of the medium, electrostatic effects and so on). Additional experiments will be
required to test this idea.

5.7.2 Physiological implications of the ∆G0’ of thiolactone formation
Autoinduction of the agr locus in S. aureus features an abrupt up-regulation of the
effector RNA levels during the exponential growth phase (29). A recent report showed
that the pheromone concentration in a liquid-medium culture of a group-I strain reaches 5
µM in two hours (178). By definition, this generates the same number of AgrDC
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fragments in the cytoplasm, which leads to a considerably elevated intracellular
concentration because of the much smaller volume of the cytoplasm compared to the
medium. For example, AgrDC production would reach an accumulative concentration of
5 mM in two hours, at a rate of 700 nM per second, assuming 1 mL cytoplasm is present
in a one liter cell culture in late exponential phase (179). Constant and efficient AIP
production therefore necessitates simultaneous removal of AgrDC since, as we have
shown, elevating the levels of this fragment can perturb the equilibrium of AgrBmediated proteolytic cyclization (Fig. 5C) (Figure 5.12). Assuming that equimolar
amounts of AgrD and AgrD(1-32)-thiolactone are present in a quasi-equilibrium with
AgrDC in post-induction S. aureus cells, the steady-state concentration of AgrDC should
be equal to the equilibrium constant for the proteolytic cyclization, Keq = 10 µM. The

Figure 5.12 Summary of the driving forces that power the formation of the AgrD(1-32)-thiolactone intermediate
The AAA+ protease proposed to degrade AgrDC, ClpXP, is highlighted in a cartoon
portraying its tertiary structure, with a hexameric ClpX ring stacking on two heptameric
ClpP rings.
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half-life of AgrDC would therefore be on the order of 10 seconds given a production (and
degradation) rate of 700 nM per second. This short lifetime of AgrD-IC indicates a
pathway in S. aureus that actively targets the peptide for degradation.

The above estimation of the in vivo lifetime of AgrDC sheds light upon two long-standing
puzzles with respect to the production of staphylococcal AIPs. The first of these involves
the observation that AIP-production is greatly reduced as a consequence of genetic or
chemical knockout of ClpP, the catalytic subunit of certain major AAA+ proteases in S.
aureus (180, 181). While this phenotype has been known for more than a decade, the
underlying mechanism has been elusive. We propose that ClpP constitutes the AAA+
protease that catalyzes the degradation of AgrDC and thus fuels the proteolytic cyclization
of AgrD (Figure 5.12). The second puzzle relates to the remarkable sequence
conservation of AgrDC (Figure 5.13). Surprisingly, mutations at most highly conserved
positions on AgrDC have no affect on the substrate recognition by AgrB (55). Given the
necessity for rapid degradation of AgrDC on agr induction, we hypothesize that a
conserved motif within AgrDC targets the peptide to the degradation machinery, either
through direct binding or mediated by a dedicated adaptor protein. Experimental tests of
this hypothesis are currently in progress.
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Figure 5.13 Multiple sequence alignment of Staphylococcal AgrDs.
All AgrD sequences from the genus Staphylococcus in the pfam database (05931) are
subject to an identity cutoff at 80%. The resulting 25 non-redundant sequences were
aligned to the hidden-Markov model of the AgrD family. Invariable and highly conserved
positions are highlighted in red and blue, respectively. Two red stars indicate positions at
which mutation to alanine abolishes AgrB-catalyzed processing in vivo.
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Chapter Six: Outlook
The work presented in this dissertation established in vitro reconstitution systems for the
quantitative biochemical and biophysical characterization of two pivotal membrane
proteins, namely, AgrC and AgrB, involved in the QS in S. aureus. Prior to our study on
AgrC, RHKs are in general believed to work as two-state switches that can be activated
only with highly specific conformational input. The discovery of a gradual conformationactivity landscape for the AgrC-I HK domain employing the GCN4-AgrC-I chimera
protein series raises an alternative model in which the signal-response properties of TCSs
are more amenable to fine adjustments in evolutionary processes. Furthermore, guided by
our thermodynamic analysis of the AgrB-mediated proteolytic cyclization of AgrD, we
found that constant and efficient degradation of the C-terminal cleavage fragment,
AgrDC, is required to power the formation of the high-energy thiolactone N-fragment. In
this chapter, opportunities to further explore the AgrC conformation-activity landscape
are discussed and experiments are proposed for the identification of the protease(s)
responsible for the turnover of AgrDC. At the end of this chapter, a chemical tagging
approach harnessing the reactivity of the AIP thiolactones to identify AIPs from other
Firmicutes species is described.

6.1 The signal-response property of the AgrC-I HK domain
In Chapter 4, the conformation of the interdomain helical linkers of AgrC-I has been
subject to symmetric rotational input imposed by a GCN4 coiled-coil fused to the Nterminus of the linkers. The auto-kinase activity changed gradually with the magnitude of
the rotation, leading to the conclusion of a gradual conformation-activity landscape
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(Figure 4.3). This understanding of the signal-response behavior of AgrC-I, however, is
rather preliminary. Firstly, the auto-kinase activity was used as the sole readout in our
analysis of the GCN4-AgrC-I chimera series, so there is no information concerning the
response of, for instance, the trans-kinase (phospho-relay) activity to the rotation of
interdomain linkers. Importantly, AIP-II, the inverse agonist of AgrC-I has been found to
inhibit the trans-kinase activity while the underlying mechanism remains unknown.
Secondly, given the vast diversity of sensor domains harnessed by RHKs in nature, it is
very unlikely that they all impose symmetric, rotational input to the interdomain linkers
that connect them to their respective HK domains. A fascinating project would therefore
involve the systematic introduction of other types of conformational input to the AgrC-I
linker pair followed by the analysis of the auto-kinase response. Thirdly, our inter-subunit
disulfide crosslinking experiment on full-length AgrC-I favored the model in which the
interdomain linker adopts a distinct, static conformation in each ligand state rather than
distributes between two discrete conformations (Figures 4.4d and 4.9). This
interpretation, however, needs to be restricted to the N-terminal half of the linker
whereby Cys substitutions were performed (residues 205-209 out of 201-211). The HK
domain, to which the C-terminus of the linker connects, on the other hand, is believed to
distribute between as few as two conformations that corresponds to the kinase-off and
kinase-on states captured in crystal structures (150). Thus, the interdomain linkers must
somehow reconcile the discrepancy between the static conformation at its N-terminus and
the conformation distribution at its C-terminus, by a yet unclear mechanism. Addressing
the above three questions will significantly expand our knowledge on the signaling
mechanism of TCSs.

	
  

125	
  

6.1.1 The trans-kinase activity and the pHis stability in GCN4-AgrC-I chimeras
As was alluded to in section 4.5.2, the AgrC-AgrA TCS would be exceptionally
amenable to the analysis of phospho-relay kinetics because AgrC lacks the phosphatase
activity that may otherwise complicate such analysis (see Figure 3.5). In reality, however,
one drawback of this system comes from the instability of AgrA: all recombinant AgrA
proteins containing the phospho-acceptor REC domain are prone to precipitation even
when presented at low-µM concentrations (data not shown). Moreover, while the transkinase kinetic data of all GCN4-AgrC-I chimeras are required to plot a conformationactivity landscape, direct reconstitution of the phospho-relay involving the auto-kinaseinactive chimeras is impractical because they cannot be pre-phosphorylated efficiently.
To circumvent these issues, a three-component, phospho-equilibration system could be
designed (Figure 6.1a), which harnesses the well-known thermodynamic reversibility of
the His-to-Asp phospho-relay (84). This system contains equimolar quantities of a donor
and an acceptor AgrC constructs, as well as a catalytic amount (less than 5% of the
donor) of AgrA that shuttles the phosphoryl group between them (Figure 6.1a).
Specifically, the phosphoryl donor should be a kinase-active AgrC-I construct that is
phosphorylated to completion and purified from the auto-kinase reaction (so that it is
nucleotide-free) and the acceptor is the subject GCN4-AgrC-I chimera. Assuming that the
kinetics of the forward (AgrC to AgrA) and reverse (AgrA to AgrC) phospho-relays are
much faster than the spontaneous dephosphorylation of AgrA (Figure 6.1a), this system is
expected to reach a quasi-equilibrium state and the phosphorylation levels of the donor
and the acceptor will approximate a thermodynamic equilibrium (Figure 6.1b, the
equilibrium phase). Notably, the position of this equilibrium will reflect the
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thermodynamic pHis stability on the subject chimera relative to the donor. These data, if
successfully obtained, will reveal the dependence of the pHis stability on the
conformation of the interdomain linkers. Meanwhile, phosphorylation of the catalyst,
AgrA, is expected to reach a steady state shortly after the reaction begins (Figure 6.1b,
the equilibration phase). The kinetic constant of the phospho-transfer from AgrA to the
subject chimera will therefore be determined based on the reaction velocity and the
steady-state phosphorylation level of AgrA. Kinetic parameters of the chimera-to-AgrA
transfer will then be derived from the quasi-equilibrium position at the equilibrium phase.
Finally, it is important to point out that the faster kinetics of phospho-relays versus

Figure 6.1 The three-component phospho-equilibration system
(a) The reaction scheme. See text for details. (b) A simulated kinetic plot depicting
phosphorylation levels of all three components as a function of time. The
phosphorylation of two His residues in each HK dimer are treated as independent events.
In panel (b), The simulation begins with an equimolar amount of the donor and the
acceptor. The parameters are arbitrarily set such that the pHis in the acceptor is 0.3kB
more stable than that in the donor.
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AgrA dephosphorylation and the AgrA stability in solution are both critical to the
predicted behavior of this phospho-equilibration system. Preliminary experiments should
be performed to confirm these prerequisites.

6.1.2 Introduction of scissoring motions to the AgrC-I interdomain linker helices
Geometrically, modifying the distance between the N-termini of the interdomain linkers
will cause the scissoring motions (Figure 6.2a, top panel). Thus, a conformation-activity

Figure 6.2 Strategies to introduce scissoring movements to the helical interdomain
linkers.
(a) Color codes of AgrC-I intracellular structural elements (top panel) and the definition
of the conformation-activity landscape about scissoring movements of the linkers (bottom
panel). The conformation descriptor could be the inter-linker distance between any two
positions close to the linker N-terminus. (b) The spacer-domain strategy: steric bulks of
the spacer-domain dimers separate the N-termini of the TM domains by a series of
distances, which is expected to translate into different scissoring conformations of the
interdomain linkers. (c) The rigid-crosslinker strategy: the N-termini of the interdomain
linkers are directly separated by a crosslinker acting as a molecular ruler.
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landscape with such motions could be plotted in the form of auto-kinase activity versus a
distance descriptor (Figure 6.2a, bottom panel). Modification of inter-linker distance can
be achieved employing two strategies. The first strategy will rely on the use of
homodimeric protein domains, herein referred to as spacer domains (Figure 6.2b). These
domains are fused to the N-terminus of an AgrC-I construct to separate the interdomain
linker pair by their steric bulk (Figure 6.2b). The fusion protein will also consist of the
last TM domain (TM-VI) and the cytosolic portion of AgrC-I. TM-VI is included due to
its critical role in the activation of the constitutive mutant, AgrC-IR238H, which
presumably occurs through promoting α-helicity in the interdomain linker (see Figures
4.1b and 4.7). Spacer domains are selected on two criteria: (i) that they homodimerize
with mid-nM or higher affinity and (ii) that the C-termini in the homodimer structure are
separated by a unique distance (Figure 6.2b). To chart the landscape, a series of spacerAgrC-I chimeras will be prepared recombinantly, reconstituted to nanodiscs for autokinase analysis, and the distance between the interdomain linkers will be gauged through
Förster resonance energy transfer (FRET)-based approaches. The second strategy will
employ chemical crosslinkers, each containing two reactive groups separated by a
conformationally rigid linker (Figure 6.2c, orange bars). These crosslinkers will be
installed between the two subunits at an interdomain-linker position and are expected to
separate the crosslinked positions by a defined distance (Figure 6.2c). For the same
aforementioned reason, the AgrC-I construct used here will also include the TM-VI.
Crosslinking may be achieved directly on the recombinantly prepared AgrC-I construct.
Alternatively, the crosslinked protein could be prepared from the expressed chemical
ligation (EPL) of two fragments: a synthetic N fragment containing the crosslinking site
and a recombinant C-fragment. Crosslinkers will be installed to the N-fragment prior to
the EPL reaction. Crosslinked AgrC-I dimers prepared in either way will be refolded and
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incorporated to nanodiscs for autokinase analysis. The distance descriptor of scissoring
will be calculated directly from the chemical structure of the crosslinkers.

6.1.3 Is the interdomain linker pair an analog-to-digital converter?
As was discussed in Section 4.5.1, the interdomain linker needs to transmit the
conformational input imposed at its N-terminus to an output discernible for the HK
domain. In the full-length AgrC-I bound to a certain ligand or a GCN4-AgrC-I chimera,
the input conformation should be constant over time (Figure 6.3a). This input fits the
definition of an analog signal in that it is a continuous function of time (see Figure 6.3c).
By stark contrast, the HK-domain dimer to which the C-termini of the linker pair connect
is believed to distribute between as few as two discrete conformational states (Figure
6.3b), each exhibiting a distinct level of auto-kinase activity (150). This notion is in part
based on the packing principle of four-helix bundles, in which gradual rotation or tilting
of the participating α-helices is not permitted (182). The auto-kinase regulation would
therefore depend on the redistribution of the HK-dimer ensemble between/among its
possible conformations (Figure 6.3b). At the single-molecule level, however, the HK
domain conformation is expected to be a discrete function of time—a property
reminiscent of a digital signal (see Figure 6.3c). In this regard, the interdomain linker pair
acts as an analog-to-digital converter.

As a future endeavor of the Muir Lab, the above model will be further elucidated
employing single-molecule FRET strategies (183), which have, to our best knowledge,
not been applied to any RHK to study the conformational ensemble of its participant
modules. The crystal structure of at least one GCN4-AgrC-I chimera is required to direct
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the placement of fluorophores, and this work is currently in progress. To confirm our
assumptions on the conformational states of the GCN4 coiled coil and the DHp four-helix
bundle, the donor-acceptor pair will first be introduced to these modules and the FRET
signal will be recorded as a function of time (Figure 6.3c). If the FRET data match our

Figure 6.3 Putative conformational distributions of the two modules flanking the
interdomain linker
(a) The static conformation introduced by the rigid-body GCN4 module. (b) The
conformation distribution discernible by the four-helix DHp module. In panels (a) and
(b), conformation distribution of seven hypothetical signaling states, A through G, are
shown. In (b), the output is arbitrarily distributed between two conformations
corresponding to kinase-active and –inactive states, respectively. (c) Predicted FRET
trace for two GCN4-AgrC-I chimeras, one kinase-active (top panels) and the other
inactive (bottom panels), given the FRET pair is installed in the GCN4 (left plots) or
DHp modules (right plots).
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expectation on their respective analog and digital behaviors, a few more GCN4-AgrC-I
chimeras exhibiting distinct auto-kinase activities will then be analyzed using the same
sets of labeling sites (Figure 6.3c). Notably, the apparent kinase activity of a chimera
should be equal to the average of all its major conformers weighed by their distribution
probabilities. In this regard, the activity level of major DHp conformers could be solved
employing simultaneous equations. If necessary, fluorophores may be moved to the N- or
C- termini of the interdomain linkers to further elucidate the conformational states at
these positions. Furthermore, once an input-output correlation of the wild-type linker is
established, its native length or sequence could be altered through mutagenesis in order to
investigate the influence of the perturbed factors on the linker’s signal transmission
property.

6.2 Degradation of the AgrD C-terminal cleavage fragment
As was discussed in section 5.7.2, the ClpXP AAA+ protease machinery is a favorable
candidate for the degradation of AgrDC. Several experiments are proposed to test this
idea. Firstly, the AgrDC-Ub-Flag2 construct (section 5.6, Figure 5.11a) will be overproduced in the wild-type S. aureus or the clpPS98A mutant that expresses a catalytically
inactive version of ClpP (Figures 6.4a and b). Assuming that AgrDC-Ub-Flag2 is also
actively degraded by ClpXP, a stronger accumulation of this AgrDC construct should be
seen in the mutant. Consequently, an increase of AgrDFL-Ub-Flag2 and a decrease of AIP
production should also be expected (Figure 6.4b). In addition, the recombinant S. aureus
ClpXP is expected to degrade the AgrDC peptide in vitro (Figure 6.4c). If both
experiments support the role of ClpXP, efforts will be made to understand the recognition
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of AgrDC by ClpXP. Specifically, previous studies have shown that most conserved
residues within AgrDC are not required for substrate recognition by AgrB (55).
Intuitively, these positions may conserve for the interaction that targets AgrDC to ClpXP.
In light of this idea, these positions will be Ala-scanned for mutations that confer
resistance to ClpXP degradation (Figure 6.4d). Once such mutations are successfully
identified, the role of the residue and its effect on the physical interaction with the AAA+
protease will be confirmed with immuno-precipitation (IP) studies (Figure 6.4e).

Figure 6.4 Identification of AgrDC degradation proteases
(a) The sequence and cartoon presentation of AgrD-IC. (b and c) Preliminary genetic (b)
and in vitro biochemical (c) experiments to validate the AgrDC degradation activity of
ClpXP. See text for details. (d and e) The alanine-scan mutagenesis approach in search of
AgrDC residues essential for ClpXP targeting. The site of Ala-mutation is highlighted in
black. (f and g) An unbiased strategy to enrich AgrDC-degrading proteases through
fractionation. In (f), the fluorescein- and dabsyl- labels are indicated in green and gray,
respectively. Any cleavage occurring between the two labeling sites is expected to
generate green fluorescence.
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While the ClpXP system is a strong candidate as an AgrDC protease, it is possible that
other cellular proteases also contribute to the degradation of this peptide. Therefore, an
unbiased, activity-guided fractionation strategy will be taken to identify them.
Accordingly, we will use an AgrDC peptide modified with a fluorescein-dabsyl donorquencher FRET pair as the substrate to follow the biochemical enrichment of protease
activity in S. aureus cell-lysate fractions (Figures 6.4f and g). Once the protease activity
has been suitably enriched, the responsible protease will be identified using mass
spectrometry.

6.3 Detection of AIP thiolactones from other Firmicutes species
The phylum Firmicutes includes not only causative agents of various infective diseases
but also a vast diversity of mutualistic symbionts of human beings. As a prime example,
metagenomic analysis of human gut revealed that Firmicutes comprises nearly 40% of
the bacterial population, and abnormalities in the abundance of key genus or species have
been related to disease states (184). Intriguingly, homologs of the agr system can be
identified in several prominent Firmicutes constituents in the gut microbiota (Figure
6.5a). Remarkably, a Eubacterium rectale strain possesses 7 AgrB homologs, each
accompanied by a unique AgrD sequence sharing the prominent features required for
AgrB recognition as well as the (thio)lactone formation (Figure 6.5a) (136). Inspired by
the cross-group inhibitory effect of S. aureus AIPs, we hypothesize that the AIPs
putatively produced by these AgrB-AgrD protease-substrate pairs are employed as
weapons for the competition among Firmicutes species that shapes their ecological niche
in the nutrient-limiting gut environment (185). Given the strong specificity of AgrC-AIP
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recognition seen in S. aureus, the signaling of each putative AIP is expected to affect the
fitness of a narrow spectrum of bacterial species. Thus, these AIPs may be harnessed as
useful tools to probe the interaction among species or manipulate the composition of the
microbiota in a phylotype-specific manner.

Because all AIP sequences are embedded in the middle of their AgrD precursors, it is
necessary to determine the site of both proteolysis events required for their maturation.
While the AgrB cleavage site can be identified with high confidence based on sequence

Figure 6.5 Identification of thiolactone AIPs from complex systems
(a) Gap-free sequence alignment of AgrD proteins from a few major Firmicutes species
in human gut. The predicted AgrB cleavage site is shown with a blank in all sequences
and indicated with an arrow. Three loci that defines the AgrB cleavage site, two enriched
of Pro and one bearing the (thio)lactone-forming Cys or Ser are highlighted in blue and
red, respectively. Two positions conserved for hydrophobic residues on the N-terminal
side of the AgrB cleavage site are shadowed in grey. (b) A chemical tagging strategy that
isolates AIP thiolactones from complex systems for MS sequencing. See text for details.
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similarity (136), delineating the N-terminal cleavage junction is challenging due to its
variability—this site is not conserved even among the closely-related S. aureus subgroups
(refer to Figure 1.6a). To determine the exact sequence of AIPs produced by Firmicutes
species in a complex system, a chemical-tagging approach harnessing the reactivity of the
conserved thiolactone is proposed (Figure 6.5b). Thiolactone AIPs from human stool
samples (or other complex systems) will be linearized by a biotin-tagged hydroxylamine
and enriched with a streptavidin-agarose matrix. Peptides released from streptavidin will
be sequenced based on mass spectrometry. A library of all AgrD genes encoded by the
microbiome will be generated using the Human Microbiome Project database
(hmpdacc.org/) and the sequences obtained for all tagged peptides will be mapped back
to their host AgrD genes. It is noteworthy that, upon the ring-opening tagging reaction,
AIPs will lose their strong proteolytic resistance conferred by the thiolactone macrocycle.
In this regard, the samples will be pre-treated with protease-inhibitor cocktails, and casein
will be included in the tagging and enrichment processes as a protective measure. Any
AIP detected and sequenced in the above process will be synthesized and re-introduced to
the complex system to dissect its impact on the fitness of its host species as well as other
symbionts.
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Chapter Seven: Methods
In this dissertation, we include the reconstitution of two disparate biochemical systems,
namely the AgrC-AgrA TCS that mediates phospho-relay, and the AgrB peptidase that
carries out proteolysis on AgrD. Nonetheless, protein production and reconstitution of
these system shares considerable similarity, as the key component in both systems is
integral membrane proteins. As a consequence, the molecular cloning and recombinant
protein production methods for all four Agr proteins are described combined, while the
biochemical assays on each system are documented separately.

7.1 Materials and Equipment
7.1.1 General Materials
All buffering salts, the LB broth, isopropyl-β-D-thiogalactopyranoside (IPTG), 1, 4dithiothreitol

(DTT),

tris-(2-carboxyethyl)

phosphine

hydrochloride

(TCEP),

iodoacetamide, Coomassie brilliant blue, phenylmethylsulfonyl fluoride (PMSF) and
nitrocellulous membranes were purchased from Fisher Scientific (Pittsburgh, PA). All
medium ingredients for S. aureus cultures were from Difco Biosciences, Inc. (San Diego,
CA). All antibiotics, non-radioactive nucleotides for AgrC-I-related assays, N, Ndimethylformamide (DMF), dimethylsulfoxide (DMSO), 2,2,2-trifluoroethanol (TFE), N,
N-diisopropylethylamine (DIEA), piperidine, triisopropylsilane (TIS), β-mercaptoethanol
(BME), N-Acetylcysteamine (NAC), lysostaphin, gluaraldehyde solution, guanidinium
chloride (GuHCl) sodium 2-sulfanylethanesulfonate (MESNa), bovine serum albumin
(BSA), and Eastman KODAK BioMax Film were purchased from Sigma-Aldrich (St.
Louis, MO). All protected amino acids, coupling reagents and Rink-amide MBHA were
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purchased from Novabiochem. [γ-32P]-Adenosine triphosphate and Ultima Gold Cocktail
was from PerkinElmer (Waltham, MA). All lipids were purchased from Avanti Polar
lipids (Alabaster, AL) and all detergents were obtained from Anatrace (Maumee, OH).
Trifluoroacetic acid (TFA) was from Halocarbon (North Augusta, SC). Anhydrous HF
was from Matheson. Nickel-nitrilotriacetic acid (Ni-NTA) resin and KOD polymerase
was from Novagen (Gibbstown, NJ). Talon cobalt resin was from Clontech (Mountain
View, CA). Glutathione Sepharose 4 Fast Flow (GS4FF) resin was from GE Healthcare
(Piscataway, NJ). The QuikChange Site-Directed Mutagenesis kit was from Agilent (La
Jolla, CA). tC2 Sep-Pak cartridges were from Waters (Milford, MA). T4 DNA ligase,
restriction enzymes and the Phusion High-Fidelity PCR kit were from New England
Biolabs (Ipswich, MA). DNA purification kits (QIAprep spin minikit, QIAquick gel
extraction kit, QIAquick PCR purification kit) were from Qiagen (Valencia, CA). Subcloning efficient DH5α competent cells and One Shot BL21(DE3) chemically competent
E. coli were purchased from Invitrogen (Carlsbad, CA) and used to generate “in-house”
high-competency cell lines. Oligonucleotides were purchased from Integrated DNA
Technologies (Coralville, IA). Codon-optimized cDNAs were generated synthetically and
purchased from GENEWIZ (South Plainfield, NJ). Plasmid-sequencing services were
ordered from GENEWIZ. DNA purification kits (QIAprep spin minikit, QIAquick gel
extraction kit, QIAquick PCR purification kit) were from Qiagen (Valencia, CA). All
denaturing gels, PVDF membrane (0.2 µm), Bio-Beads SM2 Adsorbent and goat antirabbit monoclonal antibody were from Bio-Rad (Hercules, CA). IRDye 800CW goat
anti-rabbit IgG was from LI-COR Biotechnology (Lincoln, NE). The pan-specific
antibody recognizing pHis (pHis) was purified from the anti-pHis polyclonal antiserum.
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Some synthetic AIPs and their analogs were obtained from the Muir Lab storage freezers.

7.1.2 General Equipments
Solid-phase peptide synthesis (SPPS) was carried on a Liberty Synthesizer (CEM,
Matthews, NC). Size exclusion chromatography was carried out on an ÄKTA FPLC
system from GE Healthcare using a Superdex200 10/300 column or a Superose6 10/30
HR column. For all runs, proteins were eluted over one column volume of buffer (flow
rate: 0.5 mL/min). For SEC-MALS experiments, the ÄKTA FPLC system was connected
in tandem to a DAWN HELEOS-II multi-angle light scattering instrument and OptiLab
TrEX differential refractometer. Ion-exchange chromatography was performed on the
same FPLC instrument system using a Hiprep Q FF 16/10 column. RP-HPLC was
performed on Hewlett-Packard 1100 and 1200 series instruments equipped with an
analytical C18 or C4 Vydac column (5µm, 4.6 x 150 mm) at a flow rate of 1 mL/min or a
semiprep C18 or C4 Vydac column (5µm, 10 x 250 mm) at a flow rate of 4 mL/min. All
runs used 0.1 % TFA (trifluoroacetic acid) in water (solvent A) and 90 % acetonitrile in
water with 0.1% TFA (solvent B). Electrospray ionization (ESI) and matrix-assisted laser
desorption ionization (MALDI) mass spectrometric analysis was performed on a Bruker
Daltonics MicrOTOF-Q II and a PerSeptive Voyager DE STR MALDI-TOF
spectrometer, respectively. Fluorescent anisotropy was measured using a fluorolog®-3
Model FL3-11 fluorimeter (Horiba Jobin Yvon). Coomassie stained gels and dot blots
were imaged on a LI-COR Odyssey Infrared Imager. In-gel fluorescence,
chemoluminescence and autoradiogram were detecteed using the GE ImageQuant LAS
4000. Scintillation counting was carried out on a Perkin Elmer 2450 microplate counter.
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Concentration of DNA, peptide and protein samples was measured on a nanodrop2000
intrument from Thermo scientific or a UV-vis 8453 spectrophotometer from Agilent.

7.2 Molecular cloning
7.2.1 cDNA sequence of Agr proteins
Amino acid sequences of full-length AgrB-I (1-189), AgrD-I (1-46), AgrB-II (1-187) and
AgrD-II (1-47), AgrC-I (1-430), AgrC-II (1-427), AgrC-III (1-430) and AgrA (1-238)
were obtained from the NCBI protein database (Refseq/Genebank accession:
YP_001332977.1, YP_001332978.1, NP_372560.1, NP_372561.1, YP_001332979.1,
EFT84677.1, BAB95827.1 and YP_001332980.1). The cDNA sequences were backtranslated from the amino acid sequences with optimized codons according to the default
E. coli codon usage table (186). cDNA was purchased from Genewiz. The cDNA were
received in pUC57 vectors.

7.2.2 Expression plasmids for AgrC and AgrA
Coding sequences corresponding to the desired construct of AgrC were amplified with
KOD polymerase using primers harboring appropriate restriction sites and cloned
between NdeI and XhoI sites of a pET24b or a pET15b vector, respectively. Similarly,
the coding sequence of full-length AgrA was cloned into a pACYCDuet vector between
BamHI and XhoI restriction sites. Site-directed mutagenesis of the AgrC-I construct was
performed using a QuikChange Site-Directed Mutagenesis kit using standard protocols.
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In all GCN4-AgrC-I chimeras, the N-terminal portion corresponds to residues 250-274 of
the Gcn4p protein in Saccharomyces cerevisiae (Refseq accession: NP_010907), to
which we refer as GCN41-25. The coding sequence of GCN41-25 was fused immediately
upstream to the appropriate AgrC-I coding sequence employing the overlap-extension
strategy and inserted between the NdeI and XhoI sites of the pET15b vector.

7.2.3 Expression plasmids for AgrB and AgrD constructs
AgrB-I-His6 and AgrB-II-His6
Coding sequences of full-length AgrB-I or AgrB-II were cloned between NdeI and XhoI
sites of a pET24b vector (Novagen).

Non-tagged AgrD-I and AgrD-II
A 24-nucleotide (nt) sequence encoding seven histidines and a stop codon was inserted
in-frame immediately downstream to the coding sequence of the Mxe GyrA intein in the
pTXB1 vector (NEB) to generate pTXB1-His7. Coding sequences of full-length AgrD-I
or AgrD-II were cloned between NdeI and SapI sites in pTXB1-His7.

FlagHis6-AgrD-I and AgrD-II
FlagHis6-AgrD-I and FlagHis6-AgrD-II was fused to GST within an intervening sequence
for thrombin (LDKLVPRGSS) or PreScission protease (LDLEVLFQGPGS) recognition,
respectively. Coding sequences of these two constructs was inserted between NdeI and
XhoI sites in pET24b, with a stop codon immediately downstream to the XhoI site.
Coding sequence of GST was from pGEX4T1 (GE Healthcare).
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FlagHis6-AgrD-I(1-32)-thiolactone
The coding sequence of FlagHis6-AgrD-I(1-32) was inserted into the pTXB1 vector. The
amino acid sequence of the affinity tag is MDYKDDDDKHHHHHHGG.

Plasmids for wild-type or scrambled AgrD-IC-Ub-Flag2 production in S. aureus
Production of AgrD-IC-Ub-Flag2 was achieved by co-expression of two fusion proteins,
Sumo-AgrD-IC-Ub-Flag2 and His6-Ulp1 from the pCN51 shuttle plasmid (187). The
insert sequence begins with the strong, constitutive pblaZC promoter (50), followed by
coding sequences of AgrD-IC-Ub-Flag2 and His6-Ulp1, both preceded by a consensus
Shine-Dalgarno (SD) sequence and a short spacer. This insert sequence was synthesized
by Genewiz and cloned between PstI and EcoRI sites of the vector. In a control plasmid,
coding sequence of AgrD-I33-46 (DEVEVPKELTQLHE) was substituted with that of a
scrambled peptide, TLEVKEVQELPEHD. The above substitution and insertion were
both achieved using an overlap extension PCR technique.

Site-directed mutagenesis
Expression plasmids bearing point mutations were generated from the parental, wild-type
plasmids using a QuikChange Site-Directed Mutagenesis kit following the standard
protocol.
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7.3 Recombinant protein production and reconstitution
7.3.1 Soluble proteins
With an exception of AgrA, all soluble proteins in this dissertation were prepared as
follows. E. coli BL21(DE3) cells transformed with the appropriate expression plasmid
were grown at 37 °C in one liter of LB medium containing selection antibiotics at
appropriate concentrations (100 µg/mL ampicillin, 50 µg/mL kanamycin or 35 µg/mL
chloramphenicol). When the OD600 reached 0.6, the medium was cooled down to 22°C
and overnight expression was induced by addition of 0.5 mM IPTG. Cells were harvested
at 6000 G for 20 min and the cell pellets were resuspended in 20 mL of lysis buffer (20
mM Tris, 100 mM NaCl, 1mM TECP and 1mM PMSF, pH 8.0). Cells were lysed by four
passages through a French-press homogenizer. After centrifugation at 30000 G for
30min, supernatant from the cell lysate was mixed with 4 mL of Ni-NTA resin. After
incubation at 4 °C for 60 minutes, the resin was repacked in a 25-mL Bio-Rad disposable
plastic column. The flow-through was discarded and the column was washed with 5
column volumes (CVs) of wash buffer 1 (20 mM Tris, 500 mM NaCl, 1mM TECP and
15 mM imidazole, pH 8.0) and 10 CVs of wash buffer 2 (20 mM Tris, 100 mM NaCl,
1mM TECP and 25 mM imidazole, pH 8.0). Bound protein was eluted with 1.5 CVs of
elution buffer (wash buffer 2 with 300 mM imidazole). The elution containing up to 10
mg protein was concentrated to 1mL and further purified on Superdex200 size-exclusion
chromatography, from which the desired peak fractions were collected. All GCN4-AgrCI chimera proteins were treated with thrombin for His6-tag removal prior to the sizeexclusion chromatography step. For purification of AgrA, modification to the above
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protocol involved a lowered expression temperature (at 16 °C) and inclusion of glycerol
at 20% (v/v) in all buffers.

7.3.2 Integral membrane proteins
For membrane-bound AgrB and AgrC constructs, E. coli C43(DE3) cells transformed
with the appropriate expression plasmids were grown in LB broth to an OD600 of 1.0 and
then induced at 22oC with 0.5 mM IPTG overnight expression. Cells collected from one
liter of culture were resuspended in 18  mL lysis buffer and disrupted in four passages
through a French-press homogenizer. Cell-wall debris was spun down at 15000 G for
10  min and removed. Cell-membrane vesicles were then pelleted by ultracentrifugation at
200,000 G for 1  h. The membrane fraction was extracted using 5mL of buffer containing
20  mM Tris-HCl pH 8.0, 100  mM NaCl, 5 mM BME and the detergent of choice for 3  h
at 4  °C (see below). Another ultracentrifugation step at 100,000 G for 20  min was
undertaken to clear the membrane extract.

Membrane fractions containing recombinant AgrC proteins were extracted with a buffer
containing 2% (w/v) Fos-choline-12 (FC-12). The cleared extract was subjected to NiNTA affinity chromatography as described above for soluble proteins, and the elution
containing the target protein were further purified over a Superdex200 size-exclusion
column. 0.05% (w/v) Fos-choline-14 (FC-14) was included in all buffers used in these
chromatographic steps.
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Extraction of AgrB out of E. coli membrane was performed with a buffer containing 2%
(w/v) n-dodecyl-β-D-maltopyranoside (DDM). The cleared extract was subjected to
Talon-cobalt affinity chromatography. After the loading and flow-through processes, the
column was washed with 20 CVs of wash buffer (20 mM sodium phosphate, 100 mM
NaCl, 5mM BME, 0.1% (w/v) FC-12 and 25 mM imidazole, pH 7.5). Bound protein was
eluted with 3 CVs of elution buffer (wash buffer with 500 mM imidazole). The elution
was concentrated to 1 mL and further purified on Superdex200 size-exclusion
chromatography with running buffer (20 mM phosphate, 100 mM NaCl, 0.14% (w/v)
FC-12, 1 mM TECP, pH 7.0), from which the desired peak fractions were collected.

7.3.3 AgrD constructs
Figure 7.1 shows a schematic presentation of the expression construct and the proteolytic
processing site for all recombinant AgrD constructs. In general, these constructs are
either soluble or directed to inclusion bodies when expressed in E. coli, and are affinitypurified under native or denatured conditions accordingly. After purification and
refolding (if necessary), DDM is included in the buffers for stabilization purposes and
these AgrD constructs, either before or after the autocatalytic or proteolytic processing,
are handled similarly to integral membrane proteins.

Non-tagged AgrD-I and AgrD-II
Both constructs were expressed as C-terminal GyrA-His7 fusion proteins in E. coli
BL21(DE3) cells. Transformed cells harboring the appropriate expression vector were
grown at 37oC to an OD600 = 0.6 and then induced by addition of 1.0mM IPTG. The
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culture was shaken at 37oC for 4 additional hours post-induction and cells were collected
through centrifugation. Cells were resuspended in PBS (20 mM Phosphate pH=7.5, 100
mM NaCl). PMSF (100 mM stock in ethanol) was added to the cell suspension
immediately prior to lysis at a final concentration of 1 mM. Cells were disrupted by four
passages through a French-Press. The lysate was centrifuged at 30000 G for 1hr and the
pellet resuspended in a buffer containing 7.5 M GuHCl, 50 mM phosphate buffer, pH =
7.5 and 2 mM TCEP. The suspension was homogenized, gently shaken at 4oC for 1hr and
then spun at 30000 G for 1hr. The supernatant was loaded to a column packed with NiNTA resin (Qiagen), and the resin was washed with buffer containing 25 mM imidazole
and 6 M GuHCl and eluted using a buffer containing 300 mM imidazole, 7.2 M urea and
0.05% (w/v) DDM. The eluted protein was immediately chilled in an ice-water bath and
refolded through dialysis against a series of phosphate buffers with decreasing urea

Figure 7.1 Preparation of recombinant AgrD constructs.
See text for detail protocols. GyrA, the Mxe GyrA intein; GST, glutathione S-transferase;
DTT, dithiothreitol; MESNa, 2-mercaptoethanesulfonate (MESNa).
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concentrations at 4oC. Upon dialysis, refolded AgrD-intein-His7 proteins were cleaved by
treatment with 50 mM DTT and 5 mM TCEP in the presence of 0.1% (w/v) DDM under
an argon atmosphere at RT for 12 hrs. Free intein released from DTT treatment as well as
uncleaved fusion protein was removed in a reverse-Ni-NTA affinity process. To the
combined flow-through and wash fractions (containing predominantly AgrD-DTT esters)
was then added 0.1% (v/v) FC-12. Residual urea in this solution was removed through
two concentration-dilution cycles. In each cycle, the solution was concentrated by ten
folds and and then diluted back to the original volume using a buffer containing 50 mM
phosphate pH=7.5, 50 mM DTT and 0.07% (v/v) FC-12. The solution after the second
dilution was concentrated to <5mL, to which GuHCl was added to a give a final
concentration of 6 M. EDTA was added at 10 mM and NaOH was used to basify the
solution to pH=9.5. The solution was incubated under argon atmosphere at 37oC for 4hrs
for complete saponification of the DTT ester, acidified to pH < 2 using neat TFA,
filtered, and purified over a semi-prep C4 RP-HPLC column.

FlagHis6-AgrD-I and FlagHis6-AgrD-II
Both constructs were expressed as C-terminal GST fusion proteins in E. coli BL21(DE3)
host cells. The expression culture was grown at 37oC to an OD600 = 0.6 and then was
cooled down to 16°C prior to induction by the addition of 0.4 mM IPTG. After overnight
incubation, cells were isolated from the culture medium, resuspended in lysis buffer (20
mM sodium phosphate, 100 mM NaCl, pH 7.5), and lysed by four passages through a
French-press homogenizer. After centrifugation at 30000 G for 30min, the cleared lysate
was supplemented with 0.1% (v/v) DDM and then incubated with GS4FF resin in a
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plastic column at 4 °C for 60 minutes. The lysate was then drained, and the resin was
washed by 20 CVs of lysis buffer, resuspended in 2 CVs of lysis buffer, and treated with
10 units of thrombin for AgrD-I or 0.2 mg/mL GST-tagged HRV3C protease for AgrD-II
at room temperature with gentle shaking for 3hrs(188). The released AgrD product was
collected and allowed to flow through a 4-mL bed packed with Ni-NTA resin. The NiNTA bed was washed with 10 CVs of lysis buffer with 15 mM imidazole, 10 CVs of 6 M
GuHCl buffered by Na-phosphate at pH = 7.5 and eluted with 3 CV of elution buffer (6
M GuHCl, 0.2 M acetic acid and 5 mM TCEP). Elution was purified over a semiprepscale C18 RP-HPLC column.

FlagHis6-AgrD-I(1-32)-thiolactone and its tri-Ala (F30A/I31A/M32A) mutant
Both constructs were expressed as C-terminal GyrA-CBD fusion proteins in E. coli
BL21(DE3) host cells. Protein expression and cell lysis procedures were identical to that
used for FlagHis6-AgrD preparation. Cleared cell lysate was supplemented with 0.05%
(w/v) DDM and subject to Ni-NTA purification. Upon flowing the lysate through the NiNTA column, the bed was washed with 5 CVs of wash buffer 1 (20 mM phosphate, 500
mM NaCl, 1 mM TECP 15 mM imidazole and 0.05% (w/v) DDM, pH 7.5) and 10 CVs
of wash buffer 2 (20 mM phosphate, 100 mM NaCl, 1 mM TECP 25 mM imidazole and
0.05% (w/v) DDM, pH 7.5). Bound protein was eluted with 4 CVs of elution buffer
(wash buffer 2 with 300 mM imidazole). The elution was dialyzed against a buffer
containing (20 mM phosphate, 1 mM TECP and 0.01% (w/v) DDM, pH 7.5), and then
cleaved after the addition of 100 mM MESNa and 5 mM TCEP. After an overnight
incubation, a Ni-NTA affinity step was employed to remove the GyrA-CBD generated
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during cleavage. Upon washing with MESNa-free buffers, the bound FlagHis6-AgrD-I(132)-MESNa thioester spontaneously cyclized into the thiolactone. All His-tag-containing
constructs, primarily the thiolactone and the intact fusion protein, were eluted in 100 mM
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES)-Na, 50mM EDTA, 1mM
TECP and 0.1% SDS, pH = 7.0. Concentrated elution was submitted, in 1-mL aliquots,
to

Superdex200

SEC

purification

with

running

buffer

(20

mM

2-(N-

morpholino)ethanesulfonic acid (MES)-Na, 100 mM NaCl, 0.1%SDS, 5mM Lmethionine, pH = 6.1). Fractions free from intact fusion protein were pooled and dialyzed
extensively against a buffer containing 0.1% (v/v) TFA and 5mM L-methionine until
precipitate emerged. GuHCl was added to a final molarity of 6 M, and the solution was
filtered and purified on a semiprep-scale C18 RP-HPLC column.

FlagHis6-AgrD-I(1-32)-Cys and FlagHis6-AgrD-I(1-32)-NAC
FlagHis6-AgrD-I(1-32)-thioactone (1 mg) was dissolved in 1mL 7.5 M GuHCl buffered
at pH = 7.5 with sodium phosphate. To the solution was added 50 µL 1 M TCEP together
with 100 µL 1 M L-cysteine or N-acetylcysteamine (NAC). The reaction reached
maximal conversion after 1-hr incubation at RT as analyzed by analytical RP-HPLC (not
shown). The reaction was then purified using semi-prep C18 RP-HPLC.

7.3.4 Nanodisc reconstitution and SEC-MALS analysis
The membrane scaffold protein, MSP1E3D1, was prepared as reported (139). The His7tag on the recombinant protein was removed through TEV-protease digestion followed
by anion exchange chromatography with a Hiprep Q FF 16/10 column (GE Healthcare).
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DLPC (1,2-dilauryl-sn-glycero-3-phosphocholine), DLPG (1,2-dilauryl-sn-glycero-3phospho-(1'-rac-glycerol)), DMPC, DMPG, and DMPS, POPC and POPG were dried
from organic solvents as described on the Avanti Polar Lipids website and prepared in
50mM-stocks solubilized in a buffer containing 20 mM Tris pH = 8.0, 100 mM NaCl, 5
mM TCEP and 150 mM sodium cholate.

Nanodiscs were assembled according to the general considerations described previously
(139). Lipid stocks were mixed at appropriate ratios to match the desired composition.
For empty nanodisc reconstitution employing MSP1E3D1 as the scaffold, the MSP-tolipid ratio is 1:200 for dilauryl (DL)-phospholipids, 1:150 for dimyristoyl (DM)phospholipids and 1:120 for 1-palmitoyl-2-oleoyl (PO)-phospholipids. Each TM domain
to be incorporated would displace six DL-phospholipids, five DM-phospholipids or four
PO-phospholipids. Full-length AgrC and AgrB are considered to possess six and five TM
domains, respectively. For instance, a typical reconstitution of full-length AgrC-I dimers
entails two nanodiscs being formed for the incorporation of each copy of AgrC-I dimer.
To calculate the scaffold-dimer-lipid molar ratio in the pre-assembly mixture, we first
found that two empty nanodiscs would contain four copies of MSP1E3D1 and 600 DMphospholipids. The incorporation of a 12-TM AgrC dimer is expected to display 60 lipid
molecules. Therefore, the usage of MSPE3D1, AgrC-I dimer and DM-phospholipids
should follow the molar ratio of 4:1:540.

Upon detergent removal using SM-2 Adsorbent Bio-Beads (Bio-Rad), the post-assembly
mixture was subjected to Ni-NTA affinity purification. Elutions containing AgrC-I-
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incorporated nanodiscs were resolved on a Superose6 column using the nanodisc buffer
(20 mM HEPES, 100 mM NaCl, 1 mM TCEP, pH 7.0) from which peak fractions were
pooled as product.

For SEC-MALS analysis, nanodisc samples were resolved on a Superose6 size-exclusion
column equilibrated with the nanodisc buffer. The eluate was directed to a DAWN
HELEOS-II multi-angle light scattering instrument in tandem with OptiLab TrEX
differential refractometer for real-time analysis. Flow-cells of all instruments were set at
4 oC. Fitting was accomplished using the “protein conjugate” method in the ASTRA 6.0
software package, which calculates both the averaged particle size and the protein content
utilizing UV, MALS and dRI signals simultaneously (159). Input for refractive index
increment, dn / dc, was 0.185 mL / g for protein and 0.135 mL / g for the modifier
(treating lipids as the modifier). Input for extinction coefficient of protein was 0.898 for
empty discs (corresponding to MSP1E3D1), 0.806 in an equimolar mixture of
MSP1E3D1 and AgrC-I for AgrC-I discs, and 0.840 as in an equimolar mixture of
MSP1E3D1 and AgrB-II for AgrB-II discs, all in the unit of mL / (mg · cm).

7.3.5 AgrB proteoliposome assembly
A 3:1 mixture of POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and POPG
(1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1’-rac-glycerol)) was dried from organic
solvents and then hydrated with PBST buffer containing 20 mM sodium phosphate,
100mM NaCl and 2mM TCEP pH 7.5. The liposome suspension (1.0% w/v) was stored
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at -20 oC, and thawed and ultrasound-treated in a sonicator water bath immediately prior
to use.

For proteoliposome reconstitution, liposome suspension was mixed with an equal volume
of 3.0% (w/v) 7-cyclohexylheptyl-β-D-maltopyranoside (Cymal-7) in PBST buffer and
incubated at RT until the mixture turns clear. A typical reconstitution reaction was started
by mixing 400 µL Cyaml-7-solubilized lipid with 200 µL of a 15 µM solution of SECpurified AgrB-I-His6. The mixture was incubated with 250 mg of Bio-Beads SM2 at RT
with gentle shaking for 1hr. The cloudy suspension was withdrawn from Bio-Beads and
the proteolipsomes were spun down at 17000 G at 4oC for 30min. Upon removal of
supernatant, the proteoliposomes were washed with 2 x 200 µL PBST buffer, resuspended in 450µL PBST buffer and gently sonicated before being used for biochemical
assays.

7.4 Characterization of the AgrC-AgrA TCS
7.4.1 Auto-kinase and trans-kinase assays
Detection of phosphorylated AgrC-I or AgrC-I variants: general considerations
In this work, we employed a few different readouts to detect and quantify the
phosphorylation levels of AgrC-I or AgrC-I variants. Anti-pHis dot blot was the method
of choice due to the high throughput of analysis (137). Therefore, most kinetic studies for
the forward and reverse auto-phosphorylation of AgrC-I were performed based on dotblot assays. We also employed anti-pHis western blotting in fixed time-point assays to
identify the phosphorylated species based on band positions. For some experiments we
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employed a more classic radiolabeling assay using [γ-32P]-ATP as the phosphoryl donor
and employing autoradiograghy as the readout. This was found to be especially useful
when comparing the activity of different AgrC-I constructs and GCN4-AgrC-I chimeras
due to concerns that immunodetection assays might be unduly influenced by subtle
differences in the transfer or detection properties of each construct.

Auto-phosphorylation of AgrC-I
All auto-kinase reactions were performed in reaction buffer containing 50 mM Tris-HCl,
15 mM HEPES-Na pH = 7.8, 100 mM NaCl, 5 mM MgCl2 and 1 mM TCEP. AIPs were
included as indicated (from DMSO stocks), and DMSO was added to make the overall
DMSO concentration up to 1% (v/v). Typically, an auto-kinase reaction contained 20 µM
[γ-32P]-ATP (1Ci/mmol) or 1 mM regular ATP or GTP and 1.4 µM dimeric receptor
(full-length AgrC-I variants embedded in nanodiscs, or GCN4-AgrC-I chimeras) unless
otherwise indicated. The reaction was incubated at 37 °C. In fixed time point assays,
reactions were performed for 40min with [γ-32P]-ATP or 3min with regular nucleotides.
For time courses, samples were withdrawn from the reaction at indicated time points and
quenched with gel loading buffer. All samples were processed, according to the specified
method of detection, as described in the following sections.

Phospho-relay from AgrC-I to AgrA
AgrC-I discs were phosphorylated in the absence of AIP with 50 µM [γ-32P]-ATP at 37oC
for 90 min, and subsequently exchanged into an ATP-free reaction buffer (50 mM TrisHCl, 15 mM HEPES-Na pH = 7.8, 100 mM NaCl and 1 mM TCEP) using Bio-Rad
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Micro Bio-Spin™ P-6 Gel Columns. This step gave rise to a stock containing 1.2 µM of
AgrC-I disc with 0.25 µM of pHis as quantified through scintillation counting. The stock
was equally divided into three portions, to which was added either AIP stocks or DMSO
at equal volume. These pre-phosphorylated AgrC-I samples were mixed 1:1 with AgrA
protein (3.6 µM stock in 50 mM Tris-HCl pH 8.0, 100 mM NaCl , 5 mM TCEP in 20%
(v/v) glycerol) to initiate the phospho-relay. The AgrA buffer was used to mix with
AgrC-I samples in mock reactions. All reactions were incubated at 37oC from which
samples were withdrawn at indicated time points and quantified through autoradiography.

Phospho-relay from GC214 to AgrA and AgrA dephosphorylation
GC214 (10 µM dimer) was treated with 100 µM [γ-32P]-ATP in 20-µL volume at 37oC
for 90 min, and subsequently exchanged into an ATP-free reaction buffer. The product
was diluted to 180 µL for a stock containing 0.40 µM GC214 dimer (RP-HPLC) with
0.73 µM of pHis (scintillation counting). To initiate the reaction, a mixture containing
AgrA, AgrC-I discs and/or AIP peptide were pre-incubated at 37oC for 2min, to which
32

P-labeled GC214 was then added. Final concentration of each component (if present)

was 0.1 µM for GC214 dimer, 2.0 µM for AgrA, 2.0 µM for AgrC-I discs and 10 µM for
AIP-I or AIP-II. All reactions were incubated at 37oC from which samples were removed
at indicated time points and quantified through autoradiography.

Reverse Auto-phosphorylation of AgrC-I
AgrC-I discs were phosphorylated in the absence of AIP with 2.0 mM of regular ATP at
37oC for 60min and subsequently exchanged into an ATP-free reaction buffer (50 mM
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Tris-HCl, 15 mM HEPES-Na pH = 7.8, 100 mM NaCl and 1 mM TCEP) using a
Superose6 size-exclusion column (Figure 3.10c). This step gave rise to a stock containing
4.0 µM of AgrC-I disc and 4.2 µM of pHis as quantified relative to an intermediate
standard standardized with scintillation counting. The pHis level of this stock was stable
at 4oC over 2 months (data not shown). The stock was diluted 4 fold in reaction buffer in
the presence of varying levels of ADP (0-2 mM), MgCl2 (5mM) and either AIP-I (10 µM
from a DMSO stock) or DMSO (1% v/v). The reaction was incubated at 37oC from
which samples were withdrawn at indicated time points and analyzed using anti-pHis dot
blot.

Scintillation counting
Samples from each reaction were spotted on nitrocellulose membranes in triplicate.
Samples from a mock reaction (in the absence of AgrC-I) under the same conditions were
also spotted and used as the background. Each spot was 5 µL in volume. The membranes
were air-dried and then washed 3x5min with TBST buffer (50mM Tris pH 8.5, 150 mM
NaCl and 0.1% (v/v) Tween-20) and air-dried again. Each piece of membrane was
subsequently transferred to a 4mL counting vial containing 3.5mL of Ultima Gold™
Cocktails (Perkin Elmer) and luminescence from the vial was quantified in a scintillation
counter. For quantification purposes, an aliquot of the [γ-32P]-ATP stock used in the
reactions was diluted into a series of samples of known concentration. These samples
were spotted (5 µL) in duplicate on nitrocellulose membranes and counted after drying
without TBST-wash. Correlations between count numbers (in count per minute, CPM)
and concentrations of [γ-32P]-ATP dilutions were plotted to give a working curve which
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was used to calculate the absolute pHis concentration in the background corrected
experimental samples.

Autoradiography
For detection using autoradiography, samples from auto-kinase or phospho-relay
reactions were mixed with 4x SDS sample buffer (1x concentration: 50 mM Tris-HCl pH
8.0, 2 % (w/v) SDS, 10 (v/v) % glycerol, 10 mM dithiothreitol and 0.01 (w/v) %
bromophenol blue) and immediately resolved on a 15% Tris-HCl SDS-polyacrylamide
gel. The gel was then dried, and incubated with Eastman Kodak BIOMAX MR film at
RT for an appropriate amount of time.

For quantification purposes, a highly phosphorylated AgrC-I stock was diluted into a
series of internal standards. pHis concentrations of these standards were assigned in
arbitrary units based on the dilution process. These standards were resolved on a
denaturing gel and exposed, along with gels bearing all experimental samples, to the
same piece of film. Importantly, loading volumes of all experimental and standard
samples was identical. The normalized, background-subtracted intensity of all bands on
the autoradiogram was calculated using the ImageQuant TL program, and used to
generate a working curve from which pHis levels (arbitrary units) of experimental
samples were determined.
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Anti-pHis western blot
As in the autoradiography protocol, samples from auto-kinase reactions were mixed with
4x SDS sample buffer and resolved on a 15% Tris-HCl SDS-polyacrylamide gel. Then,
anti-pHis western blot was performed as reported (137). Briefly, the resolved proteins
were electroblotted onto a PVDF membrane at 100 V for 1hr. The membrane was
blocked with 3% BSA in TBST for 30min and incubated with anti-pHis antibody diluted
1:500 in TBST with 3% BSA for 1 hr at RT. After washing with TBST (3 x 5 min), the
membrane was then incubated with goat anti-rabbit IgG-HRP conjugate (diluted 1:5000
in wash buffer with 3% BSA) for 1 hr at RT, followed by washing with TBST (3 x 5
min). The membrane was incubated with ECL chemiluminescence solution for 1 min at
RT and chemiluminescence from the membrane was imaged using ImageQuant LAS
4000. The membrane was washed with water and stained with Coomassie blue for the
visualization of loading control.

Anti-pHis dot blot
Nitrocellulose membrane (8cm x 8cm) was gridded 10 x 10 and heated on a 50oC heat
block prior to use. 2-µL samples from forward or reverse auto-kinase reactions were
directly spotted at the center of each small square. Internal standards of known absolute
or normalized pHis levels were also spotted (2 µL) in duplicate on the same membrane.
The membrane was allowed to dry, cooled to RT and blocked with 3% BSA in TBST for
30min. Anti-pHis antibody diluted 1:500 in TBST with 3% BSA was added for 1 hr at
RT. After washing with TBST (3 x 5 min) the membrane was incubated with IRDye
800CW goat anti-rabbit IgG (diluted 1:15000 in wash buffer with 3% BSA) for 1 hr at
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RT, followed by washing with TBST (3 x 5 min). The dot blot was imaged on a LI-COR
Odyssey Infrared Imager and the intensity of each dot was calculated using the built-in
densitometry software. The dot blot was washed with water and stained with Coomassie
blue for the visualization and quantification of loading. The pHis concentration of each
sample was determined using a working curve generated from the intensity-toconcentration relationship of standard samples.

7.4.2 Kinetic data processing
For kinetic studies, time course experiment of a reaction was performed in multiplicate (n
= 3 or 4). The time courses were averaged and fit to certain kinetic models, returning
kinetic parameters of the subject reaction. Curve fitting were performed using Graphpad
Prism Software.
Phospho-relay from AgrC-I to AgrA (quantified using autoradiography)
AgrC-I~P + AgrA ! AgrA~P + AgrC-I
AgrA~P + H2O ! AgrA + Pi

(Scheme 7.1)

where, AgrC-I~P and AgrA~P represent phosphorylated AgrC-I and AgrA, respectively.
To study the decay of AgrC-I~P, only the kinetic equation of the first reaction is
considered:
d[AgrC"I~ P]
="k[AgrC"I~ P][AgrA]
dt

(Equation 7.1)
!
where [AgrC-I~P] is the concentration of AgrC-I~P monomers, [AgrA] is the
!

concentration of AgrA, k is the second-order kinetic constant and t is time. In the
experimental setup, [AgrC-I~P] << [AgrA] at t = 0. Therefore, progress of the reaction
has negligible affect on [AgrA] such that the phospho-relay follows near-first-order
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kinetics with respect to AgrC-I~P. Hence, [AgrC-I~P] (in arbitrary unit) was normalized
to the [AgrC-I~P] at t = 0, and the time course was fit to the Equation 7.2:

[AgrC"I~ P]
[AgrC"I~ P]

t=0

(

)

=(1" plateau)•exp "k app •t + plateau

(Equation 7.2)

!
!

where kapp is the apparent first-order kinetic constant and plateau represents the unreactable fraction of AgrC-I~P at t = 0. The apparent half-life of AgrC-I~P, t1/2, was
obtained from Equation 7.3:
(Equation 7.3)

Phospho-relay from GC214 to AgrA and self-catalyzed dephosphorylation of AgrA
(quantified using autoradiography)
GC214~P + AgrA ! GC214 + AgrA~P
AgrA~P + H2O ! AgrA + Pi

(Scheme 7.2)

where, GC214~P and Pi represents phosphorylated GC214 and inorganic phosphate,
respectively. This reaction scheme is similar to Scheme 7.1 but quantitatively different
because the unmodified GC214 is present in much smaller amount. This drives the
phospho-relay reaction to near completion in approximately one minute (Figure 3.6c).
Thereafter, no change in [GC214~P] is observed and therefore the change in [AgrA~P]
accounts only to the self-catalyzed dephosphorylation (the second reaction). Therefore,
[AgrA~P] values (in arbitrary unit) after t = 1min were fit to the first-order decay model
for the kinetic constant. The apparent half-life of AgrA-I~P was calculated based on
Equation 7.3.
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Auto-kinase reaction of AgrC-I (quantified using autoradiography)
AgrC-I + ATP ! AgrC-I~P + ADP

(Scheme 7.3)

The initial velocity of the reaction follows Equation 7.4:

vi =

d[AgrC"I~ P]
dt

t=0

=k1[ AgrC"I]

(Equation 7.4)

!
where [AgrC-I~P] is the concentration of AgrC-I~P monomers, [AgrC-I] is the
!

concentration of free AgrC-I monomers, vi is the initial velocity and k1 is the apparent
rate constant. The concentration of AgrC-I discs was 1.4 µM (2.8 µM of each monomer)
and [γ-32P]-ATP was used at 20 µM. Thus, vi should be proportional to k1. In all
reactions, [AgrC-I~P] (in arbitrary unit) increased linearly over the first 40 minutes; R2 >
0.90. Therefore, vi was calculated as the slope of the [AgrC-I~P] time course. For ease of
comparision, vi found under different conditions was normalized to the vi in the absence
of AIP and plotted versus the equivalence of AIP-I (Figure 3.8a).

Auto-kinase reaction of AgrC-I (quantified using anti-pHis dot blot)
Taking the influence of substrate concentration, [ATP] into account, the initial velocity of
the reaction is given in Equation 7.5:

vi =

d[AgrC"I~ P]
dt

t=0

=k1[ AgrC"I]=k max

[ ATP]
[ AgrC"I]
K m +[ ATP]

(Equation 7.5)
!
where k1 is the first-order rate constant at a given ATP concentration, kmax is the first!

order rate constant assuming that ATP saturates the binding sites on AgrC-I and Km is the
apparent Michaelis constant with respect to ATP. Under the conditions employed,
consumption of ATP was negligible. Therefore, the reaction was first-order with respect
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to AgrC-I. Determination of Km and kmax entails k1 values at a series of ATP
concentrations to be calculated from vi and [AgrC-I]. vi values were either obtained from
linear regression as described in section B or, in the case of saturable time courses, using
Equation 7.6:

[AgrC"I~ P]= plateau•(1"exp("k•(t"t 0 )))

(Equation 7.6)
!
where plateau is the saturation level of pHis, and t0 is a lag time used to offset the
!

systematic error on the reaction time elapsed before sampling the first time point.
The apparent rate constant k1 was calculated using Equation 7.7:

k1 =

plateau•k
[AgrC"I]

t=0

(Equation 7.7)

!
The k1-[ATP] relationship of AgrC-I discs in different ligand states was fit to the
!

Michaelis-Menten equation (Equation 7.8), returning kmax and Km values as fitting
parameters:

k1 =k max

!
!

[ATP]
K m +[ATP]

(Equation 7.8)

D. Reverse auto-kinase reaction (quantified using anti-pHis dot blot)
AgrC-I~P + ADP ! AgrC-I + ATP

(Scheme 7.4)

Taking the influence of substrate concentration, [ADP], into account, the initial velocity
of the reaction is given in Equation 7.9:
# d[AgrC"I ~ P] t=0 &
[ADP]
(= k "1[AgrC"I ~ P]=k max
v i ="%%
[AgrC"I ~ P]
(
dt
K m +[ADP]
'
$

!
!
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(Equation 7.9)

where k-1 is the first-order rate constant at a given ADP concentration, kmax is the firstorder rate constant assuming that ADP saturates the binding sites on AgrC-I and Km is the
apparent Michaelis constant with respect to ATP. In contrast to the forward reaction, the
reverse reaction is first-order with respect to [AgrC-I~P] at any practical ADP
concentration. Absolute quantification of [AgrC-I~P] is hence not required. Therefore,
the starting material, pre-phosphorylated AgrC-I discs, was used for internal
standardization, and [AgrC-I~P] at all time points was quantified relative to the starting
point. As all time courses saturated at the end of the assays, they were fit to Equation
7.10:
(Equation 7.10)

[AgrC"I~P]=(Y 0"plateau)•exp(k"1•t)+plateau

!

The k1-[ADP] relationship of AgrC-I discs in different ligand states was fit to the

!

Michaelis-Menten equation (Equation 7.11), returning kmax and Km values as fitting
parameters:

k "1 =k max

!

[ ADP]
K m +[ ADP]

(Equation 7.11)

!

7.4.3 Determination of the dissociation constants between AgrC-I and AIP
Measurement of fluorescent anisotropy
Fluorescence measurements were performed in measurement buffer (20 mM HEPES, pH
7.0, 100 mM NaCl, 1mM TCEP, 2 µM BSA and 100 nM of empty nanodiscs). All
buffers were freshly degassed before use. Measurement of fluorescent anisotropy was
performed on a Fluorolog-3 instrument (HORIBA Jobin Yvon) equipped with automated
dual polarizers and using a Semi-Micro Fluorometer Cell (Starna Cells) with a 10-mm
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path length. The measurement chamber was held at a constant temperature of 30.0°C by
an Advanced Series AC200 thermostat (Thermo Scientific) connected to an Arctic series
refrigerated circulating water bath (Thermo Scientific). The excitation wavelength was
490 nm and emission wavelength was recorded at 520 nM, both with a bandwidth of 5
nm. Six to eight measurements were taken per titration point with an integration time of 2
sec for V/V, V/H, H/H and H/V polarizer settings (excitation/emission, V: vertical
polarization, H: horizontal polarization). The final anisotropy, r, was calculated from r =
(IVV – G × IVH)/(IVV + 2 × G × IVH), with G = IHV/IHH.

For titrations of FAM-AIP-I with AgrC-I discs, 750 µL of measurement buffer containing
2.0 nM FAM-AIP-I was transferred to the cuvette and the fluorescent anisotropy was
measured as a reference. AgrC-I discs were then added to the required concentration and
the mixture allowed to equilibrate for 5 minutes before taking the anisotropy
measurement. This process was repeated until measurement of the last titration point (at
1.5 µM of AgrC-I discs). Each titration of FAM-AIP-I was performed simultaneously
with a control titration, in which 2.0 nM of FAM-(lin)-AIP-I was included at the starting
point.

For competitive titrations with AIP-I or AIP-II, the fluorescent anisotropy of 750 µL of
measurement buffer containing 20 nM FAM-AIP-I was first measured as a reference. The
starting-point mixture was then prepared by addition of AgrC-I discs to a final
concentration of 150 nM. The desired AIP was titrated into the cuvette and the anisotropy
measured after 5 minutes equilibration.
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Data processing of fluorescent-anisotropy-based binding assays
Curve fitting were performed using Graphpad Prism Software.
A. Titrations of FAM-AIP-I with AgrC-I discs
The fluorescent anisotropy change, Δr, was calculated for each titration point as:

Δr = r – rr

(Equation 7.12)

where rr is the reference anisotropy measured in the absence of AgrC-I discs. To correct
the anisotropy increase due to the light-scattering effect of AgrC-I discs, observable only
at high-nanomolar and above, the anisotropy change in the control titration (titration of
FAM-(lin)-AIP-I), Δrc, was subtracted from the anisotropy change in the experimental
titration, Δro at each AgrC-I concentration. This resulting correction, Δro - Δrc, reflects
the anisotropy change caused by binding of FAM-AIP-I to the AgrC-I discs. Therefore,

Δro - Δrc (referred to as ΔSSAc in Figures 3.8b and 4.5c) was plotted against [AgrC-I
disc]. In titrations with AgrC-IS109VS116I mutant discs, no significant increase of Δro - Δrc
was observed so that data points were connected with a smoothed line. In titrations with
AgrC-I WT discs, the dataset was fit to the Hill equation treating AgrC-I as the ligand
(Equation 7.13):

!
!

"r0 #"rC [AIPI bound ]
[AgrC#I disc]h
=
=
[AIPI total ] [AgrC#I disc]h +K d
"rmax

(Equation 7.13)

where [AIPIbound] is the concentration of FAM-AIP-I bound to AgrC-I, [AIPItotal] is the
total concentration of FAM-AIP-I, Kd is the dissociation constant, h is the Hill coefficient
with respect to AgrC-I, and Δrmax is the Δro - Δrc value assuming 100% binding of FAMAIP-I to AgrC-I discs. Δrmax, Kd, and h were obtained as fitting parameters.
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To obtain the Hill coefficient with respect to FAM-AIP-I, we considered the Hill
equation treating FAM-AIP-I as ligand:

[AgrC"I bound ] [ AIPI free ]h
=
[AgrC"I free ]
Kd

(Equation 7.14)

!
where [AgrCIfree] and [AgrC-Ibound] are the concentration of AgrC-I sites unoccupied and
!

bound to FAM-AIP-I, respectively, and [AIPIfree] is the unbound FAM-AIP-I
concentration. Importantly, AIP-I was found to bind AgrC-I in 2:2 stoichiometry. For
each titration point, [AgrC-Ifree], [AgrC-Ibound] and [AIPIfree] could be calculated as
following:

(Equation 7.15)

(Equation 7.16)

[ AgrC"I free ] = 2 # [ AgrC"I disc] - [ AgrC"I bound ]
!
!

(Equation 7.17)

Where Vtotal is the total volume of the titration system including the volume of titrant
added.
was then plotted with [AIPIfree]. To avoid large relative errors in [AIPIfree]
and [AgrC-Ibound], only data points meeting the criterion of

were

included in the dataset. Fitting the dataset to the eq.14 returned values of Kd and h. Kd and
h from four individual titrations were pooled and shown as mean ± SD in the main text.
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B. Competitive titrations with native AIPs
The fluorescent anisotropy change, Δr (referred to as ΔSSA in Figure 3.8d), was
calculated for each titration point and plotted with the concentration of [AIP] in a semilog plot. Since FAM-AIP-I was found to bind AgrC-I non-cooperatively, we treated
AgrC-I as independent monomers. The dataset was fit to Equation 7.18, which was
simplified from the literature (189):

,

where

(Equation 7.18)

In the above, Kd, FAM-AIP, the dissociation constant of FAM-AIP-I, was 122nM. Δrmax, the
anisotropy change assuming 100% binding of FAM-AIP-I to AgrC-I disc, was calculated
from the Δr and the concentration of FAM-AIP-I and AgrC-I disc at the starting point.
Bmax was calculated as:
(Equation 7.19)
Kd, AIP, the dissociation constant of native AIP, was the only variable parameter in the
fitting process. For each AIP, Kd values obtained from three individual titrations were
pooled and shown as mean ± SD in the main text.

7.4.4 Other methods related to the AgrC-AgrA TCS:
Co-migration assays employing FAM-AIP-I
AgrC-I discs or empty discs (1.5 nmol) were incubated with 10 nmol FAM-AIP-I in 500
µL of nanodisc buffer at 30oC for 30min. The mixture was then resolved on Superose6

	
  

166	
  

size-exclusion chromatography running with nanodisc buffer. The eluate was collected in
0.25-mL size fractions, and fluorescence intensity (λex = 490 nm, λem = 520nm) of the
fractions was recorded on a Molecular Devices Spectramax M3 micro plate reader. The
fluorescence intensity was plotted with the elution volume of the fraction and connected
with a smoothed line. This fluorescence chromatogram overlaid with the UV
chromatogram recorded by the UV detector (λ= 280 nm) is shown in Figure 3.2b.

AIP Stability Assays
AIP-I or AIP-II (2 nmol) was incubated in 100 µL solution buffered at pH = 7.0 for 3hrs
(AIP-I) or at pH = 8.0 for 1hr (AIP-II) at 37oC in the presence or absence of 0.2 nmol of
AgrC-I discs. Control samples without incubation were also prepared. To each sample
was added 50 µL of acetonitrile, and the mixture was centrifuged at 17000 G for 5
minutes. Supernatant was analyzed by RP-HPLC on a C18 column using a 0-70B%
gradient. The percentage of intact AIPs remaining after incubation with buffer or AgrC-I
discs was determined from the peak area and plotted as mean ± SD (n=3) in Figure 3.7c.

Iodoacetamide capture of the hypothetic AgrC-AIP-I covalent complex
FAM-AIP-I (100 pmol) was incubated with AgrC-I discs (40 pmol) in 20 µL buffer (20
mM HEPES pH 7.0, 100 mM NaCl and 1 mM TCEP) at 37oC for 30 minutes.
Iodoacetamide was then added to 50 mM (final concentration) and the mixture was
incubated at 37°C for additional 30 minutes. The mixture was then denatured with 4 x
(v/v) thio-free loading buffer (50 mM Tris-HCl pH 7.5, 2 % (w/v) SDS, 10 % (v/v)
glycerol and 0.01 % (w/v) bromophenol blue). Two control samples were prepared under
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identical procedures in the absence of either FAM-AIP-I or iodoacetamide. All samples
were resolved on Criterion 15% Tris-HCl SDS-polyacrylamide gel, which was first
scanned for in-gel fluorescence and then stained with Coomassie blue to confirm the
equal loading of AgrC-I protein.

Circular-dichroism (CD) analysis of the TMH-DHp linker peptides
CD spectra were taken on a ChirascanTM CD spectrometer equipped with a Quantum
TC125 temperature control unit at 20oC. Path length of the cuvette was 1mm. The HPLCpurified peptide was dissolved in a 100-µM stock solution. This stock was diluted into
15-µM samples containing 10 mM sodium phosphate pH = 7.0, 50 mM NaF, and 0%,
10%, 20%, 30%, 40% or 50% TFE (v/v). For each peptide, CD spectra of six samples
were corrected for buffer background and Helical content (H) was calculated as:

H=

" 222
" 222
=
" max #40000• (1# 2.5/n) +100•T

(Equation 7.20)

!
!

where θ222 is the mean residue ellipticity at 222 nm in (deg·cm2·dmol-1), n is the length of
the peptide (in residue) and T is temperature in oC (190).

Inter-subunit disulfide formation within AgrC-I cysteine point mutant dimers
Oxidized glutathione (GSSG) was dissolved at 60 mM in a buffer containing 20 mM
HEPES and 100 mM NaCl, and pH of the solution was readjusted to 7.0. Nanodiscs
incorporated with WT or cysteine-mutant AgrC-I proteins were prepared at 1.0 µM in a
buffer containing 20 mM HEPES pH 7.0, 100 mM NaCl and 0.2 mM TCEP. These
nanodisc stocks were incubated with either AIP-I, AIP-II or vehicle (DMSO). The final
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concentration of each AIP was 10 µM. To initiate oxidation, 10 µL from each aliquot was
mixed with 2µL GSSG solution. These mixtures were incubated at 37oC for 10min before
mixing with 4 x thiol-free SDS sample buffer. A ‘non-oxidized’ control reaction was
prepared by mixing 10 µL from the AIP-free aliquot with SDS sample buffer and 2 µL
GSSG solution simultaneously; this procedure controlled for spurious oxidation postdenaturation. Oxidation reactions were resolved on Criterion 15% Tris-HCl SDSpolyacrylamide gel. The gel was stained with Coomassie blue, scanned with an LI-COR
Odyssey Infrared Imager and quantified with the build-in densitometry software.
Intensity of each AgrC dimer band was normalized to the MSP band in the same lane.
Level of disulfide formation was calculated by subtracting normalized AgrC-I dimer
band intensity of the mock-treated discs from the oxidized discs for each AgrC-I mutant.

Lipidation of the AgrC-I208-430 construct
To introduce lipid anchors using maleimide chemistry, an AgrC-I intracellular construct
bearing an N-terminal cysteine need to be prepared. To ensure specificity, the native
cysteine at position 371 was mutated to serine. The AgrC-I208-430 (M208C/C371S) with
either a wild-type or an R238H mutant HK domain was expressed as an N-terminal His6Sumo fusion and purified using Ni-NTA affinity chromatography following standard
methods (section 7.3.1). The elutate was first dialyzed to imidazole-free and then treated
with the Sumo protease, Ulp1, at 16oC overnight. The His6-Sumo released upon
proteolysis was removed through a reverse Ni-NTA step, and the AgrC-I208-430 was
concentrated and further purified on Superdex200 size-exclusion chromatography with
running buffer (20 mM HEPES, 100 mM NaCl, and 1mM TECP, pH 7.0)
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For lipidation, the purified AgrC-I208-430 (M208C/C371S) proteins were adjusted to a
concentration between 70-80uM (in dimer). 200uL of the substrate was added to 200uL
of lipidation reagents containing 50mM of HEPES pH = 7.6, 2.5 mM of TCEP (preneutralized), 10 mM DPPE:MCC and 5% (w/v) FC-12. The reaction was incubated at RT
for 40min and quenched with 20 mM of BME (final concentration). Analytical HPLCMS revealed excellent conversion and specificity. The reaction was purified on
Superdex200 size-exclusion chromatography with running buffer containing 0.05% FC14, and fractions containing the lipidated AgrC-I construct was used for nanodisc
reconstitution following standard methods (section 7.3.4).

Limited proteolysis of AgrC-I205-430 and GCN4-AgrC-I chimeras
All substrate proteins were diluted to 100 µM (in dimer, 5-6 mg/mL) in cleavage buffer
(20 mM Phosphate pH=7.5, 100 mM NaCl). Trypsin (5 mg/mL prepared in 1mM HCl)
was serial-diluted in cleavage buffer to five concentrations, i.e. 1.0, 0.5, 0.25, 0.125 and
0.062 in the unit of mg / mL. Each trypsin dilute (5 µL) was mixed with a 15-µL aliquot
from each substrate protein, resulting in altogether 20 proteolysis reactions. Each reaction
(20uL system) was incubated on ice for 20min and then stopped by adding 5 µL of 1M
TFA. 5 µL of the acid-treated reaction was immediately transferred into 20 µL of 100
mM phosphpate pH 7.5 containing cOmplete protease inhibitor cocktail (Roche) at 10X
working concentration. To the rest 20 µL of each reaction was added 180 µL 7.5M
guanidinium chloride to dissolve the emerging precipitate.All inhibitor-treated samples
were denatured by the addition of 15 µL of 4X SDS-PAGE sample buffer. These samples
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were subsequently analyzed on Criterion 15% Tris-HCl SDS-polyacrylamide gel with
Coomassie staining.

The guanidinium-chloride-solubilzed samples were used for HPLC analysis. RP-HPLC
was performed with analytical C18 columns using a 0–70% B gradient over 20 minutes.
For two reactions in which AgrC-I205-430 and GC206 was digested with the 0.5 mg/mL
trypsin dilute, primary peaks eluted between 10 and 20 minute from the HPLC were
analyzed with mass spectrometry. Trptic fragments were identified from the primary
sequences of AgrC-I205-430 and GC206 using the FindPept tool.

7.5 Characterization of the AgrB-AgrD peptidase-substrate pair
7.5.1: Biochemical assays based on AgrB-I prteoliposomes
Proteolysis/hydrolysis assays
For a typical 100 µL reaction, to 45 µL PBST buffer was added 5µL of a 400 µM
solution of AgrD-I or FlagHis6-AgrD(1-32)-thiolactone substrate in DMSO. At t = 0, 50
µL AgrB-I proteoliposomes (containing 2 µM AgrB-I monomer as quantified by SDSPAGE) were added with rigorous mixing and the reaction tube was immediately
transferred into a 37oC water bath. 20µL aliquots were withdrawn at indicated time points
and mixed with 4 X SDS sample buffer before resolved on 16.5% Tris-Tricine SDSPAGE. For HPLC-MS analysis, the reaction could be linearly scaled up. At the indicated
time points, 100 µL of the reconstitution system was mixed with 400 µL of a solution
containing 7.5 M GuHCl, 0.1 M TFA and then subject to Sep-Pak solid phase extraction
(SPE, see below). The Sep-Pak eluate was lyophilized, dissolved in the GuHCl-TFA
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solution and resolved on a C4 (for non-tagged constructs) or C18 (for FlagHis6-tagged
constructs) analytical RP-HPLC column. For proteolysis reactions, a linear gradient with
increasing buffer B percentage from 0 to 90% between t = 5 min and 35 min was used.
For hydrolysis reactions, a two-segment gradient was employed with buffer B percentage
increasing from 0 to 50% in the first 5 min and from 50 to 90% between t = 5 min and 25
min. Peaks with significant absorbance at 214 nm were collected for ESI-MS analysis.

Ligation assays
Immediately prior to ligation assays, AgrB-I proteolipsomes were spun down and resuspended in PBST buffer containing AgrD-IC-NH2 peptide at 2X final concentration.
This suspension was mixed with PBST buffer and 400 µM DMSO stock of FlagHis6AgrD-I(1-32)-thiolactone at a volume ratio of 50:45:5 to initiate the reaction. At
indicated time points, 100 µL aliquots from the reaction were acidified, Sep-Pakprocessed and analyzed using RP-HPLC-MS as described in the previous section.

Sep-Pak SPE
The tC2 Sep-Pak cartridge (100 mg adsorbant, Waters) was activated with 3 x 1 mL of
HPLC solvent B and then equilibrated with 2 x 1 mL of HPLC solvent A. Samples
acidified with the GuHCl-TFA solution (see section 7-5) were then load on to the
cartridge. The cartridge was subsequently washed with 2 x 1 mL of HPLC solvent A and
bound protein was eluted consecutively with 0.5 mL 50% (v/v) acetonitrile in water, 0.5
mL 67% (v/v) acetonitrile in water and 1 mL of 75% (v/v) acetonitrile in water. All
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solvents used for elution were buffered by 10 mM triethylammonium-acetate at pH = 8.0.
The combined eluate was lyophilized.

7.5.2 Ring-opening of FlagHis6-AgrD-I(1-32)-thiolactone and AIP-I
A 3 M aqueous solution of N-acetylcysteamine (NAC) was prepared and buffered at pH
= 7.0 using 100mM HEPES-Na. For each reaction, a 10X NAC solution was prepared
from this concentrated stock through serial dilution using 100 mM HEPES-Na pH = 7.0.
The following three buffers were used in the reaction:
HBST buffer: 100 mM HEPES-Na, 100 mM NaCl, 2 mM TCEP, pH=7.0;
Liposome buffer: 1 volume of the 1% (w/v) liposomal suspension diluted in 4 volumes of
HBST buffer;
GuHCl buffer: 100 mM HEPES-Na, 7.5 M GuHCl, 2 mM TCEP, pH=7.0;
Each reaction was initiated by combining 50 µL 1M TCEP-Na (buffered at pH = 7.0),
100µL 10X NAC solution and 50 µL of a 400 µM DMSO stock of FlagHis6-AgrD-I(132)-thiolactone or AIP-I with 800 µL of one of the above three buffers. For reactions
performed in HBST or GuHCl buffers, aliquots (100 µL for AIP-I or 20 µL for FlagHis6AgrD-I(1-32)-thiolactone) were removed and analyzed by C18 analytical RP-HPLC at
indicated time points. For reactions containing liposomes, aliquots were added to 0.5 mL
0.1 M aqueous TFA and freeze-dried. The lyophilized sample was triturated with 150 µL
GuHCl-TFA solution. The extract was then cleared through centrifugation and 100 µL of
the supernatant was analyzed on RP-HPLC. Ring-opening reactions of the tri-Ala
mutants of FlagHis6-AgrD-I(1-32)-thiolactone and AIP-I were initiated, processed and
analyzed using the same procedures.
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Analytical HPLC columns and gradients:
Samples from reactions involving AIP-I: solvent B percentage 20% to 50% over 15min;
Samples from reactions involving tri-Ala mutant of AIP-I: solvent B percentage 0% to
30% with 15min;
Samples from reactions involving wild-type or tri-Ala mutant of FlagHis6-AgrD-I(1-32)thiolactone: two-segment gradient such that solvent B percentage increases from 0% to
50% in 5 min and then to 80% in 15min.

7.5.3 Quantification methods
Quantification of all species in the proteolysis reaction from HPLC analysis
The proteolysis reaction begins with 20 µM pure FlagHis6-AgrD-I. This AgrD-I construct
has two tyrosines, both located in the N-fragment that results from AgrB-I cleavage.
Therefore, the full-length AgrD-I, the linear and the thiolactone N-fragment should have
identical extinction coefficients at 280 nm. Peak areas of these species in the 280-nm
HPLC chromatogram are hence proportional to their respective molarities. The molar
fraction of each species (out of the sum of three) was calculated accordingly after
factoring in their respective SPE recovery (see below). The molarity of AgrD-IC is given
by the sum of the molarity of both linear and thiolactone N-fragments as a consequence
of mass balance.

To determine the relative SPE recovery, FlagHis6-AgrD-I, FlagHis6-AgrD-I(1-32)-Cys
[as a surrogate of FlagHis6-AgrD-I(1-32)] and the FlagHis6-AgrD-I(1-32)-thiolactone Nfragment were mixed at a moderate ratio, and part of the mixture was diluted to an
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overall molarity of 20µM in a buffer containing phospholipids. This sample was
incubated at 37oC for 30min and then subject to the Sep-Pak SPE following the standard
method provided in section 7.5.2. The SPE eluate and the mixture prior to dilution were
resolved on HPLC and the molar fractions of each species were plotted (Figure 7.2a).
Relative Sep-Pak recovery of each species is calculated as the ratio between its post- and
pre-SPE molar fraction relative to the sum of three.

Quantification of the ligation reaction based on HPLC-MS analysis
The ligation reaction starts with 20 µM FlagHis6-AgrD-I(1-32)-thiolactone and a variable
concentration of AgrD-IC-NH2. The starting thiolactone overlaps, on the RP-HPLC
chromatogram, with the ligation product, but is separable from the linear FlagHis6-AgrDI(1-32). Again, due to the lack of a chromogenic residue in the AgrD-IC segment, the
extinction coefficient at 280 nm is expected to be the same for the starting thiolactone,
the linear AgrD(1-32) and the ligation product AgrD. Accordingly, the linear AgrD(1-32)
was quantified based on RP-HPLC peak areas as described in the previous section. The
molar ratio between the starting thiolactone and the ligation product was determined
using MS. Briefly, MS spectra were recorded for the eluate containing AgrD and both
AgrD(1-32) fragments and the profile between m/z = 600 and 2000 was de-convoluted
using the “maximum entropy” method (191). Target MS range and instrument resolution
were set at 3000-8000 Da and 10000, respectively. The peaks corresponding to the
starting thiolactone (5694.2Da) and ligation product (7359.2Da) in the de-convoluted
profile were integrated. The molar ratio between the two species was calculated from

	
  

175	
  

their MS intensity after factoring in a coeffecient that accounts for their difference in
ionization efficiency (see below).

Figure 7.2 Correction of the systematic errors introduced by the Sep-Pak procedure
or the ionization bias of the MS
(a) The relative Sep-Pak recovery among FlagHis6-AgrD-I, FlagHis6-AgrD-I(1-32)thiolactone, and FlagHis6-AgrD-I1-32-Cys: bar graph shows the molar fraction of each
species in a mixture of three before (open bars) or after (closed bars) solid-phase
extraction (SPE) using Sep-Pak. Pre- and post-SPE samples were quantified using HPLC.
Error bars = range (n = 2). (b to d) The relative ionization efficiency of FlagHis6-AgrD-I
with respect to FlagHis6-AgrD-I(1-32)-thiolactone. (b) RP-HPLC preparation of standard
samples A and B: 20µM of FlagHis6-AgrD-I(1-32)-thiolactone was treated with 300µM
AgrDC in the presence of AgrB-I proteoliposomes or mock-treated and then subject to
RP-HPLC. Shaded segments of elution were collected from the ligation (as sample A)
and the mock treatment (as sample B). Both samples were diluted to the same molarity;
(c) Deconvoluted mass spectra for mixtures of samples A and B at indicated ratios. (d)
The working curve: plot shows the MS peak intensity ratio between FlagHis6-AgrD-I(132) and FlagHis6-AgrD-I as a function of the reciprocal of the weight of sample A in the
mixture. The inverse reciprocal of the y-intercept, k, converts MS peak intensity ratio to
the molar ratio by simple multiplication. Error bars (range between two parallels) are not
visible due to the size of data symbols.
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Relative MS ionization efficiency of FlagHis6-AgrD-I with respect to FlagHis6-AgrDI(1-32)-thiolactone
This procedure was used to empirically determine a coeffecient, k, that converts the MS
peak intensity ratio between the starting thiolactone (TL) and the full-length ligation
product (FL) (ITL/IFL) into the molarity ratio (cTL/cFL). Note that these two species cannot
be resolved on RP-HPLC.
(Equation 7.21)
For simplicity, we prepared sample B containing pure TL and sample A as a mixture
containing predominantly FL. To this end, 20µM of FlagHis6-AgrD-I(1-32)-thiolactone
was treated with 300µM AgrDC in the presence of AgrB-I proteoliposomes or mocktreated and then subject to RP-HPLC. The whole HPLC peak was collected from the
ligation (as sample A) and the mock treatment (as sample B) (Figure 7.2b). Based on
their peak areas on the 280-nm RP-HPLC chromatogram, both samples were diluted to
the same molarity. Assuming the molar fraction of FL in sample A to be x (x<1), the TLto-FL molarity ratio in a A-B mixture is given by equation 22:
(Equation 7.22)

where VA and VB are the volume of A and B in the mixture. Equation 7.21 and Equation
7.22 could be transformed into:
(Equation 7.23)
Therefore, after plotting the MS intensity ratio between TL and FL versus the overall
volume of the A-B mixture divided by the participating sample A volume, linear
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regression of the plot returns k as the inverse reciprocal of the y-intercept (Figure 7.2c
and d).

Quantification of the thioester/thiolactone in the ring-opening assays
Molar ratios of AIP-I-NAC thioester versus AIP-I or FlagHis6-AgrD(1-32)-NAC
thioester versus FlagHis6-AgrD(1-32)-thiolactone were quantified based on integration of
280-nm RP-HPLC chromatograms.

7.5.4 Construction of S. aureus strains and western blotting analysis thereof
Shuttle plasmids for the pblaZC-driven co-expression of Sumo-AgrDC-Ub-Flag2 and
His6-Ulp1 were first electroporated into strain RN4220 (a restriction-deficient host) and
then transduced to strain RN6390 (agr-I wild type) or RN7206 (RN6390 carrying an agr
locus deletion) via phage 80 using standard protocols (192). Transductants were grown in
CYGP medium containing 10 µg/mL erythromycin at 37oC. Upon reaching the stationary
phase, cells from a 1 mL culture were collected, washed twice with ice-cold water and
finely resuspended in fresh CYGP medium on ice. 20 mL CYGP medium containing 10
ug/mL erythromycin was inoculated with 40 µL cell suspension (c.a. 2x108 cfu) and then
shaken at 250 rpm at 30oC. Cell density was measured every 30 min. When OD600
exceeded 0.60, cell culture was diluted using fresh CYGP medium to give an OD600 of
between 0.20 and 0.60 prior to measurement, and the readout was then corrected for the
dilution.
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For the detection of AgrDC-Ub-Flag2 and AgrD-Ub-Flag2 using anti-Flag western blot, 1
mL cell culture was sampled when the culture OD600 reached 0.50, 1.00, 1.50 and 2.00.
Cells were pelleted and resuspended in lysis buffer (10mM Tris-HCl 8.0, 1mM TCEP,
100µM ZnCl2, supplemented with 50 µg/mL lysostaphin and 1X protease inhibitor
cocktail). The volume of suspension was proportional to the cell density of the original
sample (50 µL per 1.0 OD600). The suspension was incubated at 37oC for 30 min, mixed
with appropriate amount of 3X SDS-PAGE loading dye and boiled at 95oC for 10min.
Samples were then resolved on 15% Tris-HCl SDS-PAGE. To avoid interference of
western blotting by endogenous protein A, the PAGE gel was cut at the level of the
37.5kDa standard band and the upper half was stained with Coomassie blue for loading
control. Proteins in the lower half of the gel were transferred to a PVDF membrane and
blotted with Flag-specific mouse monoclonal antibody (Sigma-Aldrich) using standard
protocols. After blotting the membrane with goat anti-mouse IgG HRP conjugate (BioRad), bands were visualized through chemiluminescence.

Extracellular AIP-I activity in plasmid-free or transformed RN6390 culture was
determined using a reporter gene assay (39). Briefly, RN9222 (an agr-I reporter strain
harboring a β-lactamase gene driven by a P3 promoter) was grown in CYGP medium at
37oC to OD600 = 0.60. A 50-µL aliquot of the culture was mixed with 50µL fresh CYGP
(for background) or cell-free medium isolated from RN6390 samples. The mixture was
cultured at 37oC for 1hr and cell density (OD600) was measured. Then, 50 µL of the
mixture was transferred to a 96-well plate and mixed with 50 µL 200 µM nitrocephin in
assay buffer (100 mM phosphate-Na pH = 5.9, 27% (v/v) propylene glycol, 5 mM
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sodium azide). Progress of the substrate hydrolysis was monitored at 37oC in a plate
reader. The slope of the linear increase of absorbance at 490 nm during the initial period
of the reaction was designated as the β-lactamase activity in (0.001 absorbance unit/min).
The final result was background-subtracted and normalized by the pre-reaction cell
density of RN9222.

7.5.5 Other experiments related to AgrB and AgrD
Glutaraldehyde crosslinking of AgrB-II
Crosslinking was performed on SEC-purified AgrB-II protein solubilized by FC-12. The
protein was diluted in PBST buffer (20 mM sodium phosphate, 100 mM NaCl and 2 mM
TCEP pH 7.5) supplemented with 0.14% FC-12 to 2.5 µM. 20 mM glutaraldehyde was
prepared in 100 mM phosphate buffer (pH = 7.5) immediately prior to use. The
crosslinking was performed at room temperature. 90µL of protein and 10µL crosslinker
were mixed at t = 0, and 20µL aliquots were withdrawn at indicated time points and
quenched by mixing with 2µL 1M Tris buffered at pH=8.7. The t = 0 control was
prepared by adding first 2µL 1M Tris pH=8.7 and then 2µL crosslinker to 18µL protein
stock. All quenched reactions were mixed with 4X SDS sample buffer and resolved on 420% TGX SDS-PAGE.

Proteolysis assays using AgrB-II nanodiscs
SEC-purified AgrB-II nanodiscs were diluted in PBST such that each nanodisc sample
contains 2 µM AgrB-II (counted as monomers). FlagHis6-AgrD-II was dissolved in
DMSO at 0.5 mM, from which 1 µL was mixed with 25µL AgrB-II nanodisc sample.
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Reactions were incubated at 37oC for 2hr before mixing with 4 X SDS sample buffer and
resolved on Criterion 16.5% Tris-Tricine SDS-polyacrylamide gel. The gel was stained
with Coomassie blue.
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Appendix
Appendix Table 1. All RHK hits from the database search for HPK10 homologs in
Chapter 2
Phylum

Species

0
0
0
0
0
0
0
0
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5

"G1-box"
Residue
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn

Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes

420

5

Asn

Firmicutes

443
426
447
438
447
442
423
435
422

5
5
5
5
5
5
5
5
5

Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn

Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes

Streptococcus infantis
Enterococcus mundtii
Lactobacillus kefiranofaciens ZW3
Lactobacillus crispatus ST1
Enterococcus faecalis
Desulfosporosinus meridiei DSM 13257
Staphylococcus pettenkoferi
Staphylococcus massiliensis
Clostridium arbusti
Streptococcus anginosus
Facklamia ignava
Bacillus coahuilensis
Clostridium arbusti
Lachnospiraceae bacterium 10-1
Leuconostoc pseudomesenteroides
Lactobacillus crispatus
Thermacetogenium phaeum DSM 12270
Solibacillus silvestris StLB046
Bacillus sp. SG-1
Lysinibacillus sphaericus
Lysinibacillus sphaericus C3-41
Brevibacillus brevis NBRC 100599
Brevibacillus
Streptococcus vestibularis
Lactobacillus curvatus
Streptococcus intermedius
Streptococcus agalactiae
Enterococcus faecium
Lactobacillus ultunensis
Leuconostoc lactis
Lysinibacillus sphaericus C3-41
Clostridium cellulovorans 743B
Streptococcus gallolyticus
Lactobacillus curvatus
Dolosigranulum pigrum
Lactobacillus sakei
Enterococcus villorum
Lactobacillus sp. 66c
Lactobacillus crispatus
Staphylococcus saprophyticus
Streptococcus sp. oral taxon 056
Enterococcus pallens
Carnobacterium maltaromaticum LMA28
Oribacterium
Enterococcus gilvus
Enterococcus malodoratus
Enterococcus avium
Enterococcus saccharolyticus
Lactobacillus plantarum subsp. plantarum STIII
Streptococcus merionis
Enterococcus faecalis
Streptococcus thoraltensis
Enterococcus mundtii
Streptococcus sobrinus
Streptococcus criceti
Pediococcus claussenii ATCC BAA-344
Streptococcus gallolyticus UCN34
Lactobacillus pentosus

Entry

Accession Number

Length

TMH

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48

WP_006147676.1
WP_010734516.1
YP_004561998.1
YP_003602088.1
WP_016623240.1
YP_006621934.1
WP_002471760.1
WP_009384255.1
WP_010241734.1
WP_003037768.1
WP_006701462.1
WP_010170763.1
WP_010241389.1
WP_016230456.1
WP_010275906.1
WP_005723496.1
YP_006920935.1
YP_006462487.1
WP_006837370.1
WP_010861419.1
YP_001697754.1
YP_002771205.1
WP_005833804.1
WP_003094496.1
WP_004271011.1
WP_003069924.1
WP_001872392.1
WP_002300816.1
WP_007126042.1
WP_009999978.1
YP_001699604.1
YP_003842650.1
WP_009854992.1
WP_004271266.1c
WP_004634648.1
WP_016264937.1
WP_010752094.1
WP_009557583.1
WP_005725782.1
WP_002482782.1
WP_009443765.1
WP_010757654.1
YP_006991522.2
WP_009535076.1
WP_010781286.1
WP_010742519.1
WP_016179641.1
WP_016176172.1

203
224
233
230
228
387
220
240
256
274
232
404
291
303
283
343
282
435
437
435
435
450
441
317
316
308
334
352
334
355
353
379
454
385
430
398
365
377
395
365
404
397
430
435
433
441
441
436

49

YP_003926231.1

50
51
52
53
54
55
56
57
58

WP_018373329.1
WP_016624566.1
WP_018380719.1
WP_010736347.1
WP_019782329.1
WP_004225929.1
YP_005004303.1
YP_003431422.1
WP_003638473.1
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59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99

WP_004242076.1
WP_006917176.1
WP_004049770.1
WP_016623999.1
WP_003665154.1
WP_007126043.1
WP_009431292.1
WP_016307854.1
YP_001307802.1
YP_004090305.1
WP_002847577.1
WP_005945720.1
WP_016220195.1
WP_001639479.1
YP_005119571.1
WP_002579318.1
WP_003410367.1
YP_001311644.1
WP_003446201.1
WP_010766320.1
WP_004071405.1
WP_010234544.1
WP_010772171.1
WP_016622707.1
WP_016216882.1
WP_016226170.1
WP_016226738.1
WP_016292271.1
YP_003781661.1b
YP_001786573.1
WP_010750902.1
WP_010768675.1
WP_010719091.1
WP_016215903.1
WP_010779009.1
WP_009732097.1
WP_006596699.1
WP_002885486.1
WP_002889753.1
YP_007988158.1
WP_016287036.1

448
427
430
381
425
432
366
439
420
433
432
424
440
362
406
439
435
439
445
430
433
451
431
434
440
431
428
436
449
450
424
430
428
434
443
434
445
439
445
420
434

5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6

Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn

Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes

100

YP_004287481.1

435

6

Asn

Firmicutes

101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123

WP_016304832.1
WP_002604771.1
WP_002280560.1
WP_010739752.1
YP_003064445.1
WP_018164077.1
WP_010744242.1
WP_002943511.1
WP_018378535.1
WP_004058876.1
WP_003702872.1
WP_002313965.1
YP_006069688.1
WP_004255283.1c
WP_019787615.1
YP_878135.1
WP_005880245.1
WP_009553709.1b
WP_003376164.1
WP_018375371.1
WP_018376391.1
WP_020992797.1
WP_018373287.1

434
437
441
433
419
450
440
445
444
441
426
421
438
441
448
437
451
422
439
436
435
441
436

6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6

Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn

Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
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Streptococcus mitis
Lactobacillus coleohominis
Lactobacillus murinus
Enterococcus faecalis
Lactobacillus reuteri
Lactobacillus ultunensis
Peptoniphilus sp. oral taxon 375
Lachnospiraceae bacterium A2
Clostridium beijerinckii NCIMB 8052
Ruminococcus albus 7
Ruminococcus albus
Faecalibacterium prausnitzii
Dorea sp. 5-2
Staphylococcus aureus
Bacillus cereus F837/76
Clostridium butyricum
Clostridium butyricum
Clostridium beijerinckii NCIMB 8052
Clostridium pasteurianum
Enterococcus moraviensis
Clostridium sp. ASF502
Clostridium arbusti
Enterococcus caccae
Enterococcus faecalis
Dorea sp. 5-2
Lachnospiraceae bacterium 3-2
Lachnospiraceae bacterium 10-1
Lachnospiraceae bacterium 28-4
Clostridium ljungdahlii DSM 13528
Clostridium botulinum A3 str. Loch Maree
Enterococcus villorum
Enterococcus phoeniculicola
Enterococcus faecium
Eubacterium sp. 14-2
Enterococcus gilvus
Streptococcus sp. F0442
Streptococcus australis
Streptococcus salivarius
Streptococcus salivarius
Lactobacillus plantarum subsp. plantarum P-8
Lachnospiraceae bacterium 3-1
Streptococcus gallolyticus subsp. gallolyticus
ATCC BAA-2069
Lachnospiraceae bacterium A2
Clostridium hathewayi
Streptococcus mutans
Enterococcus malodoratus
Lactobacillus plantarum JDM1
Streptococcus henryi
Enterococcus raffinosus
Streptococcus suis
Streptococcus ovis
Eubacterium plexicaudatum
Lactobacillus salivarius
Enterococcus faecium
Streptococcus salivarius JIM8777
Streptococcus mitis
Streptococcus sobrinus
Clostridium novyi NT
Enterococcus durans
Lactobacillus saerimneri
Clostridium botulinum
Streptococcus orisratti
Streptococcus orisratti
Streptococcus sp. 2_1_36FAA
Streptococcus merionis

124
125
126
127
128
129
130
131
132

WP_018164876.1
WP_010817845.1
YP_002561848.1
WP_008535279.1
WP_009754525.1
WP_004240956.1
WP_004195387.1
YP_006067616.1
WP_003139433.1

440
437
439
446
447
444
454
444
458

6
6
6
6
6
6
6
6
6

Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn

Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes

133

YP_005173501.1

436

6

Asn

Firmicutes

134
135
136
137
138
139
140
141

WP_016224073.1
WP_004049925.1
WP_016184462.1
WP_016226189.1
WP_010815375.1
WP_003646469.1b
YP_005004345.1
WP_007124555.1
WP_003641980.1b

435
441
457
438
428
446
432
453

6
6
6
6
6
6
6
6

Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn

Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes

,c

442

6

Asn

Firmicutes

Lactobacillus plantarum

YP_007986684.1
YP_003621756.1
WP_004070366.1
WP_003637608.1
WP_003637610.1
WP_007060938.1
YP_003842389.1
WP_016293822.1
WP_002834212.1
WP_010751948.1
WP_003695050.1
WP_016184472.1
YP_005047496.1
WP_004908337.1
WP_002328140.1
WP_008469780.1
YP_006796412.1
WP_003708561.1
WP_007126030.1
WP_010690030.1
WP_003665180.1
NP_964473.1
WP_003692144.1
WP_003699415.1
YP_193512.1
WP_010018224.1
WP_005720992.1
WP_009558353.1
WP_020806829.1
WP_002878748.1
WP_003616411.1
YP_004293001.1
WP_010727102.1
WP_016624980.1
WP_010816586.1
WP_003616444.1b
WP_002373740.1
WP_010751677.1
WP_009461668.1
WP_007714334.1
WP_009982749.1
WP_010761975.1
WP_009172438.1
WP_010718901.1
WP_010752108.1

420
435
454
440
442
432
434
457
434
433
439
427
441
434
427
444
432
430
445
420
420
419
416
430
426
435
442
440
439
443
451
442
419
432
414
417
498
412
423
438
402
430
418
420
420

6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6

Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn

Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes

Lactobacillus plantarum subsp. plantarum P-8
Leuconostoc kimchii IMSNU 11154
Clostridium sp. ASF502
Lactobacillus pentosus
Lactobacillus pentosus
Clostridium carboxidivorans
Clostridium cellulovorans 743B
Lachnospiraceae bacterium M18-1
Pediococcus pentosaceus
Enterococcus villorum
Lactobacillus ruminis
Enterococcus columbae
Clostridium clariflavum DSM 19732
Leuconostoc citreum
Enterococcus faecium
Lactobacillus hominis
Leuconostoc carnosum JB16
Lactobacillus salivarius
Lactobacillus ultunensis
Lactobacillus animalis
Lactobacillus reuteri
Lactobacillus johnsonii NCC 533
Lactobacillus ruminis
Lactobacillus salivarius
Lactobacillus acidophilus NCFM
Lactobacillus farciminis
Lactobacillus crispatus
Lactobacillus sp. 66c
Lactobacillus gasseri
Lactobacillus delbrueckii
Lactobacillus delbrueckii
Lactobacillus acidophilus 30SC
Enterococcus faecium
Enterococcus faecalis
Enterococcus faecalis
Lactobacillus delbrueckii
Enterococcus faecium
Enterococcus villorum
Lachnospiraceae bacterium 2_1_46FAA
Clostridium asparagiforme
Ruminococcus flavefaciens
Enterococcus haemoperoxidus
Clostridium sp. DL-VIII
Enterococcus faecium
Enterococcus villorum

142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
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Streptococcus henryi
Enterococcus faecalis
Streptococcus uberis 0140J
Streptococcus sp. C150
Streptococcus sp. oral taxon 056
Streptococcus mitis
Streptococcus suis
Streptococcus salivarius 57.I
Lactococcus raffinolactis
Leuconostoc mesenteroides subsp.
mesenteroides J18
Lachnospiraceae bacterium 3-2
Lactobacillus murinus
Enterococcus columbae
Lachnospiraceae bacterium 3-2
Enterococcus faecalis
Lactobacillus plantarum
Pediococcus claussenii ATCC BAA-344
Lactobacillus antri

188
189
190
191
192
193
194
195

WP_016250704.1
WP_005338206.1
WP_009982643.1
WP_005215399.1
WP_005923174.1
YP_001558714.1
WP_004610893.1
WP_007867475.1
YP_001332979.1a,

435
435
427
427
438
446
408
435

6
6
6
6
6
6
6
6

Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn

Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes

c

430

6

Asn

Firmicutes

WP_000387802.1
WP_002464788.1
WP_002488053.1
WP_002469368.1
YP_007384612.1
WP_002481722.1
WP_002509116.1
WP_002511407.1
YP_004149866.1
WP_007474155.1
WP_000263507.1
YP_006464114.1
WP_002598585.1b
WP_010631760.1
WP_002200091.1
NP_346725.1
YP_003845678.1
WP_010294543.1
WP_007062817.1

430
429
429
432
429
433
432
431
430
435
431
433
428
437
447
447
434
445
465

6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
7
7
7
7

Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn

Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes

216

YP_007454888.1

454

7

Asn

Firmicutes

217
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219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248

WP_018371070.1
WP_009170117.1
YP_006787706.1
YP_007939695.1
WP_010826789.1
WP_002314968.1
YP_001451369.1c
YP_003822135.1
WP_009253846.1
YP_007939348.1
WP_010720219.1
WP_018380441.1
WP_010723115.1
WP_005590517.1
WP_003075490.1c
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WP_004261048.1
WP_006595333.1b
WP_000402607.1
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437
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426
444
441
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439
444
447
439
439
446
440
447
440
439
439
449
441
445

7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7

Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
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Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
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Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
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YP_006904098.1

444

7

Asn

Firmicutes

250

WP_010758329.1

433

7

Asn

Firmicutes
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199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
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Enterococcus cecorum
Dorea formicigenerans
Ruminococcus flavefaciens
Clostridium celatum
Faecalibacterium prausnitzii
Clostridium phytofermentans ISDg
Clostridium spiroforme
Clostridium citroniae
Staphylococcus aureus subsp. aureus str.
Newman
Staphylococcus aureus
Staphylococcus simiae
Staphylococcus hominis
Staphylococcus epidermidis
Staphylococcus warneri SG1
Staphylococcus simulans
Staphylococcus arlettae
Staphylococcus equorum
Staphylococcus pseudintermedius HKU10-03
Listeria fleischmannii
Bacillus cereus
Solibacillus silvestris StLB046
Clostridium colicanis
Sporolactobacillus vineae
Bacillus cereus
Clostridium acetobutylicum ATCC 824
Clostridium cellulovorans 743B
Clostridium sp. JC122
Clostridium carboxidivorans
Clostridium saccharoperbutylacetonicum N14(HMT)
Streptococcus massiliensis
Clostridium sp. DL-VIII
Clostridium acidurici 9a
Clostridium pasteurianum BC1
Enterococcus faecalis
Enterococcus faecium
Streptococcus gordonii str. Challis substr. CH1
Clostridium saccharolyticum WM1
Lachnospiraceae bacterium 3_1_57FAA_CT1
Clostridium pasteurianum BC1
Enterococcus faecium
Streptococcus thoraltensis
Enterococcus faecium
Streptococcus cristatus
Streptococcus intermedius
Streptococcus thoraltensis
Pediococcus acidilactici
Streptococcus intermedius
Streptococcus sp. oral taxon 058
Streptococcus sanguinis
Streptococcus cristatus
Streptococcus sp. SK140
Streptococcus mitis
Clostridium pasteurianum
Streptococcus infantis
Streptococcus entericus
Clostridium botulinum
Streptococcus sp. C300
Streptococcus infantarius
Streptococcus mitis
Streptococcus australis
Streptococcus sp. SK643
Streptococcus dysgalactiae subsp. equisimilis
AC-2713
Enterococcus pallens

	
  

251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299

WP_019278667.1
WP_018369941.1
WP_009004071.1
YP_006003161.1
YP_002743992.1
YP_006082817.1
WP_010756667.1
WP_003643808.1
WP_003025428.1
WP_016220081.1
WP_000231528.1
WP_003073361.1
WP_016287680.1
YP_003621251.1b
WP_017285146.1
WP_016307158.1
WP_016282345.1
WP_016220284.1
WP_010770640.1
WP_016219150.1
YP_006744460.1
WP_016295538.1
WP_010707474.1
WP_003639720.1
WP_004079905.1
WP_016623052.1
WP_016625521.1
WP_004635172.1
WP_004635179.1
WP_010770253.1
YP_536800.1
WP_004049677.1
YP_007988137.1
YP_005861339.1b
WP_010771509.1
YP_003602296.1
YP_194634.1
WP_009896878.1
WP_005718161.1
WP_010762052.1
WP_008680295.1
WP_016208990.1
YP_007828746.1
WP_009985441.1b
WP_008423253.1
YP_004104667.1
WP_006445121.1
WP_005361465.1
WP_002586250.1

438
444
466
447
444
447
423
446
435
432
441
438
458
437
444
454
450
454
422
513
435
448
475
442
446
430
424
439
442
409
429
442
445
443
451
447
440
452
468
436
416
419
442
440
420
425
445
425
434

7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7

Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn

Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes

300

YP_007458077.1

416

7

Asn

Firmicutes

301
302
303
304
305
306
307
308
309
310
311
312
313
314
315

WP_007863964.1
WP_006782132.1
WP_006863055.1
WP_005331796.1
WP_019679521.1
WP_003480616.1
WP_002847701.1
YP_004103515.1
WP_005353871.1
YP_004545147.1b
YP_007790596.1
WP_018702136.1
WP_016227154.1
WP_004801384.1
WP_016184116.1

445
432
460
435
434
420
439
448
444
439
440
445
438
421
434

7
7
7
7
7
7
7
7
7
7
7
7
7
7
7

Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn
Asn

Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
Firmicutes
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Clostridium botulinum
Streptococcus marimammalium
Clostridium sp. D5
Streptococcus thermophilus ND03
Streptococcus equi subsp. zooepidemicus
Streptococcus suis D12
Enterococcus pallens
Lactobacillus plantarum
Streptococcus anginosus
Dorea sp. 5-2
Streptococcus mitis
Streptococcus intermedius
Lachnospiraceae bacterium 3-1
Leuconostoc kimchii IMSNU 11154
Streptococcus agalactiae
Lachnospiraceae bacterium A2
Lachnospiraceae bacterium A4
Dorea sp. 5-2
Enterococcus caccae
Dorea sp. 5-2
Leuconostoc gelidum JB7
Lachnospiraceae bacterium M18-1
Enterococcus faecalis
Lactobacillus pentosus
Clostridium sp. ASF502
Enterococcus faecalis
Enterococcus faecalis
Dolosigranulum pigrum
Dolosigranulum pigrum
Enterococcus caccae
Lactobacillus salivarius UCC118
Lactobacillus murinus
Lactobacillus plantarum subsp. plantarum P-8
Lactobacillus johnsonii DPC 6026
Enterococcus caccae
Lactobacillus crispatus ST1
Lactobacillus acidophilus NCFM
Clostridium difficile
Lactobacillus crispatus
Enterococcus haemoperoxidus
Clostridium sp. 7_2_43FAA
Clostridium sartagoforme
Ruminococcus champanellensis 18P13
Ruminococcus flavefaciens
Clostridium sp. Maddingley MBC34-26
Ruminococcus albus 7
Clostridium hylemonae
Eubacterium ventriosum
Clostridium clostridioforme
Clostridium saccharoperbutylacetonicum N14(HMT)
Clostridium citroniae
Clostridium hathewayi
Marvinbryantia formatexigens
Dorea formicigenerans
Ruminococcus flavefaciens
Clostridium perfringens
Ruminococcus albus
Ruminococcus albus 7
Eubacterium siraeum
Desulfotomaculum ruminis DSM 2154
butyrate-producing bacterium SSC/2
Anaeromusa acidaminophila
unclassified Lachnospiraceae
Eggerthia catenaformis
Enterococcus columbae

316
317
318
319
320
321
322
323
324
325
326

WP_016316494.1
WP_018579518.1
YP_003820510.1
WP_000447891.1
WP_002477479.1c
YP_003471243.1
YP_006677599.1
WP_002151242.1
WP_007124101.1
YP_001621389.1
YP_003821953.1

445
453
434
427
429
429
436
439
450
444
650

7
7
7
7
7
7
7
7
7
7
8

327
328
329
330

WP_017024785.1
WP_004396401.1
WP_016545474.1
YP_004340943.1

555
551
802
433

2
2
0
0

Asn
Firmicutes
Asn
Firmicutes
Asn
Firmicutes
Asn
Firmicutes
Asn
Firmicutes
Asn
Firmicutes
Asn
Firmicutes
Asn
Firmicutes
Asn
Firmicutes
Asn
Firmicutesd
Asn
Firmicutes
non-HPK10 hits
Asp
Proteobacteria
Asp
Proteobacteria
Asp
Spirochaetes
Asp
Euryarchaeota

a:

Anaerotruncus sp. G3(2012)
Erysipelothrix tonsillarum
Clostridium saccharolyticum WM1
Staphylococcus aureus
Staphylococcus epidermidis
Staphylococcus lugdunensis HKU09-01
Listeria monocytogenes SLCC2540
Bacillus cereus
Lactobacillus antri
Acholeplasma laidlawii PG-8A
Clostridium saccharolyticum WM1
Vibrio rumoiensis
Vibrio metschnikovii
Leptospira wolffii
Archaeoglobus veneficus SNP6

The query sequence for the first round of database search;
b: Query sequences for the second round of database search;
c: Founding members of the HPK10 subfamily (125). 7 sequences in the table covers 12
out of 15 founding with at >75% sequence identity. The rest 3 are not deposited in the
Refseq database.
d: There is controversy on whether the class Mollicutes should be placed in the phylum
Firmicutes or Tenericutes (193).
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Appendix Table 2. AgrD constructs prepared as starting materials or detected as
products in Chapter 5.
Entry

Construct Name

Tags/Terminal Groups
R1-AgrD-R2

R1= H-, R2 = -OH
R1= H-, R2 = -OH
R1= H-MDYKDDDDKHHHHHHGG-;
3*
FlagHis6-AgrD-I
R2 = -LDKLVPR-OH
R1= H-MDYKDDDDKHHHHHHGG-;
4*
FlagHis6-AgrD-II
R2 = -LDLELVFQ-OH
R1= H-MDYKDDDDKHHHHHHGG-;
5
FlagHis6-AgrD-I-NH2
R2 = -NH2
C
AgrD -R2
C
R2 = -OH
6
AgrD-I
R2 = -OH
7
AgrD-IIC
C
R2 = -LDKLVPR-OH
8
AgrD-I -LDKLVPR
C
R2 = -NH2
9**
AgrD-I -NH2
R1-AgrD(1-32)-thiolactone
R1= H-,
10
AgrD-I(1-32)-thiolactone
R1= H-,
11
AgrD-I(1-32)-thiolactone
FlagHis6-AgrD-IR1= H-MDYKDDDDKHHHHHHGG-;
12*
(1-32)-thiolactone
R1-AgrD(1-32)
R1= H-,
13
AgrD-I(1-32)
R1= H-,
14
AgrD-II(1-32)
R1= H-MDYKDDDDKHHHHHHGG-;
15
FlagHis6-AgrD-I(1-32)
Others
16**
AIP-I
H-YST(CDFIM)***
17**
AIP-I tri-Ala mutant
H-YST(CDAAA)***
FlagHis6-AgrD-IH-MDYKDDDDKHHHHHHGGMNTLFNL
18*
(1-32)-thiolactone
LFELITGILKNIGNIAAYST(CDAAA)***
tri-Ala mutant
The sequence of full-length AgrD-I (residues 1-46) is
MNTLFNLFFDFITGILKNIGNIAAYSTCDFIMDEVEVPKELTQLHE
The sequence of full-length AgrD-II (residues 1-47) is
MNTLVNMFFDFIIKLAKAIGIVGGVNACSSLFDEPKVPAELTNLYDK
*: constructs prepared from recombinant proteins;
**: constructs synthesized chemically;
***: parenthesis indicates residues that form the thiolactone macrocycle.
1*
2*
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Appendix Figure 1. RP-HPLC-MS results of all synthetic or recombinantly
prepared AgrD constructs described in Chapter 5
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Appendix Figure 1 (continued)
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Appendix Figure 2. MS results of all AgrD products from the biochemical reactions
described in Chapter 5.
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Appendix Figure 2 (continued)
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Appendix Figure 2 (continued)
Deconvoluted MS
(monoisotopic)
Mw, calc = 901.3Da
Mw, obs = 901.3Da

AIP-I-NAC
(tri-Ala mutant)

Deconvoluted MS
(average)
Mw, calc = 5813.5Da
Mw, obs = 5812.7Da

FlagHis6AgrD-I(1-32)-NAC

Deconvoluted MS
(average)
Mw, calc = 5635.2Da
Mw, obs = 5634.6Da

FlagHis6AgrD-I(1-32)-NAC
(tri-Ala mutant)

	
  

193	
  

References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.

	
  

Nealson KH & Hastings JW (1979) Bacterial Bioluminescence - Its Control and
Ecological Significance. Microbiol Rev 43(4):496-518.
Eberhard A, et al. (1981) Structural Identification of Autoinducer of
Photobacterium-Fischeri Luciferase. Biochemistry-Us 20(9):2444-2449.
Engebrecht J, Nealson K, & Silverman M (1983) Bacterial Bioluminescence Isolation and Genetic-Analysis of Functions from Vibrio Fischeri. Cell 32(3):773781.
Engebrecht J & Silverman M (1984) Identification of Genes and Gene-Products
Necessary for Bacterial Bioluminescence. P Natl Acad Sci-Biol 81(13):41544158.
Fuqua WC, Winans SC, & Greenberg EP (1994) Quorum Sensing in Bacteria the Luxr-Luxi Family of Cell Density-Responsive Transcriptional Regulators. J
Bacteriol 176(2):269-275.
Waters CM & Bassler BL (2005) Quorum sensing: Cell-to-cell communication in
bacteria. Annual Review of Cell and Developmental Biology 21:319-346.
Miller MB & Bassler BL (2001) Quorum sensing in bacteria. Annu Rev Microbiol
55:165-199.
Shapiro JA (1998) Thinking about bacterial populations as multicellular
organisms. Annu Rev Microbiol 52:81-104.
Parsek MR & Greenberg EP (2005) Sociomicrobiology: the connections between
quorum sensing and biofilms. Trends Microbiol 13(1):27-33.
Kuipers OP, de Ruyter PGGA, Kleerebezem M, & de Vos WM (1998) Quorum
sensing-controlled gene expression in lactic acid bacteria. J Biotechnol 64(1):1521.
Zhu J, et al. (2002) Quorum-sensing regulators control virulence gene expression
in Vibrio cholerae. P Natl Acad Sci USA 99(5):3129-3134.
Novick RP (2003) Autoinduction and signal transduction in the regulation of
staphylococcal virulence. Mol Microbiol 48(6):1429-1449.
Dubnau D & Losick R (2006) Bistability in bacteria. Mol Microbiol 61(3):564572.
Hammerschmidt K, Rose CJ, Kerr B, & Rainey PB (2014) Life cycles, fitness
decoupling and the evolution of multicellularity. Nature 515(7525):75-+.
Dufour P, et al. (2002) High genetic variability of the agr locus in Staphylococcus
species. J Bacteriol 184(4):1180-1186.
Schuster M, Sexton DJ, Diggle SP, & Greenberg EP (2013) Acyl-Homoserine
Lactone Quorum Sensing: From Evolution to Application. Annual Review of
Microbiology, Vol 67 67:43-63.
Lyon GJ & Novick RP (2004) Peptide signaling in Staphylococcus aureus and
other Gram-positive bacteria. Peptides 25(9):1389-1403.
Okada M, et al. (2005) Structure of the Bacillus subtilis quorum-sensing peptide
pheromone ComX. Nat Chem Biol 1(1):23-24.
Pottathil M & Lazazzera BA (2003) The extracellular Phr peptide-rap
phosphatase signaling circuit of Bacillus subtilis. Front Biosci 8:D32-D45.

194	
  

20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.

	
  

Ji GY, Beavis R, & Novick RP (1997) Bacterial interference caused by
autoinducing peptide variants. Science 276(5321):2027-2030.
Chen X, et al. (2002) Structural identification of a bacterial quorum-sensing
signal containing boron. Nature 415(6871):545-549.
Pesci EC, et al. (1999) Quinolone signaling in the cell-to-cell communication
system of Pseudomonas aeruginosa. P Natl Acad Sci USA 96(20):11229-11234.
Takano E (2006) gamma-Butyrolactones: Streptomyces signalling molecules
regulating antibiotic production and differentiation. Curr Opin Microbiol
9(3):287-294.
Manefield M & Turner SL (2002) Quorum sensing in context: out of molecular
biology and into microbial ecology. Microbiol-Sgm 148:3762-3764.
Mayville P, et al. (1999) Structure-activity analysis of synthetic autoinducing
thiolactone peptides from Staphylococcus aureus responsible for virulence. P Natl
Acad Sci USA 96(4):1218-1223.
Ng WL & Bassler BL (2009) Bacterial Quorum-Sensing Network Architectures.
Annu Rev Genet 43:197-222.
Lyon GJ & Muir TW (2003) Chemical signaling among bacteria and its
inhibition. Chem Biol 10(11):1007-1021.
Hibbing ME, Fuqua C, Parsek MR, & Peterson SB (2010) Bacterial competition:
surviving and thriving in the microbial jungle. Nat Rev Microbiol 8(1):15-25.
Ziebandt AK, et al. (2004) The influence of agr and sigma(B) in growth phase
dependent regulation of virulence factors in Staphylococcus aureus. Proteomics
4(10):3034-3047.
Wright JS, Jin R, & Novick RP (2005) Transient interference with staphylococcal
quorum sensing blocks abscess formation. P Natl Acad Sci USA 102(5):16911696.
Coleman G, Jakeman CM, & Martin N (1978) Patterns of Total Extracellular
Protein Secretion by a Number of Clinically Isolated Strains of StaphylococcusAureus. J Gen Microbiol 107(Jul):189-192.
Mallonee DH, Glatz BA, & Pattee PA (1982) Chromosomal Mapping of a Gene
Affecting Enterotoxin-a Production in Staphylococcus-Aureus. Appl Environ
Microb 43(2):397-402.
Recsei P, et al. (1986) Regulation of Exoprotein Gene-Expression in
Staphylococcus-Aureus by Agr. Mol Gen Genet 202(1):58-61.
Peng HL, Novick RP, Kreiswirth B, Kornblum J, & Schlievert P (1988) Cloning,
Characterization, and Sequencing of an Accessory Gene Regulator (Agr) in
Staphylococcus-Aureus. J Bacteriol 170(9):4365-4372.
Morfeldt E, Janzon L, Arvidson S, & Lofdahl S (1988) Cloning of a
Chromosomal Locus (Exp) Which Regulates the Expression of Several
Exoprotein Genes in Staphylococcus-Aureus. Mol Gen Genet 211(3):435-440.
Janzon L & Arvidson S (1990) The Role of the Delta-Lysin Gene (Hld) in the
Regulation of Virulence Genes by the Accessory Gene Regulator (Agr) in
Staphylococcus-Aureus. Embo J 9(5):1391-1399.
Novick RP, et al. (1993) Synthesis of Staphylococcal Virulence Factors Is
Controlled by a Regulatory Rna Molecule. Embo J 12(10):3967-3975.

195	
  

38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.

	
  

Novick RP, et al. (1995) The Agr P2 Operon - an Autocatalytic Sensory
Transduction System in Staphylococcus-Aureus. Mol Gen Genet 248(4):446-458.
Ji GY, Beavis RC, & Novick RP (1995) Cell density control of staphylococcal
virulence mediated by an octapeptide pheromone. P Natl Acad Sci USA
92(26):12055-12059.
Huntzinger E, et al. (2005) Staphylococcus aureus RNAIII and the
endoribonuclease III coordinately regulate spa gene expression. Embo J
24(4):824-835.
Geisinger E, Adhikari RP, Jin RZ, Ross HF, & Novick RP (2006) Inhibition of rot
translation by RNAIII, a key feature of agr function. Mol Microbiol 61(4):10381048.
Boisset S, et al. (2007) Staphylococcus aureus RNAIII coordinately represses the
synthesis of virulence factors and the transcription regulator Rot by an antisense
mechanism. Gene Dev 21(11):1353-1366.
Said-Salim B, et al. (2003) Global regulation of Staphylococcus aureus genes by
rot. J Bacteriol 185(2):610-619.
Cheung GYC, Wang R, Khan BA, Sturdevant DE, & Otto M (2011) Role of the
Accessory Gene Regulator agr in Community-Associated Methicillin-Resistant
Staphylococcus aureus Pathogenesis. Infect Immun 79(5):1927-1935.
Queck SY, et al. (2008) RNAIII-Independent Target Gene Control by the agr
Quorum-Sensing System: Insight into the Evolution of Virulence Regulation in
Staphylococcus aureus. Mol Cell 32(1):150-158.
Chatterjee SS, et al. (2013) Essential Staphylococcus aureus toxin export system.
Nat Med 19(3):364-367.
Jarraud S, et al. (2000) Exfoliatin-producing strains define a fourth agr specificity
group in Staphylococcus aureus. J Bacteriol 182(22):6517-6522.
Lyon GJ, Wright JS, Muir TW, & Novick RP (2002) Key determinants of
receptor activation in the agr autoinducing peptides of Staphylococcus aureus.
Biochemistry-Us 41(31):10095-10104.
Traber KE, et al. (2008) agr function in clinical Staphylococcus aureus isolates.
Microbiol-Sgm 154:2265-2274.
Geisinger E, Chen J, & Novick RP (2012) Allele-Dependent Differences in
Quorum-Sensing Dynamics Result in Variant Expression of Virulence Genes in
Staphylococcus aureus. J Bacteriol 194(11):2854-2864.
Shine J & Dalgarno L (1975) Determinant of Cistron Specificity in Bacterial
Ribosomes. Nature 254(5495):34-38.
Kozak M (2005) Regulation of translation via mRNA structure in prokaryotes and
eukaryotes. Gene 361:13-37.
Libby EA, Roggiani M, & Goulian M (2012) Membrane protein expression
triggers chromosomal locus repositioning in bacteria. P Natl Acad Sci USA
109(19):7445-7450.
Qiu RD, Pei WH, Zhang LS, Lin JQ, & Ji GY (2005) Identification of the
putative staphylococcal AgrB catalytic residues involving the proteolytic cleavage
of AgrD to generate autoinducing peptide. J Biol Chem 280(17):16695-16704.

196	
  

55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.

	
  

Thoendel M & Horswill AR (2009) Identification of Staphylococcus aureus AgrD
Residues Required for Autoinducing Peptide Biosynthesis. J Biol Chem
284(33):21828-21838.
Zhang LS, Lin JQ, & Ji GY (2004) Membrane anchoring of the AgrD N-terminal
amphipathic region is required for its processing to produce a quorum-sensing
pheromone in Staphylococcus aureus. J Biol Chem 279(19):19448-19456.
Kavanaugh JS, Thoendel M, & Horswill AR (2007) A role for type I signal
peptidase in Staphylococcus aureus quorum sensing. Mol Microbiol 65(3):780798.
Thoendel M & Horswill AR (2013) Random mutagenesis and topology analysis
of the autoinducing peptide biosynthesis proteins in Staphylococcus aureus. Mol
Microbiol 87(2):318-337.
Zhang LS, Gray L, Novick RP, & Ji GY (2002) Transmembrane topology of
AgrB, the protein involved in the post-translational modification of AgrD in
Staphylococcus aureus. J Biol Chem 277(38):34736-34742.
White SH & von Heijne G (2008) How translocons select transmembrane helices.
Annu Rev Biophys 37:23-42.
von Heijne G (2006) Membrane-protein topology. Nat Rev Mol Cell Bio
7(12):909-918.
Zhang LS & Ji GY (2004) Identification of a staphylococcal AgrB segment(s)
responsible for group-specific processing of AgrD by gene swapping. J Bacteriol
186(20):6706-6713.
Gonzalez DJ, et al. (2014) N-Terminal ArgD Peptides from the Classical
Staphylococcus aureus Agr System Have Cytotoxic and Proinflammatory
Activities. Chem Biol 21(11):1457-1462.
Schwartz K, et al. (2014) The AgrD N-Terminal Leader Peptide of
Staphylococcus aureus Has Cytolytic and Amyloidogenic Properties. Infect
Immun 82(9):3837-3844.
Lina G, et al. (1998) Transmembrane topology and histidine protein kinase
activity of AgrC, the agr signal receptor in Staphylococcus aureus. Mol Microbiol
28(3):655-662.
Wang LN, et al. (2014) New insight into transmembrane topology of
Staphylococcus aureus histidine kinase AgrC. Bba-Biomembranes 1838(3):988993.
Thoendel M, Kavanaugh JS, Flack CE, & Horswill AR (2011) Peptide Signaling
in the Staphylococci. Chem Rev 111(1):117-151.
Beining PR, Huff E, Prescott B, & Theodore TS (1975) Characterization of Lipids
of Mesosomal Vesicles and Plasma-Membranes from Staphylococcus-Aureus. J
Bacteriol 121(1):137-143.
Gao R & Stock AM (2009) Biological Insights from Structures of TwoComponent Proteins. Annu Rev Microbiol 63:133-154.
Dutta R & Inouye M (2000) GHKL, an emergent ATPase/kinase superfamily.
Trends in Biochemical Sciences 25(1):24-28.
Cisar EA, Geisinger E, Muir TW, & Novick RP (2009) Symmetric signalling
within asymmetric dimers of the Staphylococcus aureus receptor histidine kinase
AgrC. Mol Microbiol 74(1):44-57.

197	
  

72.
73.
74.
75.
76.
77.

78.
79.
80.
81.
82.

83.

84.
85.

	
  

Srivastava SK, Rajasree K, Fasim A, Arakere G, & Gopal B (2014) Influence of
the AgrC-AgrA Complex on the Response Time of Staphylococcus aureus
Quorum Sensing. J Bacteriol 196(15):2876-2888.
Lyon GJ, Wright JS, Christopoulos A, Novick RP, & Muir TW (2002) Reversible
and specific extracellular antagonism of receptor-histidine kinase signaling. J Biol
Chem 277(8):6247-6253.
Wright JS, Lyon GJ, George EA, Muir TW, & Novick RP (2004) Hydrophobic
interactions drive ligand-receptor recognition for activation and inhibition of
staphylococcal quorum sensing. P Natl Acad Sci USA 101(46):16168-16173.
Geisinger E, George EA, Muir TW, & Novick RP (2008) Identification of ligand
specificity determinants in AgrC, the Staphylococcus aureus quorum-sensing
receptor. J Biol Chem 283(14):8930-8938.
Malone CL, Boles BR, & Horswill AR (2007) Biosynthesis of Staphylococcus
aureus the Synechocystis autoinducing peptides by using DnaB mini-intein. Appl
Environ Microb 73(19):6036-6044.
Lyon GJ, Mayville P, Muir TW, & Novick RP (2000) Rational design of a global
inhibitor of the virulence response in Staphylococcus aureus, based in part on
localization of the site of inhibition to the receptor-histidine kinase, AgrC. P Natl
Acad Sci USA 97(24):13330-13335.
McDowell P, et al. (2001) Structure, activity and evolution of the group I
thiolactone peptide quorum-sensing system of Staphylococcus aureus. Mol
Microbiol 41(2):503-512.
Johnson JG, Wang BY, Debelouchina GT, Novick RP, & Muir TW (2015)
Increasing AIP Macrocycle Size Reveals Key Features of agr Activation in
Staphylococcus aureus. Chembiochem 16(7):1093-1100.
George EA, Novick RP, & Muir TW (2008) Cyclic peptide inhibitors of
staphylococcal virulence prepared by Fmoc-based thiolactone peptide synthesis. J
Am Chem Soc 130(14):4914-4924.
Fowler SA, Stacy DM, & Blackwell HE (2008) Design and synthesis of
macrocyclic peptomers as mimics of a quorum sensing signal from
Staphylococcus aureus. Org Lett 10(12):2329-2332.
Tal-Gan Y, Stacy DM, & Blackwell HE (2014) N-Methyl and peptoid scans of an
autoinducing peptide reveal new structural features required for inhibition and
activation of AgrC quorum sensing receptors in Staphylococcus aureus. Chem
Commun 50(23):3000-3003.
Tal-Gan Y, Stacy DM, Foegen MK, Koenig DW, & Blackwell HE (2013) Highly
Potent Inhibitors of Quorum Sensing in Staphylococcus aureus Revealed Through
a Systematic Synthetic Study of the Group-III Autoinducing Peptide. J Am Chem
Soc 135(21):7869-7882.
Stock AM, Robinson VL, & Goudreau PN (2000) Two-component signal
transduction. Annu Rev Biochem 69:183-215.
Nikolskaya AN & Galperin MY (2002) A novel type of conserved DNA-binding
domain in the transcriptional regulators of the AlgR/AgrA/LytR family. Nucleic
Acids Res 30(11):2453-2459.

198	
  

86.
87.
88.
89.
90.

91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.

	
  

Sidote DJ, Barbieri CM, Wu T, & Stock AM (2008) Structure of the
Staphylococcus aureus AgrA LytTR domain bound to DNA reveals a beta fold
with an unusual mode of binding. Structure 16(5):727-735.
Nicod SS, et al. (2014) Systematic mutational analysis of the LytTR DNA
binding domain of Staphylococcus aureus virulence gene transcription factor
AgrA. Nucleic Acids Res 42(20):12523-12536.
Reynolds J & Wigneshweraraj S (2011) Molecular Insights into the Control of
Transcription Initiation at the Staphylococcus aureus agr operon. J Mol Biol
412(5):862-881.
Koenig RL, Ray JL, Maleki SJ, Smeltzer MS, & Hurlburt BK (2004)
Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region. J
Bacteriol 186(22):7549-7555.
Warne SE & Dehaseth PL (1993) Promoter Recognition by Escherichia-Coli RnaPolymerase - Effects of Single-Base Pair Deletions and Insertions in the Spacer
DNA Separating the -10 and -35 Regions Are Dependent on Spacer DNASequence. Biochemistry-Us 32(24):6134-6140.
Morfeldt E, Taylor D, Vongabain A, & Arvidson S (1995) Activation of AlphaToxin Translation in Staphylococcus-Aureus by the Trans-Encoded Antisense
Rna, Rnaiii. Embo J 14(18):4569-4577.
Sun F, et al. (2012) Quorum-sensing agr mediates bacterial oxidation response via
an intramolecular disulfide redox switch in the response regulator AgrA. P Natl
Acad Sci USA 109(23):9095-9100.
Reyes D, et al. (2011) Coordinated Regulation by AgrA, SarA, and SarR To
Control agr Expression in Staphylococcus aureus. J Bacteriol 193(21):6020-6031.
Cheung AL, Bayer AS, Zhang GY, Gresham H, & Xiong YQ (2004) Regulation
of virulence determinants in vitro and in vivo in Staphylococcus aureus. Fems
Immunol Med Mic 40(1):1-9.
Chien YT, Manna AC, & Cheung AL (1998) SarA level is a determinant of agr
activation in Staphylococcus aureus. Mol Microbiol 30(5):991-1001.
Manna A & Cheung AL (2001) Characterization of sarR, a modulator of sar
expression in Staphylococcus aureus. Infect Immun 69(2):885-896.
Bronner S, Monteil H, & Prevost G (2004) Regulation of virulence determinants
in Staphylococcus aureus: complexity and applications. Fems Microbiol Rev
28(2):183-200.
Majerczyk CD, et al. (2008) Staphylococcus aureus CodY negatively regulates
virulence gene expression. J Bacteriol 190(7):2257-2265.
Liu KQ, Bittner AN, & Wang JD (2015) Diversity in (p)ppGpp metabolism and
effectors. Curr Opin Microbiol 24:72-79.
Roux A, Todd DA, Velazquez JV, Cech NB, & Sonenshein AL (2014) CodYMediated Regulation of the Staphylococcus aureus Agr System Integrates
Nutritional and Population Density Signals. J Bacteriol 196(6):1184-1196.
Cegelski L, Marshall GR, Eldridge GR, & Hultgren SJ (2009) The biology and
future prospects of antivirulence therapies (vol 6, pg 17, 2008). Nat Rev Microbiol
7(11):836-836.
Kong KF, Vuong C, & Otto M (2006) Staphylococcus quorum sensing in biofilm
formation and infection. Int J Med Microbiol 296(2-3):133-139.

199	
  

103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.

117.

118.

	
  

Otto M (2004) Quorum-sensing control in Staphylococci - a target for
antimicrobial drug therapy? Fems Microbiol Lett 241(2):135-141.
Rothfork JM, et al. (2004) Inactivation of a bacterial virulence pheromone by
phagocyte-derived oxidants: New role for the NADPH oxidase in host defense. P
Natl Acad Sci USA 101(38):13867-13872.
Peterson MM, et al. (2008) Apolipoprotein B Is an Innate Barrier against Invasive
Staphylococcus aureus Infection. Cell Host Microbe 4(6):555-566.
Hall PR, et al. (2013) Nox2 Modification of LDL Is Essential for Optimal
Apolipoprotein B-mediated Control of agr Type III Staphylococcus aureus
Quorum-sensing. Plos Pathog 9(2).
Mansson M, et al. (2011) Inhibition of Virulence Gene Expression in
Staphylococcus aureus by Novel Depsipeptides from a Marine Photobacterium.
Mar Drugs 9(12):2537-2552.
Igarashi Y, et al. (2015) Avellanin C, an inhibitor of quorum-sensing signaling in
Staphylococcus aureus, from Hamigera ingelheimensis. The Journal of
antibiotics.
Desouky SE, et al. (2015) Cyclodepsipeptides produced by actinomycetes inhibit
cyclic-peptide-mediated quorum sensing in Gram-positive bacteria. Fems
Microbiol Lett 362(14).
Gordon CP, Williams P, & Chan WC (2013) Attenuating Staphylococcus aureus
Virulence Gene Regulation: A Medicinal Chemistry Perspective. J Med Chem
56(4):1389-1404.
Gilligan PH (1991) Microbiology of Airway Disease in Patients with CysticFibrosis. Clin Microbiol Rev 4(1):35-51.
Murray EJ, et al. (2014) Targeting Staphylococcus aureus Quorum Sensing with
Nonpeptidic Small Molecule Inhibitors. J Med Chem 57(6):2813-2819.
Leonard PG, Bezar IF, Sidote DJ, & Stock AM (2012) Identification of a
Hydrophobic Cleft in the LytTR Domain of AgrA as a Locus for Small Molecule
Interactions That Inhibit DNA Binding. Biochemistry-Us 51(50):10035-10043.
Sully EK, et al. (2014) Selective Chemical Inhibition of agr Quorum Sensing in
Staphylococcus aureus Promotes Host Defense with Minimal Impact on
Resistance. Plos Pathog 10(6).
Park J, et al. (2007) Infection control by antibody disruption of bacterial quorum
sensing signaling. Chem Biol 14(10):1119-1127.
Nakayama J, et al. (2006) Revised model for Enterococcus faecalis fsr quorumsensing system: the small open reading frame fsrD encodes the gelatinase
biosynthesis-activating pheromone propeptide corresponding to staphylococcal
agrd. J Bacteriol 188(23):8321-8326.
Garmyn D, Gal L, Lemaitre JP, Hartmann A, & Piveteau P (2009)
Communication and autoinduction in the species Listeria monocytogenes: A
central role for the agr system. Communicative & integrative biology 2(4):371374.
Cooksley CM, et al. (2010) Regulation of neurotoxin production and sporulation
by a Putative agrBD signaling system in proteolytic Clostridium botulinum. Appl
Environ Microbiol 76(13):4448-4460.

200	
  

119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
135.
136.

	
  

Vidal JE, et al. (2012) Evidence that the Agr-like quorum sensing system
regulates the toxin production, cytotoxicity and pathogenicity of Clostridium
perfringens type C isolate CN3685. Mol Microbiol 83(1):179-194.
Annis DA, Nickbarg E, Yang X, Ziebell MR, & Whitehurst CE (2007) Affinity
selection-mass spectrometry screening techniques for small molecule drug
discovery. Current opinion in chemical biology 11(5):518-526.
Casino P, Rubio V, & Marina A (2009) Structural Insight into Partner Specificity
and Phosphoryl Transfer in Two-Component Signal Transduction. Cell
139(2):325-336.
Mechaly AE, Sassoon N, Betton JM, & Alzari PM (2014) Segmental Helical
Motions and Dynamical Asymmetry Modulate Histidine Kinase
Autophosphorylation. Plos Biol 12(1).
Marina A, Waldburger CD, & Hendrickson WA (2005) Structure of the entire
cytoplasmic portion of a sensor histidine-kinase protein. Embo J 24(24):42474259.
Bilwes AM, Quezada CM, Croal LR, Crane BR, & Simon MI (2001) Nucleotide
binding by the histidine kinase CheA. Nature Structural Biology 8(4):353-360.
Grebe TW & Stock JB (1999) The histidine protein kinase superfamily. Advances
in Microbial Physiology, Vol 41 41:139-227.
Dago AE, et al. (2012) Structural basis of histidine kinase autophosphorylation
deduced by integrating genomics, molecular dynamics, and mutagenesis. P Natl
Acad Sci USA 109(26):E1733-E1742.
Zhang Z, et al. (1998) Protein sequence similarity searches using patterns as
seeds. Nucleic Acids Res 26(17):3986-3990.
Huang Y, Niu BF, Gao Y, Fu LM, & Li WZ (2010) CD-HIT Suite: a web server
for clustering and comparing biological sequences. Bioinformatics 26(5):680-682.
Papadopoulos JS & Agarwala R (2007) COBALT: constraint-based alignment
tool for multiple protein sequences. Bioinformatics 23(9):1073-1079.
Eddy SR (1998) Profile hidden Markov models. Bioinformatics 14(9):755-763.
Krogh A, Larsson B, von Heijne G, & Sonnhammer ELL (2001) Predicting
transmembrane protein topology with a hidden Markov model: Application to
complete genomes. J Mol Biol 305(3):567-580.
Cheung J & Hendrickson WA (2010) Sensor domains of two-component
regulatory systems. Curr Opin Microbiol 13(2):116-123.
Martin B, et al. (2010) Expression and maintenance of ComD-ComE, the twocomponent signal-transduction system that controls competence of Streptococcus
pneumoniae. Mol Microbiol 75(6):1513-1528.
Havarstein LS, Diep DB, & Nes IF (1995) A Family of Bacteriocin Abc
Transporters Carry out Proteolytic Processing of Their Substrates Concomitant
with Export. Mol Microbiol 16(2):229-240.
Lin DYW, Huang S, & Chen J (2015) Crystal structures of a polypeptide
processing and secretion transporter. Nature 523(7561):425-U492.
Wuster A & Babu MM (2008) Conservation and evolutionary dynamics of the agr
cell-to-cell communication system across firmicutes. J Bacteriol 190(2):743-746.

201	
  

137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.

	
  

Kee JM, Oslund RC, Perlman DH, & Muir TW (2013) A pan-specific antibody
for direct detection of protein histidine phosphorylation. Nat Chem Biol 9(7):416U428.
Denisov IG, Grinkova YV, Lazarides AA, & Sligar SG (2004) Directed selfassembly of monodisperse phospholipid bilayer nanodiscs with controlled size. J
Am Chem Soc 126(11):3477-3487.
Ritchie TK, et al. (2009) Reconstitution of Membrane Proteins in Phospholipid
Bilayer Nanodiscs. Methods in Enzymology; Liposomes, Pt F 464:211-231.
Veesler D, et al. (2009) Production and biophysical characterization of the CorA
transporter from Methanosarcina mazei. Analytical Biochemistry 388(1):115-121.
Kee JM & Muir TW (2012) Chasing Phosphohistidine, an Elusive Sibling in the
Phosphoamino Acid Family. Acs Chem Biol 7(1):44-51.
Grimshaw CE, et al. (1998) Synergistic kinetic interactions between components
of the phosphorelay controlling sporulation in Bacillus subtilis. Biochemistry-Us
37(5):1365-1375.
Geisinger E, Muir TW, & Novick RP (2009) agr receptor mutants reveal distinct
modes of inhibition by staphylococcal autoinducing peptides. P Natl Acad Sci
USA 106(4):1216-1221.
Scaramozzino F, White A, Perego M, & Hoch JA (2009) A Unique GTPDependent Sporulation Sensor Histidine Kinase in Bacillus anthracis. J Bacteriol
191(3):687-692.
Kenney LJ (1997) Kinase activity of EnvZ, an osmoregulatory signal transducing
protein of Escherichia coli. Archives of Biochemistry and Biophysics 346(2):303311.
Tawa P & Stewart RC (1994) Kinetics of Chea Autophosphorylation and
Dephosphorylation Reactions. Biochemistry-Us 33(25):7917-7924.
Thomas SA, Brewster JA, & Bourret RB (2008) Two variable active site residues
modulate response regulator phosphoryl group stability. Mol Microbiol
69(2):453-465.
Tran QH & Unden G (1998) Changes in the proton potential and the cellular
energetics of Escherichia coli during growth by aerobic and anaerobic respiration
or by fermentation. European Journal of Biochemistry 251(1-2):538-543.
Gunstone FD, Harwood JL, & Padley FB (1994) The Lipid handbook (Chapman
and Hall, London ; New York) 2nd Ed pp xiii, 722, 551 p.
Casino P, Rubio V, & Marina A (2010) The mechanism of signal transduction by
two-component systems. Current Opinion in Structural Biology 20(6):763-771.
Albanesi D, et al. (2009) Structural plasticity and catalysis regulation of a
thermosensor histidine kinase. P Natl Acad Sci USA 106(38):16185-16190.
Diensthuber RP, Bommer M, Gleichmann T, & Moglich A (2013) Full-Length
Structure of a Sensor Histidine Kinase Pinpoints Coaxial Coiled Coils as Signal
Transducers and Modulators. Structure 21(7):1127-1136.
Wang C, et al. (2013) Mechanistic Insights Revealed by the Crystal Structure of a
Histidine Kinase with Signal Transducer and Sensor Domains. Plos Biol 11(2).
Mccaldon P & Argos P (1988) Oligopeptide Biases in Protein Sequences and
Their Use in Predicting Protein Coding Regions in Nucleotide-Sequences.
Proteins-Structure Function and Genetics 4(2):99-122.

202	
  

155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.
170.

171.
172.

	
  

Scholtz JM & Baldwin RL (1992) The Mechanism of Alpha-Helix Formation by
Peptides. Annu Rev Bioph Biom 21:95-118.
Thompson KS, Vinson CR, & Freire E (1993) Thermodynamic Characterization
of the Structural Stability of the Coiled-Coil Region of the Bzip Transcription
Factor Gcn4. Biochemistry-Us 32(21):5491-5496.
Moglich A, Ayers RA, & Moffat K (2009) Design and Signaling Mechanism of
Light-Regulated Histidine Kinases. J Mol Biol 385(5):1433-1444.
Capra EJ & Laub MT (2012) Evolution of Two-Component Signal Transduction
Systems. Annual Review of Microbiology, Vol 66 66:325-347.
Wang BY, Zhao AS, Novick RP, & Muir TW (2014) Activation and Inhibition of
the Receptor Histidine Kinase AgrC Occurs through Opposite Helical
Transduction Motions. Mol Cell 53(6):929-940.
Casino P, Miguel-Romero L, & Marina A (2014) Visualizing
autophosphorylation in histidine kinases. Nat Commun 5.
Molnar KS, et al. (2014) Cys-Scanning Disulfide Cross linking and Bayesian
Modeling Probe the Transmembrane Signaling Mechanism of the Histidine
Kinase, PhoQ. Structure 22(9):1239-1251.
Matamouros S, Hager KR, & Miller SI (2015) HAMP Domain Rotation and
Tilting Movements Associated with Signal Transduction in the PhoQ Sensor
Kinase. Mbio 6(3).
Alm E, Huang K, & Arkin A (2006) The evolution of two-component systems in
bacteria reveals different strategies for niche adaptation. Plos Comput Biol
2(11):1329-1342.
Stiffler MA, Hekstra DR, & Ranganathan R (2015) Evolvability as a Function of
Purifying Selection in TEM-1 beta-Lactamase. Cell 160(5).
Moore JO & Hendrickson WA (2012) An Asymmetry-to-Symmetry Switch in
Signal Transmission by the Histidine Kinase Receptor for TMAO. Structure
20(4):729-741.
Cheung J & Hendrickson WA (2009) Structural Analysis of Ligand Stimulation
of the Histidine Kinase NarX. Structure 17(2):190-201.
Martin RB (1998) Free energies and equilibria of peptide bond hydrolysis and
formation. Biopolymers 45(5):351-353.
Lehninger AL, Nelson DL, & Cox MM (2005) Lehninger principles of
biochemistry (W.H. Freeman, New York) 4th Ed.
Grimsley GR, Scholtz JM, & Pace CN (2009) A summary of the measured pK
values of the ionizable groups in folded proteins. Protein Sci 18(1):247-251.
Guthrie JP (1978) Hydrolysis of Esters of Oxy Acids - Pka Values for Strong
Acids - Bronsted Relationship for Attack of Water at Methyl - Free-Energies of
Hydrolysis of Esters of Oxy Acids - and a Linear Relationship between FreeEnergy of Hydrolysis and Pka Holding over a Range of 20 Pk Units. Can J Chem
56(17):2342-2354.
Illuminati G & Mandolini L (1981) Ring-Closure Reactions of Bifunctional Chain
Molecules. Accounts Chem Res 14(4):95-102.
MacKenzie KR (2006) Folding and stability of alpha-helical integral membrane
proteins. Chem Rev 106(5):1931-1977.

203	
  

173.
174.
175.
176.
177.
178.

179.
180.
181.
182.
183.
184.
185.
186.
187.
188.
189.

	
  

Boldog T, Grimme S, Li MS, Sligar SG, & Hazelbauer GL (2006) Nanodiscs
separate chemoreceptor oligomeric states and reveal their signaling properties. P
Natl Acad Sci USA 103(31):11509-11514.
Kirchdoerfer RN, et al. (2011) Structural Basis for Ligand Recognition and
Discrimination of a Quorum-quenching Antibody. J Biol Chem 286(19):1735117358.
Arnison PG, et al. (2013) Ribosomally synthesized and post-translationally
modified peptide natural products: overview and recommendations for a universal
nomenclature. Nat Prod Rep 30(1):108-160.
Scheffner M, Nuber U, & Huibregtse JM (1995) Protein Ubiquitination Involving
an E1-E2-E3 Enzyme Ubiquitin Thioester Cascade. Nature 373(6509):81-83.
Buczek O, Krowarsch D, & Otlewski J (2002) Thermodynamics of single peptide
bond cleavage in bovine pancreatic trypsin inhibitor (BPTI). Protein Sci
11(4):924-932.
Junio HA, et al. (2013) Quantitative analysis of autoinducing peptide I (AIP-I)
from Staphylococcus aureus cultures using ultrahigh performance liquid
chromatography-high resolving power mass spectrometry. J Chromatogr B 930:712.
Maass S, et al. (2011) Efficient, Global-Scale Quantification of Absolute Protein
Amounts by Integration of Targeted Mass Spectrometry and Two-Dimensional
Gel-Based Proteomics. Anal Chem 83(7):2677-2684.
Bottcher T & Sieber SA (2008) beta-Lactones as Specific Inhibitors of CIpP
Attenuate the Production of Extracellular Virulence Factors of Staphylococcus
aureus. J Am Chem Soc 130(44):14400-14401.
Frees D, Qazi SNA, Hill PJ, & Ingmer H (2003) Alternative roles of ClpX and
ClpP in Staphylococcus aureus stress tolerance and virulence. Mol Microbiol
48(6):1565-1578.
Brändén C-I & Tooze J (1999) Introduction to protein structure (Garland Pub.,
New York) 2nd Ed pp xiv, 410 p.
Joo C, Balci H, Ishitsuka Y, Buranachai C, & Ha T (2008) Advances in singlemolecule fluorescence methods for molecular biology. Annu Rev Biochem 77:5176.
Clemente JC, Ursell LK, Parfrey LW, & Knight R (2012) The Impact of the Gut
Microbiota on Human Health: An Integrative View. Cell 148(6):1258-1270.
Fischbach MA & Sonnenburg JL (2011) Eating For Two: How Metabolism
Establishes lnterspecies Interactions in the Gut. Cell Host Microbe 10(4):336-347.
Grote A, et al. (2005) JCat: a novel tool to adapt codon usage of a target gene to
its potential expression host. Nucleic Acids Res 33:W526-W531.
Charpentier E, et al. (2004) Novel cassette-based shuttle vector system for grampositive bacteria. Appl Environ Microb 70(10):6076-6085.
Vergis JM & Wiener MC (2011) The variable detergent sensitivity of proteases
that are utilized for recombinant protein affinity tag removal. Protein Expres Purif
78(2):139-142.
Swillens S (1995) Interpretation of Binding Curves Obtained with High Receptor
Concentrations - Practical Aid for Computer-Analysis. Mol Pharmacol
47(6):1197-1203.

204	
  

190.
191.
192.
193.

Scholtz JM, Qian H, York EJ, Stewart JM, & Baldwin RL (1991) Parameters of
Helix-Coil Transition Theory for Alanine-Based Peptides of Varying Chain
Lengths in Water. Biopolymers 31(13):1463-1470.
Ferrige AG, Seddon MJ, & Jarvis S (1991) Maximum-Entropy Deconvolution in
Electrospray Mass-Spectrometry. Rapid Commun Mass Sp 5(8):374-377.
Ram G, et al. (2012) Staphylococcal pathogenicity island interference with helper
phage reproduction is a paradigm of molecular parasitism. P Natl Acad Sci USA
109(40):16300-16305.
Davis JJ, Xia F, Overbeek RA, & Olsen GJ (2013) Genomes of the class
Erysipelotrichia clarify the firmicute origin of the class Mollicutes. Int J Syst Evol
Microbiol 63(Pt 7):2727-2741.

	
  

	
  

205	
  

